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2ABSTRACT
Tuberculosis (TB) has re-emerged as a potential health threat in both developed and
developing countries. Notification rates in the United Arab Emirates (UAE) increased from
23 to 85 cases per 100,000 population between 1997 and 2003, an increase that has been
attributed to the presence of two Mycobacterium tuberculosis strains (Annual Statistical
Reports, 1998; Dissanayake et al., 2001; Annual Statistical Reports, 2003).
The principal aim of this study was to assess TB epidemiology in Al Ain, UAE, in
both UAE nationals and immigrants, using two genotypic methods: spoligotyping and
MIRU typing. A panel of 194 clinical isolates of M. tuberculosis complex was studied.
Eight global clades (CAS, Haarlem, LAM, EAI, Beijing, Africanum, T, X) and five
families were identified present in Al Ain. Strains were divided into principal genetic
groups by katG463/gyrA95 typing; group 1 was dominant. Two isolates were identified as
Mycobacterium kansasii by 16S rRNA sequence analysis. A high clustering rate of 46%
was detected by spoligotyping, compared to only 5.6% using MIRU typing, indicating a
low transmission rate. Identical MIRU profiles among two patients confirmed transmission
from an immigrant to a national.
The study revealed that tuberculin skin test detected more positive latent TB cases
(51%) among immigrants than nationals (21%); while results for the two groups for active
cases from chest radiography were comparable.
Although drug dispensing is not properly controlled, since patients can buy drugs
without prescription, this study showed that it has no direct effect on development of TB
drug resistance. Sequencing of rpoB showed the prevalence of rifampin resistance to be
low; only one isolate held a resistance mutation and another with a mutation unlinked to
resistance.
These findings identified Mycobacterium clonal structure and suggested the
exogenous nature of TB in Al Ain. Recommendations to improve the screening policy to
detect and treat both active and latent cases of TB among immigrants at arrival check points
have been made.
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CHAPTER 1 INTRODUCTION
1.1 GENERAL INTRODUCTION
Tuberculosis (TB) is a contagious disease with a high mortality rate mainly caused
in humans by Mycobacterium tuberculosis (Koch, 1882), a member of the M. tuberculosis
complex (MTBC). The M. tuberculosis complex also includes Mycobacterium bovis,
Mycobacterium africanum and Mycobacterium microti (Wayne and Kubica, 1986) which
typically cause animal infections but can also cause zoonosis. TB is primarily transmitted
from individual to individual via the aerosol route, but oral infection of M. bovis by the
ingestion of contaminated milk can also occur. The disease can be divided into pulmonary
TB, in which infection is confined to the lungs, and extra-pulmonary TB, where infection is
found in other parts of the body, such as lymph nodes, skin, gastrointestinal tract, bones,
and central nervous system (CNS). Pulmonary TB is the most common form of the
disease, which accounts for almost 85% of all TB cases; it is frequently seen in children
and to a less extent in adult patients (McAdams et al., 1995).
The majority of the 2.23 billion individuals infected with M. tuberculosis harbour a
latent infection, where the bacteria are contained within the granuloma, and persist for
years or decades. Approximately 10% of those with latent infections will progress to
clinical (active) disease, although the trigger behind this is undetermined; and this
percentage increases substantially with immunodeficiency (Tufariello et al., 2003). Because
the disease often has along incubation period it is typically difficult to properly spot the
index case or trace contacts in order to limit further spread of infection using conventional
epidemiology alone (Stylo, 1980; Prodinger, 2007). In addition, latent infections which
become active may result in increased transmission, and therefore require efficient tests to
detect latency (Selwyn et al., 1989). The epidemiology of the disease has further been
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compounded and modified with the occurrence of TB co-infected with human
immunodeficiency virus (HIV), and development of multiple drug resistance (Coovadia et
al., 1998; Allix-Béguee et al., 2008). These reasons necessitated the emergence of
genotyping where DNA fingerprints of M. tuberculosis complex (MTBC) isolates
recovered from different patients are analysed to differentiate between exogenous and
endogenous infections, identify treatment failures, and detect laboratory cross-
contamination (Allix-Béguee et al., 2008). In addition, these DNA fingerprints can be
compared to determine transmission links and control strategies with the aid of classical
epidemiology (Prodinger, 2007).
1.2 DESCRIPTION OF M. TUBERCULOSIS
M. tuberculosis is assigned to the genus Mycobacterium, family Mycobacteriaceae,
order Actinomycetales, class Actinomycetes (Chester, 1897). The majority of
mycobacteria exist as saprophytes but a small group are pathogenic. The genus comprises
of 71 identified species which are split on the basis of growth rate into two major groups:
the fast growers and the slow grower species (Godreuil et al., 2007). The fast growing
bacteria produce visible colonies within seven days under appropriate conditions. They
include several species such as Mycobacterium fortuitum and Mycobacterium abscessus
that have limited pathogenic effects and produce atypical clinical signs in humans and
animals. In contrast, the slow growers, comprising MTBC, Mycobacterium avium,
Mycobacterium leprae and Mycobacterium kansasii, elicit more pathogenicity in humans
and animals, and cause chronic diseases (Godreuil et al., 2007).
M. tuberculosis has a rod-shaped appearance with a width ranging from 0.2 µm to
0.6 µm and a length ranging from 1 µm to 10 µm (Godreuil et al., 2007). It is non-motile,
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non-capsulated Gram-positive aerobic or facultative anaerobic bacterium. The genus
shares genetic similarity and phenotypic characteristics with other genera including;
Nocardia, Corynebacterium and Actinomycetes (van Soolingen et al., 2001). Mycobacteria
show marked tropism to lung tissues probably due to the presence of abundant oxygen
(Chester, 1897; van Soolingen et al., 2001). They are also facultative intracellular
pathogens infecting macrophages, where they reside and subsequently disseminate to
different parts of the body (van Soolingen et al., 2001). M. tuberculosis has the ability to
synthesise most of nutrients essential for its survival including amino-acids, vitamins and
enzyme co-factors (Godreuil et al., 2007). The cell wall of the organism is a unique
structure mainly composed of mycolic acid and peptidoglycan, which give the genus its
acid fast characteristic, allowing mycobacteria to be visualised microscopically using Ziehl-
Nielsen stained sputum smears in which the organisms will be seen as red rods embedded
in a blue background of the counter stain (Godreuil et al., 2007).
1.3 GLOBAL TB INCIDENCE/PREVALENCE
'Incidence' is the number of individuals that become ill with a specific disease
during a specific time within a susceptible population (Prescott et al., 1996). Two factors
determine the incidence of TB in a community: a predisposed environment that increases
the chances of close contacts to develop the primary infection, and the reactivation of a
latent M. tuberculosis infection (Prescott et al., 1996). The World Health Organisation
(WHO) estimated 9.27 million fresh cases (139 cases per 100,000 population) of which
1.37 million (5%) were HIV positive cases worldwide in 2007 (WHO report, 2009). In the
same year, the deaths from TB were 1.32 million plus 456,000 deaths from TB among
people co-infected with HIV (WHO report, 2009). Different regions have different TB
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incidence estimates. High estimates of TB incidence accounting for up to 34% were
reported in Southeast Asia, 31% in Africa, 22% in Western Pacific, 6% in Eastern
Mediterranean, 5% in Europe and 4% in Americas have been reported (WHO reports,
2007; 2009).
‘Prevalence’ is the total number of infected individuals within a population at any
one time and depends on both the incidence rate and the duration of illness (Prescott et al.,
1996). The global prevalent cases of TB were estimated as 13.7 million (206 cases per
100,000 population) in 2007 of which an estimated 687,000 cases were HIV positive
(WHO report, 2009). The prevalence TB rates have remained in increase from 1990s to
2007 in African and European Regions, but the rates were in decline in the Regions of the
Americans, Southeast Asia, Eastern Mediterranean and Western Pacific (WHO report,
2009).
The global TB epidemic has been aggravated by the emergence of disease-
outbreaks caused by multi-drug resistant strains of M. tuberculosis (MDR-TB) and
extensively drug-resistant TB (XDR-TB), and emergence of HIV epidemics (Raviglione,
1995; Cohn et al., 1997; Rattan et al., 1998; Campos et al., 2003; Blumberg et al., 2005;
Migliori et al., 2007). Despite many efforts to curtail the disease, it remains a global
problem with an enormous impact on public health and has grave implications for the
global economy. Factors considered to be contributing to the resurgence of TB epidemics
in Western countries have included: migration of people from developing into developed
countries, increased air travel, globalisation of world economies, and the negligence of
tuberculosis control programmes by many countries (Raviglione et al., 1995; Raviglione,
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2003). Such factors have further limited the effectiveness of TB control programmes by
complicating treatment and prevention protocols.
1.4 TB TRANSMISSION/PATHOGENESIS/HOST IMMUNE RESPONSE
Transmission of TB typically occurs as a result of coughing or sneezing from
infected patients releasing aerosols containing M. tuberculosis to a susceptible individual in
close contact resulting in a primary disease or after an elapse period of latent infection with
reactivation of the disease (Dannenberg, 1989; Flynn and Chan, 2001; Godreuil et al.,
2007; Patel et al., 2007). Inhalation of the infectious aerosol leads to entrapment of the
bacilli in the distal lung alveoli. Thereafter, the organisms are engulfed by local
macrophages, in which they replicate and spread via the lymphohaematogenous route to
colonize secondary sites involving specific stages (Godreuil et al., 2007). The infection is
further disseminated by dendritic cells which present the antigens to T-cells and this
process is further enhanced by virulent mycobacteria residing inside phagosomes but
inhibiting phagosome-lysosome fusion and thus avoiding the host’s immune response
(Armstrong and Hart, 1975; Nathan and Hibbs, 1991; Tascon et al., 2000).
Virulent mycobacteria possess specific determinants composed of regions of
difference 1 (RD1) genes coding for early secretory antigen-6 (ESAT-6) and culture filtrate
protein-10 (CFP-10), which are located within a specialized early secretory system (ESX-1)
and incriminated in the pathogenesis of M. tuberculosis (Ernst et al., 2007). It is believed
that complexes of such proteins bind to the cell surface receptor of infected macrophages
and alter the structure of cell surface receptor (Ernst et al., 2007). The altered macrophage
cell surface receptor attracts more uninfected macrophages, which join the infected
macrophage pool with increased spreading of infection. The components of the complex
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substrates are also thought to contribute to the induction of IFN-β secretion, suppression of
the release of pro-inflammatory cytokines and inhibition of phagosome-lysosome fusion
(Stanley et al., 2003; MacGurn et al., 2005). Pathogenic mycobacteria may use other
virulence factors, such as katG which encodes a catalase peroxide to break down toxic
hydrogen and organic peroxides induced by activated macrophages (Smith, 2003). They
also develop certain virulence mechanisms that inhibit acidification of phagosomes and
activity of enzymes to avoid killing (van Crevel et al., 2002). The integration of these
mechanisms assists mycobacteria to avoid the host’s bactericidal microenvironment
resulting in active disease in 10% of all infected individuals within two years of infection
incuding some with tuberculous granulomas (Nathan and Hibbs, 1991; Tufariello et al.,
2003). However, most immunocompetent individuals control infection by induction of a
robust cellular immune response mediated by cytokines, such as interferon gamma (IFN-γ),
chemokines and isoform nitric oxide synthetase (iNOS) (van Crevel et al., 2002; Mathema
et al., 2006). Alternatively, released or uncontrolled replicating M. tuberculosis creates
immense inflammatory responses causing primary disease with severe lung and brain
tissues damage with fatal consequences (Zugar and Lowy, 1996). The primary disease is
associated with lower lung disease, lung lobe infiltration, pleural involvement, and
adenopathy whereas secondary or reactivated disease is characterized by upper lung lesion
and cavitations (Geng et al., 2005). Genetic background and diversity among genotypes of
M. tuberculosis has a great role in virulence and transmissionbility (Lopez et al., 2003).
For example, Beijing genotype strains can suppress generation of cytokines causing
progressive lung pneumonia and more deaths; while Canetti genotypes exert limited
pneumonia and no deaths (Lopez et al., 2003).
23
1.4.1 TB Clinical signs/relevance to epidemiology
The symptoms of active TB are often non-specific and mainly pulmonary; the patient may
present with fever, chronic persistent cough with or without blood, lack of appetite, night
sweats, weight loss and severe thoracic pain. Failure of the immune system to combat
tubercle bacilli causes haematogenous spread of organisms to various sites to produce
extra-pulmonary disease (Carrol et al., 2001). The extra-pulmonary form has many
manifestations and accounts for only 20% of all cases (Martin and Lazarus, 2000).
Haematogenous dissemination to the brain or meninges results in tuberculosis meningitis
(TBM) (Carrol et al., 2001). TBM is a debilitating disease characterized by symptoms of
fever, headache, and lowered level of consciousness and stiffening of the neck (American
Thoracic Society, 2000; Carrol et al., 2001). In childhood, it is mainly a manifestation of
severe extra-pulmonary TB (Zugar and Lowy, 1996). There is evidence to suggest that
there is a close relationship between TBM strains isolated in the UK (Parish, unpublished
data). DNA from eight UK isolates from TBM cases was provided by Professor Tanya
Parish and MIRU-typed to examine the degree of variation between them.
The defined course of infection with M. tuberculosis is dependent upon the inter-
play of a number of factors such as the host, environment and the organism. In addition,
the clinical presentation of the disease has been shown to vary between ethnic groups, in
relation to the infecting strain (Malik and Godfrey-Faussett, 2005). For instance, in
England and Wales, one study showed that the majority of people originating from the
Indian subcontinent were prone to extra-pulmonary TB, dominated by mycobacterial
lymphoadenopathy (Kumar et al., 1997; Malik and Godfrey-Faussett, 2005). Genito-
urinary TB was found to be more frequent in white populations, while pericardial TB was a
more common phenomenon in Sub-Saharan Africans (Kumar et al., 1997). This could be
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attributed to genetic susceptibility and host-pathogen interaction. In the presence of co-
infection with IV the clinical picture is altered with extra-pulmonary signs predominating
(Harries et al., 2001). Clinical presentations of TB and virulence may further vary with
respect to strain genetic changes. Infection with the Beijing strain causes a febrile response
during early treatment with anti-tuberculosis drugs (Ngoc Lan, et al., 2003). Increased
virulence of these strains and their ability to fight against hostile microenvironment of the
host immune system is thought to be related to genetic alterations in mutator (mutT) genes
and other factors (Rad et al., 2003; Malik and Godfrey-Faussett, 2005). Treatment failures
and relapses, and ability to spread more quickly to persons in contact leading to outbreaks
have also been reported in association with the Beijing strain (Ngoc Lan, et al., 2003; Rad
et al., 2003).
1.4.2 TB latency period and mechanisms of latency
Latent infection with M. tuberculosis is defined as a subclinical stage of disease
with no clinical signs, radiographic abnormality and absence of bacterial isolation in a
patient with a positive Mantoux test who remains non-infectious (Broekmans et al., 2002).
Following haematogenous spread of M. tuberculosis bacilli, majority (90%) of people curb
infection and may remain persistently or latently infected for life (Flynn and Chan, 2001).
Mechanisms which are involved in the establishment of persistence are largely not well-
known (Flynn and Chan, 2001). It is believed that interplay exists between the host that
holds infection and the bacillus that developed certain defensive strategies to evade
destruction (Tufariello et al., 2003). Once M. tuberculosis arrives in the lung, it comes in
contact with alveolar macrophages via Toll-like receptors and others resulting in its
internalisation and induction of inflammatory cytokines, such as tumour necrosis factor
25
alpha (TNF- ) and chemokines, for e.g., interleukin-8 (IL-8) (van Crevel et al., 2002;
Tufariello et al., 2003). These biological products act as signals for infection and
contribute to attraction of monocyte-derived macrophages and dendritic cells to
phagocytose tubercle bacilli (van Crevel et al., 2002). Dendritic cells then migrate to the
regional lymph nodes and present antigens to prime CD4 and CD8 T cells (Tufariello et al.,
2003). When primed, the T cells elaborate in numbers and travel back to the affected lung
tissue to counteract infection. Joining such back migration to the same area are B cells,
macrophages and different cell types which eventually terminates in a granuloma
formation, a characteristic of the latency period, where bacteria are confined in the lung
tissue with restricted spread (Sutherland, 1976; Tufariello et al., 2003; Brodie and Schluger,
2005).
1.4.3 Reactivation of latent infection
The shift from latent infection to active pulmonary TB is featured by replication of
dormant bacteria in a reactivation process which is probably due to alteration in the host’s
immune response contributing to increased incidence of TB in adults (Flynn and Chan,
2001). Several host factors have been cited in this instance including; infection with HIV,
diseases like diabetes mellitus, malnutrition, use of immunosuppressive medications,
alcoholism or host intrinsic factors, for example, TB susceptible genes and vitamin D
deficiency (Comstock et al., 1975; Wilkinson et al., 2000; Kaufmann, 2001; Malik and
Godfrey-Faussett, 2005). The likelihood of reactivation varies and ranges from 2% to 23%
(Gedde-Dahl, 1952).
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1.5 DIAGNOSIS OF M. TUBERCULOSIS INFECTION
Proper identification of a patient with TB is critical for effective treatment, and
prevention of transmission. Inappropriate diagnosis may result in wrong treatment, cause
ill-health and increase costs (Kambashi et al., 2001). TB is diagnosed, particularly in active
pulmonary, mainly by suspected clinical signs, chest radiography, examination of sputum
smears for acid-fast bacilli, response to therapy, culture of bacteria from sputum or
pulmonary secretions, Mantoux skin test, and serological methods (Grange and Laszlo,
1990; Brodie and Schluger, 2005). Classically cultured members of MTBC can be
differentiated by biochemical tests with variable results; while mycobacteriophage typing
identifies M. tuberculosis strains but with a few limitations (Bates and Fitzhugh, 1967;
Hoffner et al., 1993). Extra-pulmonary TB is often difficult to diagnose because suspected
clinical symptoms are only presumptive; chest X-ray and Mantoux skin test are less
specific, serological techniques do not distinguish between strains and microscopic sputum
smear examination is non-sensitive although the test is cheap and easy to practise (Grange
and Laszlo, 1990; Wilkinson et al., 1997). Hence, extra-pulmonary TB requires more
sophisticated imaging techniques superior to X-ray, such as computed tomography (CT)
and magnetic resonance imaging (MRI). However, definitive diagnosis of extra-pulmonary
TB requires biopsy of the affected tissue/organ for histology and culture (Hopewell, 1994).
The same radiographic techniques and culturing of cerebrospinal fluid (CSF) are used to
diagnose TBM (Rock et al., 2008). Examination of acid fast bacillus (AFB) in Ziehl-
Nielsen CSF stained smears and polymerase chain reaction (PCR) are also applied (Rock et
al., 2008). Moreover, culturing of pathological materials of isolates to iisolate the causative
agent permits drug susceptibility testing, and molecular epidemiological studies. Culturing
mycobacteria, especially pathogenic types which tend to be slow growers, is however a
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time consuming procedure and presents several technical problems (Sharp et al., 2000;
Brodie and Schluger, 2005). In recent years many more sensitive tests, including
microscopic observation drug susceptibility assay (MODA), and molecular techniques,
such as DNA sequencing, PCR analysis with amplification of 16S rRNA, have been
developed and facilitated rapid detection of M. tuberculosis and drug resistance (Kaul,
2001; Moore et al., 2004; Brodie and Schluger, 2005). The application of these techniques
is limited by the fact that they are rather expensive and may not be available in resource-
poor countries. For diagnosis of TB cases related to HIV infection, a combination of
clinical data and laboratory investigations is necessary since asymptomatic clinical signs of
TB predominate, host anergy develops and normal chest radiography has been shown in as
many as 14% of sputum positive cultures (Colebunders and Bastian, 2000; Aderaye et al.,
2004; van Cleeff et al., 2005; Reid et al., 2006).
More recently advanced in vitro techniques, termed gamma interferon release
assays (GIRAS), have been utilized to identify active and latent TB cases, and to
differentiate between M. tuberculosis latent infection and M. bovis Bacilli Chalmette
Guérin (BCG) vaccine immunization (Pai et al., 2004). Both techniques are based on
measuring the production of interferon gamma (IFN-γ) after sensitization of T-lymphocytes
in blood sample with ESAT-6 or CFP-10 antigens. One of the techniques (QuantiFERON-
TB Gold) uses mixtures of synthetic peptides, representing two proteins present in M.
tuberculosis: early secretory antigenic target-6 (ESAT-6) and culture filtrates protein-10
(CFP-10), in an ELISA test to measure the amount of IFN-γ produced after one to two days
incubation (Pai et al., 2004). The other test (T SPOT.TB) employs ELISPOT to detect the
number of sensitized T cells releasing the cytokine within five to six days. Any IFN-γ 
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release indicates M. tuberculosis infection as the vaccine strain lacks the RD1 encoding the
tested antigen. Although the results of these assays have overcome the disadvantages of
Mantoux skin test, neither the latter nor interferon assays can distinguish active TB from
latent infection which warrants further research work (Pai et al., 2004). In addition, GIRAS
must be performed within 12 hours post collection of whole blood (Madariaga et al., 2007).
1.6 INTERACTION OF M. TUBERCULOSIS WITH HIV INFECTION AND
CONSEQUENCES OF DIAGNOSIS
Tuberculosis and HIV diseases are chronic immunosuppressive diseases, where dual
existence affects each other. Individual suspects with recent TB co-infected with HIV
exhibit rapid progression to active disease (Daley et al., 1992; Coovadia et al., 1998). In a
setting with abundant TB, high HIV prevalence increased TB incidence among HIV-
positive and HIV-negative individuals and further caused a high level of TB recurrence
after therapy (Elliott et al., 1993; Sonnenberg et al., 2001, 2004). In this respect,
continuous use of chemophylactic TB drugs is needed to clear subsequent burden of
infection. Similar increases in TB incidence were also observed among females in some
African countries like Zimbabwe, where HIV prevalence is high (Nsubuga et al., 2002). In
South Africa increased TB incidence among gold miners is associated with co-infection
with HIV in HIV positive adult men resulting in escalating TB transmission (Kambashi et
al., 2001; Sonnenberg et al., 2004; Reid et al., 2006). Other reports have shown that HIV
infection in TB persons incubating dormant M. tuberculosis escalates the chances of
reactivating latent TB at an annual rate of 7% to 10% in comparison with only 5% to 10%
per person’s whole life (Lagrange et al., 2004). However, reactivation of TB in children
with HIV is a delayed phenomenon and less frequent (Coovadia et al., 1998). The co-
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existence of TB and HIV infections urges collaborative extensive efforts between the
control programmes of both diseases (Reid et al., 2006).
Ten percent of all HIV positive individuals have been found to be at risk of
developing TB within a year post-diagnosis (Colebunders and Bastian, 2000). The course
of HIV might be altered by co-infection with M. tuberculosis as the latter induces excessive
host macrophages that act as resident homes for HIV virions expressing increased virus
load levels and leading to rapid development of acquired immunodeficiency virus
syndrome (AIDS) (Toossi et al., 1993). Other researchers have argued against the latter
means of progression even though TB has contributed to approximately 12% of the global
deaths due to HIV disease (Corbett et al., 2003). During the early stages of co-infection
with HIV, M. tuberculosis attacks the lung tissue causing pulmonary TB; but as HIV
burden increases, drastic drop in the count of host CD4 cells results in transformation of
infection into extra-pulmonary TB with asymptomatic clinical signs (Colebunders and
Bastian, 2000; Godreuil et al., 2007). While effective treatment of HIV patients co-
infected with M. tuberculosis using appropriate anti-tuberculosis drugs might delay virus
replication, improve health and prevent development of drug resistance (Pape et al., 1993;
WHO, 2003), thorough treatment requires efficient and deliberate implementation of HIV
programmes that address the TB problem (Reid et al., 2006).
1.7 INFLUENCE OF RISK FACTORS ON TUBECULOSIS AND TRANSMISSION
Several studies have cited various risk factors implicated in TB and spread of the
disease in order to assist in proper utilization of public healthcare resources and prioritize
targets for TB control. In this connection, the most significant independent risk factor in
association with active pulmonary or extra-pulmonary TB is HIV infection contributing to
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ongoing transmission among individuals (Corbett et al., 1999; 2003; Godfrey-Faussett and
Ayles, 2003; Cailhol et al., 2005; Reid et al., 2006). Age has also been shown as a risk
factor in increasing TB incidence; while women have been found to be more susceptible to
TB than men probably due to the effect of female hormones or underreporting of TB cases
(Sonnenberg et al., 2004; Cailhol et al., 2005). Other risk factors include; past history of
TB in the family, smoking, place of residence, place of origin, and alcoholism (Lienhardt et
al., 2005; Patel et al., 2007; van Deutekom et al., 2005). In countries with low TB
incidence, immigrants from countries with high TB prevalence constitute potential
increased risk for recent transmission of infection to local populations (Borgdorff et al.,
1998; Dale et al., 2005). In some industrialized countries, TB revival has been linked to
certain risk factors, such as overcrowding, reduced funding, poverty, homelessness,
improper TB management and negligence in implementing TB control programme (Bhatti
et al., 1995; Gutierrez et al., 1998). In different parts of the world, consumption of
unpasturised milk was observed in association with TB caused by M. bovis (Coker et al.,
2006). Silicosis, an occupational disease occurring among mine workers exposed to silica
dust, predisposes TB and non-tuberculous mycobacteria (NTM) infections (Sonnenberg et
al., 2004). Other researchers reported the occurrence of TB transmission in hospitals in
association with healthcare workers born in countries with high TB burden but without
further continued spread (Anderson et al., 2007).
1.8 GENETIC PREDISPOSITION OF TB
Host genetic factors have been been implicated in the mechanism by which TB
infection is acquired (Puffer, 1944). Genetic role was associated with infection after
increased susceptibility to TB was observed in people and their relatives originating from
31
areas with no previous history of the disease (Stead, 1992). Likewise, an extremely high
incidence of clinical TB has been reported during disease-outbreaks in certain races of
people, such as the Native Americans whose ancestors had no experience of the infection
(Stead, 1997). The association of clinical TB with certain genes such as the human
leukocyte antigen (HLA) class II alleles has been noted, for example in Cambodian and
Indian populations (Goldfeld et al., 1998; Ravikumar et al., 1999). In addition, two TB
susceptibility loci have been identified in African populations (Bellamy et al., 2000).
Subsequent molecular studies have indicated that congenital defects of immunity
affecting both the adaptive and innate immune systems can predispose to severe TB.
Children affected by primary immunodeficiency diseases, such as hyper-immuno-globulin
M, develop disseminated TB and are prone to infections caused by NTM and the attenuated
BCG vaccine strain (Abel and Casanova, 2000; Reichenbach et al., 2001). A variety of
genetic disorders, such as complete or partial interferon gamma receptor 1 (IFN-γR1) 
deficiencies, complete interleukin- 12 (IL)-12 p40 deficiencies or complete IL-12 receptor
ß1 (IL-12R ß1) deficiency also predispose to mycobacterial diseases (Casanova and Abel,
2002).
Polymorphic mutations in NRAMP1 (natural resistance-associated macrophage
protein 1) have been reported to induce susceptibility to TB in the Gambian population
(Casanova and Abel, 2002) and Flores-Villanueva et al. (2005) linked the susceptibility of
Mexican adults to TB to a mutation in the promoter region of the monocyte chemotactic
protein 1 (MCP) gene, which results in decreased IL-12 production (Flores-Villanueva et
al., 2005).
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1.9 TREATMENT OF TB AND SIDE-EFFECTS OF ANTI-TB DRUGS
TB is treated by the first line drugs of isoniazid (INH), rifampin (RIF),
pyrazinamide (PZA) and ethambutol (EMB) for two months, then INH and RIF for a
further four months under standard directly observed therapy, short course (DOTS), an
acronym term used and recommended by the WHO for global treatment and control of TB
(WHO, 1997; American Thoracic Society, CDC, and Infectious Diseases Society of
America, 2003; Dye et al., 2005). If treatment with the first line drugs does not work, the
second line drugs, including quinolones (ofloxacin, ciprofloxacin), cycloserine,
aminoglycosides (kanamycin, capreomycin and amikacin), and ethionamide, are given
(Migliori et al., 1999). Inadequate treatment and non-compliance lead to the development
of selected mutated resistant and MDR-TB (resistance to at least INH and RIF) strains
(Ramaswamy and Musser, 1998). Chemotherapy of MDR-TB cases involves the use of
highly toxic second line drugs e.g., fluoroquinolones are used despite drug toxicity as there
is no alternative treatment and in order to prevent ongoing transmission (Migliori et al.,
1999; Yong et al., 2005). In addition, treatment of MDR-TB cases takes longer, is more
expensive and can result in severe side-effects. More recently, emergence of extensively
drug-resistant TB (XDR-TB) has been reported among patients (Migliori et al., 2007).
Extensively resistant strains of M. tuberculosis do not respond to treatment with INH and
RIF plus fluoroquinolone, and at least one of three injectable drugs (kanamycin, amikacin
or capreomycin) (United States (US) Centres for Disease Control and Prevention (CDC),
2006; Migliori et al., 2007). A number of factors have contributed to such emergence
including poor patient compliance and primary care, HIV emergence, low community
awareness and inappropriate implementation of DOTS strategy (Hamilton et al., 2007).
The evolved XDR-TB M. tuberculosis strains may pose great public health threat among
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patients concerned causing deaths, particularly in immunocompromised patients , such as
those with HIV/AIDS, and further spread in the community (Masjedi et al., 2006; Migliori
et al., 2007). Alternative treatment for XDR-TB is limited and its emergence can hinder
any existing or future TB control programmes and disrupt WHO Stop TB Strategy, a global
plan based on DOTS and designed by WHO and Partners to stop TB from 2006-2015 by
halving prevalence and deaths relative to 1990 standard (Migliori et al., 2007; Dye et al.,
2006; WHO, 2007). The XDR-TB phenomenon has globally spread across several
countries in USA, Asia, Europe and Africa (Migliori et al., 2007).
Treatment with first or second line anti-TB drugs elicits several side effects.
Treatment with INH may cause hepatitis, neuropathy, lupus erythematous syndrome, mood
changes and drowsiness (Migliori et al., 1999) while RIF treatment may produce side-
effects of drug interactions, abdominal disturbance, diarrhoea, mild hepatitis and
thrombocytopenia (Migliori et al., 1999). PZA causes abdominal upset, hyperuricaemia,
hepatitis, arthritis and skin rash, EMB may result in optic neuritis and abdominal
disturbance (Girling, 1978; 1984). SM produces the main side-effects of ototoxicity and
nephrotoxicity (Migliori et al., 1999). The side-effects for the second-line drugs such as
quinolones (ofloxacin, ciprofloxacin) include headache, abdominal cramps, nausea,
dizziness and anxiety. Cycloserine causes psychotic symptoms, low mood, headache and
depression; aminoglycosides (kanamycin, capreomycin and amikacin) cause ototoxicity
and nephrotoxicity while treatment with ethionamide elicits stomach problems, nausea,
vomiting and hepatitis (Migliori et al., 1999). Hence, treatment of all patients with TB
including those complicated by treatment and treatment of special cases e.g., liver disease
or HIV cases should be monitored and managed carefully to avoid the complications of
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these side effects (Migliori et al., 1999). These side effects can not be ignored as they pose
great public health concern and add more financial burden on TB management, particularly
in prolonged treatment. Knowledge about these side-effects will draw attention to the value
of prevention aspect of TB management.
1.10 TB PROPHYLACTIC CHEMOTHERAPY/BENEFITS AND RISKS
The main aim of prophylactic therapy is to minimize the risk of developing TB
especially, in individuals with latent infection by using INH for a period of one year
(International Union Against Tuberculosis Committee on Prophylaxis, 1982). To achieve
satisfactory results, compliance to chemoprophylaxis is essential. The preventive strategy
should also target potential risk groups such as immigrants, particular ethnic minorities,
HIV-infected individuals and homeless people to reduce TB transmission (Broekmans et
al., 2002). One should however, be aware of the known INH toxic effects of hepatitis,
neuropathy and skin hypersensitivity (Migliori et al., 1999).
1.11 MOLECULAR DRUG RESISTANCE OF M. TUBERCULOSIS
The acquisition of drug resistance by M. tuberculosis is chromosomal and is caused
by mutations involving specific regions such as insertion elements, nucleotide substitutions
and small deletions as well as mutations in genes coding for activating enzymes, the targets
of anti-TB drugs (Ramaswamy and Musser, 1998). Primary infection of patients by a
prevalent resistant strain circulating in the study area is one of the means suggested for the
development of resistance. In addition, insufficient treatment and non-compliance may
create appropriate environment for the selection of drug resistant phenotypes (Ramaswamy
and Musser, 1998). Another mechanism implicated in the development of drug resistance
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is the role of evolution in conferring. Using genetic markers, Bifani et al. (1996)
characterized a MDR-TB clone resembling strain W in association with isoniazid (INH),
rifampin (RIF) and streptomycin (SM) resistance in nosocomial a transmission of infection
in a hospital in New York City. The emerged resistance in these strains was thought to
have been gradually gained and and that it had evolutionarily descended from a common
origin and subsequently expanded. Another study employing genotypic analysis identified
a single M. tuberculosis strain harbouring MDR-TB recovered from serial sputum materials
collected from 13 infected patients (Post et al., 2004). Interestingly, four out of the 13
resistant strains had more than one mutation coding for drug resistance. The authors also
observed a mixture of bacterial subpopulations for the same strain probably developed by
distinct mutations imposed by treatment in various lung sites. Recently, other workers have
described a further mechanism involving increased expression of specific genes causing
drug tolerance. Pasca et al. (2005) have proposed that elevated expression of a
transmembrane drug efflux protein, termed mycobacterial membrane proteins large
(MmpL), encoded by mmpL7. MmpL mediates INH-resistance by actively transporting the
drug out of the bacterial cell. Using genotypic analysis of M. tuberculosis strains collected
from different regions in combination with conventional methods have identified resistant
strains with XDR-TB designated to Haalem-1, Beijing, KwaZulu Natal (KZN) and East
African Indian-3 (EAI-3) families (Masjedi et al., 2006; Migliori et al., 2007).
1.12. MECHANISM OF RESISTANCE TO ANTI-TB DRUGS
Intrinsic resistance of M. tuberculosis to antibiotics is attributed to the impaired
permeability of the mycobacterial cell wall to drug influx (Jarlier and Nikaido, 1994). The
mechanism of acquired mycobacterial drug resistance is thought to be due to the
36
accumulation of mutations in genes coding for drug targets and drug-activating enzymes
(Morris et al., 1995). Isoniazid (INH) and rifampin (RIF) are potent first line
antituberculous drugs in addition to streptomycin (SM), ethambutol (EMB) and
pyrazinamide (PZA) (Ramaswamy and Musser, 1998). Treatment failure of TB with first-
line drugs has necessitated the use of second-line drugs including fluoroquinolones (e.g.,
ofloxacin); ethionamide; aminoglycosides (kanamycin and amikacin) and others (Nachega
and Chaisson, 2003). In spite the presence of the second line lines, the increasing
resistance of M. tuberculosis strains to first line drugs poses a global concern.
Isoniazid has been used as a primary drug against M. tuberculosis since the 1950s
(Bernstein et al., 1952). Isoniazid-resistance is associated with mutations in at least three
genes: katG, encoding a catalase-peroxidase enzyme; inhA, encoding an enzyme involved
in cell wall synthesis; and ahpC, encoding an alkyl hydroperoxidase (Middlebrook et al.,
1954; Heym et al., 1992; 1993; 1994).
Rifampicin is a potent anti-tuberculosis agent used for treatment since 1971 and
used as a marker for development of anti-TB drug resistance. The mechanism of action of
rifampin involves the interaction of the drug with ß subunit of RNA polymerase encoded
by rpoB, resulting in failure of transcription; translation and synthesis of RNA (Johnston et
al., 1976; Miller et al., 1994). The majority of RIF-resistant M. tuberculosis isolates carry
mutations in rpoB located in a 69 bp or 81bp ‘hot spot’ region of the gene termed RIF
resistance-determining region (RRDR) and most frequently occur within codons 531, 526
and 516 (Musser, 1995; de Miranda et al., 2001; Ma et al., 2006).
Streptomycin is one of the first-line TB drugs, which kill M. tuberculosis by
blocking the synthesis of ribosomal proteins (Ozturk et al., 2005). These proteins are
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encoded by 16S rRNA gene (rrs) and rpsL (Ramaswamy and Musser, 1998). Mutations in
these genes cause resistance to SM (Huang et al., 2003).
Ethambutol is a bactericidal first-line anti-TB drug which eliminates tubercle bacilli
by inhibiting the synthesis of arabinogalactan encoded by embABC gene cluster
(Ramaswamy and Musser, 1998; Hazbón et al., 2005). Mutation in the gene cluster results
in development of EMB resistance (Hazbón et al., 2005).
Pyrazinamide is utilized as a first-line drug to treat TB as it kills tubercle bacilli by
inducing harmful acidic conditions where released pyrazinamidase transforms
pyrazinamide to pyrazinoic acid (Ramaswamy and Musser, 1998). As pyrazinamidase is
encoded by pncA, mutation in this gene mediates PZA resistance (Ramaswamy and Musser,
1998).
Fluoroquinolones are synthetic by-products of nalidixic acid which represent one
group of the second-line of drugs for treatment of TB (Dessus Babus et al., 1998). These
drugs act on DNA gyrase as their target. The DNA gyrase is encoded by gyrA and has
many functions including ATP (adenosine triphosphate) catalytic activity, DNA replication
and transcription (Dessus Babus et al., 1998). Once these drugs interact with DNA gyrase,
these functions will be inhibited and bacilli killed (Ramaswamy and Musser, 1998). Hence,
mutation in gyrA is associated with fluoroquinolones resistance (Ramaswamy and Musser,
1998).
Capreomycin (CAP), viomycin (VIO), kanamycin (KAN) and amikacin (AMI) are
second-line anti-TB drugs that inhibit protein synthesis (Ramaswamy and Musser, 1998).
Development of resistance to these drugs is rare as their use is relatively uncommon
(Ramaswamy and Musser, 1998). Little is known about their mechanism of resistance and
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andthat is true for only a few, for example, CAP. Resistance to CAP is conferred by
mutation in tlyA (Maus et al., 2005). These genes encode TlyA, an rRNA
methyltransferase to which CAP binds and inhibits translation and ribosomal protein
synthesis. In the absence of this gene product, resistance to CAP develops (Maus et al.,
2005).
1.13 ORIGIN AND EVOLUTION OF M. TUBERCULOSIS
Evolutionary studies are of significance in molecular epidemiology and have been
employed to explore population genetics (Alland et al., 2003). Being a member of MTBC,
M. tuberculosis was previously thought to have evolved from M. bovis, an animal
pathogen, as an ancient progenitor when animals were domesticated (Stead et al., 1995).
Several studies have however, argued against such a notion (Rothschild et al., 2001; Brosch
et al., 2002; Gutierrez et al., 2005). M. tuberculosis complex strains are hypothesized to
possess a clonal structure that displays a high degree of genetic similarity at the nucleotide
sequence level with little or no evidence of lateral gene transfer and have identical 16S
rRNA sequence (Sreevatsan et al., 1997; Supply et al., 2003; Baker et al., 2004). Due to
this clonality, MTBC strains are thought to have diverged from a single lineage probably
resembling ancestral M. tuberculosis strains or Mycobacterium canettii that is predicted to
have existed and reached a evolutionary bottleneck as far back as 20,000 to 35,000 years
ago (Sreevatsan et al., 1997; Brosch et al., 2002; Gutacker et al., 2002). M. tuberculosis
specific deletion 1 (TbD1) and deletion of RD also support such hypothesis (Brosch et al.,
2002). Further continued accumulative losses of genomic RDs have resulted in branching
of other species from the major M. tuberculosis lineage in a successive and stepwise order
that begun initiated with M. africanum (one RD), followed by M. microti (four RDs) and
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ended with M. bovis as the most recent species lacking eight RDs (Brosch et al., 2002).
Rothschild et al. (2002) recovered a M. tuberculosis isolate from 17,000 year old
archaeological bison remains believed to have evolved from M. africanum and M.
tuberculosis rather than from M. bovis (Rothschild et al., 2001). In addition Mostowy et al.
(2002) designated all M. tuberculosis/M. africanum isolates devoid of genomic deletions to
principle genetic groups (PGGs), which designate MTBC organisms to one of three
genotypic groups based on combinations of polymorphism at katG codon 463 and gyrA
codon 95 (Sreevatsan et al., 1997), and all other remaining isolates, including that of M.
bovis containing ≥ 1 deletion/genome, to group 1. Recent analyses using of six ‘house-
keeping’ genes (katG, gyrA, gyrB, rpoB, hsp65 and sodA) and the entire 16S rRNA
sequence have identified a specific group, named prototuberculosis species which includes
M. canettii, in Dijbouti, East Africa, from which the present day M. tuberculosis population
probably developed and gradually disseminated around the world (Gutierrez et al., 2005).
It has been estimated that the early association of tubercle bacillus or putative smooth
bacilli ancestors with human beings who lived in the African region causing TB disease
occurred about three million years ago (Gutierrez et al., 2005; Ernst et al., 2007).
1.14 NON-TUBERCULOUS MYCOBACTERIA (NTM)
i) History and significance of NTM
Pinner (1935) first discovered organisms of mycobacterial species other than MTBC
and called them atypical mycobacteria. In the 1950s these cosmopolitan microorganisms
were thought to be saprophytic environmental contaminants living in water sources and the
soil (O’Brien et al., 1987). Since then they have been called by several names, such as
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anonymous, opportunistic, environmental mycobacteria, mycobacteria other than tubercle
bacilli (MOTT), and non-tuberculous mycobacteria (NTM) (Wallace et al., 1990), which is
now the internationally approved name (Wallace et al., 1990; Katoch and Mohan, 2001).
NTM are known to infect the lung causing pulmonary and non-pulmonary forms of disease,
particularly in immuno-compromised individuals such as the elderly, HIV and patients with
cystic fibrosis (Nassos et al., 1991; Kennedy and Weber, 1994). The most common species
implicated in NTM pulmonary disease are M. avium, Mycobacterium abscessus,
Mycobacterium kansasii, Mycobacterium xenopi and Mycobacterium malomoense (Marras
and Daley, 2002). Transmission of NTM infection occurs mainly via ingestion of
contaminated materials, but no human to human transmission has been reported
(Falkinham, 2002).
ii) Clinical signs of NTM disease
NTM infection impairs health and causes a variety of pathological syndromes in the
form of pulmonary and disseminated disease esspecially, in AIDS patients, involving
lymphadenitis, cutaneous infections and Crohn’s disease (American Thoracic Society,
1997; Vary et al., 1990). The prevalence and distribution of various species of NTM
differs worldwide, but more cases are diagnosed in developed countries with lower
incidence of TB than in developing countries (Falkinham, 1996). This is probably due to
the availability of advanced instruments and identification techniques in developed
countries (T. Brown, personal experience by people working in Health Protection Agency
(HPA) and Mycobacterium Reference Unit (MRU) at Queen Mary’s University).
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1.15 DIAGNOSIS OF NTM
Diagnosis and detection of NTM infections has posed many difficulties to clinicians
and diagnostic laboratories. Many NTMs are clinically and microscopically
indistinguishable from M. tuberculosis complex, thus leading to false positives and
inconclusive results (American Thoracic Society, 2000; Koh et al., 2005). Untreatable TB
cases have a high probability of being NTM infection but this has to be confirmed by
isolation of the NTM by culture from sputum or pulmonary lavages (Wallace et al., 1990).
Difficulties have also been encountered in interpreting and assessing the significance of the
recovered NTM organisms. Culturing is made difficult by the fact that organisms need to
be in sufficient numbers and precisely recovered from the corresponding pathological
sampled lung tissue (American Thoracic Society, 2000; Koh et al., 2005). Identification of
NTM phenotypes is performed using growth rates, pigment formation, biochemical tests,
determination of antibiotic susceptibility profile and chromatographic analysis of lipids
(Vestal, 1977; Duffey et al., 1996). Molecular tests, which are performed to provide
supplementary data to phenotypic characterization, include gene probing, pulsed field gel
electrophoresis, insertion sequenced based restriction fragment length polymorphism
(RFLP) procedures and amplification of 16S rRNA (Evans et al., 1992; Kikuchi et al.,
1994; Kirschner and Bottger, 1998; Vanitha et al., 2003). Amplification of 16S rRNA and
sequencing of the PCR product have been shown to achieve accurate identification
techniques for NTM to the species level (Bottger, 1989; Bottger, 1992; Kirschner and
Bottger, 1998). The 16S rRNA target sequence is present in every micro-organism and has
a molecular size of ~1,550 bp containing conserved and variable regions (Bōddinghaus et
al., 1990). The 16S rRNA gene has been utilized in different tasks including taxonomic and
evolutionary purposes as well as determination of phylogenetic relationships (Clarridge III,
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2004). The gene is also a valuable genetic tool in the identification of other bacteria to the
species level particularly, non-cultured bacteria or bacteria that are difficult to grow in
culture e.g., Coxiella burnetii (Brouqui and Raoult, 2001; Clarridge III, 2004).
1.16 TREATMENT OF NTM
Chemotherapy of NTM infections has been problematic for clinicians, in terms of
deciding to treat or not the underlying case, and also selecting the effective drug(s) and
duration of the treatments (Falkinham, 1996; Nemery et al., 2005). Different species of
NTM require different treatments, as some have developed drug resistance to adapt their
niche (Falkinham, 1996). For example, M. kansasii infections are preferably treated by a
combination of rifampin, isoniazid and ethambutol (with or without streptomycin) for a
period of 18 months as recommended by The American Thoracic Society guidelines
(1997). On the other hand, M. avium complex is typically treated with macrolides;
clarithromycin, rifampin, and ethambutol for two months but may continue for one year or
until sputum cultures become negative (Koh et al., 2005). In extensive lung infection with
M. avium complex, streptomycin is intermittently used with the previous combination
regimen (Koh et al., 2005). In strains which resist treatment with macrolides or severely
affected, surgical incision is recommended to remove the lesion (Koh et al., 2005). These
antimycobacterial antibiotics have some adverse reactions including thrombocytopenia,
leukopenia and hepatotoxicity, and treatment is often further complicated by the
development of resistance (Koh et al., 2005; 2006).
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1.17 GENOME OF M. TUBERCULOSIS
The genome of M. tuberculosis is 4,411,529bp in size, encompassing about 4000
genes (Cole et al., 1998). It is characterized by its high GC content and abundant repeated
sequences (Cole et al., 1998). Of the total number of genes, more than 200 encode for
enzymes involved in the metabolism of fatty acids including ß-oxidation of fatty acids
(Smith, 2003). These abundant enzymes degrade fatty acid, a rich source of carbon atoms
that could nourish M. tuberculosis in the host’s tissues leading to increased pathogenicity
(Smith, 2003). Another group of genes encoding glycine rich proteins; proline-glutamine
(PE) and proline-proline-glutamine (PPE) have been found to contribute to the organism’s
virulence and immune variation (Cole et al., 1998; Choudhary et al., 2004). The PPE
proteins possess a rich depot of the amino-acid asparagine, which supplies the organism
with nitrogen (Grosset, 1993). Associated with PE and PPE genes are dispersed repeat
DNA sequences, termed polymorphic guanine-cytosine rich sequences (PGRs), and major
polymorphic tandem repeats (MPTR), that may have an immunological role (Grosset,
1993; Poulet and Cole, 1995). The PGR proteins are believed to suppress major
histocompatibility complex (MHC) class 1 antigen presentation and deleteriously affecting
the host immune response (Cole et al., 1998). A further set of genes encoding regulatory
proteins are incriminated in tactical response to combat any adverse change in the
surrounding environment (Smith, 2003). The abundant repeated DNA sequences are
variable and these include duplicate copies of certain genes, insertion elements e.g. IS6110
found in clusters among several different families and a set of scattered DNA repeats
present in several copies e.g., mycobacterial interspersed repetitive units (MIRUs) (Smith,
2003).
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1.18 M. TUBERCULOSIS COMPLEX (MTBC) GENOMIC DIVERSITY
Members of the MTBC are genetically very closely related, with a high degree of
conservative inter-strain DNA homology, and only a difference estimated as less than
0.05% between species, subspecies and strains (Poulet and Cole, 1995; Cole et al., 1998;
Magdalena et al., 1998). The study of genetic diversity among strains of M. tuberculosis
has implications in pathogenicity and transmissibility, the design and preparation of
vaccines, identification of candidate genes for drug targets, and improving molecular
diagnostic techniques (Poulet and Cole, 1995; Kato-Maeda et al., 2001). Such genetic
variation may be a major factor in the emergence of many mycobacterial strain variants
involved in causing global TB epidemics; and some are useful for epidemiological studies
and for classification of the organisms into groups or constructing phylogeny (Poulet and
Cole, 1995; Sreevatsan et al., 1997; Kato-Maeda et al., 2001; Arnold, 2007). Molecular
epidemiology tools/techniques utilize such changes to identify the causative agent, the
strain and trace back the source of TB-outbreaks in different geographical localities to
combat the disease. Genetic markers have different molecular clocks, where the term
‘molecular clock’ of a genetic marker refers to the rate change in the strain’s pattern,
whether it is slow or fast, over time (Prodinger, 2007). Markers with higher diversity, such
as MIRU typing, are more applicable in differentiating strains than spoligotyping which
acquires limited variability and slower molecular clock (Supply et al., 1997; Soini et al.,
2000; Mathema et al., 2006; Arnold, 2007).
1.19 ROLE OF GENOTYPING IN TB TRANSMISSION DYNAMICS
Genotyping of M. tuberculosis has contributed significantly to traditional TB
epidemiology and improved our knowledge of understanding the complexity of
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transmission pathways within communities. This was based on the assumption that patients
who are infected with strains exhibiting the same fingerprints or designated to the same
clusters are originated from the same recent common progenitor, while those infected with
strains having distinct RFLP profiles are considered to be unrelated denoting reactivation of
infection contracted from another source (van Embden et al., 1993; van Soolingen et al.,
2001). The transmission dynamic complexity of reactivation is derived from the unique
behaviour of the pathogen, which infects only a small proportion of individuals and remains
dormant for a long period before it springs on, becomes active and transmits infection
(Hirsh et al., 2004). Prior to the invention of molecular epidemiological tools, the rate of
new infection of individuals by transmission was estimated to be approximately 10% by
contact tracing (Burgos and Pym, 2002). Contact tracing methods can however be
misleading and a number of molecular studies have shown that limited and casual contact
may precipitate an ongoing transmission. Valway et al. (1998) have documented an
outbreak due to recent transmission in a rural community with a low TB incidence. Most
of the people infected lived distances apart but met often. Likewise, an ongoing
transmission has resulted from just a short period of contact (van Soolingen et al., 1999).
Higher clustering rates accounting for nearly 25% in San Francisco, 30% in New Jersey,
40% in New York and 47% in Amsterdam were reported between patients in association
with epidemiologic links or shared risk factors e.g., poverty or infection with HIV in the
absence of strains that were related any form of shape (Small et al., 1994; van Deutekom et
al., 1997; Bishai et al. 1998; Mathema et al., 2002).
However, great caution should be exercised when interpreting and drawing
conclusions from identical fingerprinting results. Identical DNA profiles have been
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obtained from a diverse collection of isolates originating from Tanzania, South Africa,
Malawi, Zimbabwe and Kenya probably due to a prevalent strain that emerged from one
source and subsequently expanded to all the other areas (Picard, 2000). Again, recent TB
transmission in the absence of contacts has been reported to occur during an outbreak as a
result of simultaneous reactivation of cases as demonstrated by RFLP patterns (Dahle et al.,
2005). To comment on levels of clustering/strains relationship in any molecular study, it is
recommended that the study must have a genuine question to resolve, must have chosen
typing methods to apply and defined geographic area for studying. For instance, Mathema
et al. (2002) spotted three patients as part of a recent transmission chain, which was
verified by distinct spoligotyping coupled with geographic aggregation and demographic
characteristics although these patients had non-identical IS6110 RFLP profiles. Hence, the
above studies have proved that transmission dynamics are complex necessitating the use of
multiple genetic markers in order to achieve high resolution of strain genetic diversity and
to avoid ambiguity (Cowan et al., 2005; Clark et al., 2006).
1.20 GENOTYPING METHODS USED IN MOLECULAR EPIDEMIOLOGY
Molecular epidemiology involves molecular biology, epidemiology, molecular
medicine and statistics and is fundamental to investigating genotypic determinants and
environmental factors involved in disease causation and distribution (Mathema et al.,
2006). Phenotypic methods such as biotyping, antibiotic susceptibility typing,
bacteriophage typing and serological methods have been used with little success as
organisms’ properties often vary (Tenover et al., 1997). On the other hand, genotypic
methods, such as insertion sequence IS6110 typing, is more capable of discriminating
epidemiologically unlinked strains and is biologically slow enough to efficiently determine
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associations between identical strains (van Embden et al., 1993). Hence, phenotypic and
genotypic methods have been used for strain typing of bacteria as they complement
epidemiological investigations (Tenover et al., 1997). Molecular studies have shown that
members of the MTBC are genetically closely-related, even though a few genetic
differences were encountered and identified in specific hot spots loci dispersed over the
lengh of the genome (Frothingham et al., 1994; Sreevatsan et al., 1997; Musser et al., 2000;
Gutacker et al., 2002). TB research entered a new age after publication of the complete
genome sequence of M. tuberculosis (Cole et al., 1998). Variable regions have been
targeted to study MTBC clonal relatedness, improve understanding of transmission
patterns, identify emerging strains, and to define the biogeography of specific phenotypic
strains (Gagneux et al., 2006; Gagneux and Small, 2007). Genotyping M. tuberculosis has
been valuable to understanding TB epidemiology; and can be used to confirm laboratory
cross-contamination, determine the distribution of epidemic strains within a population,
evaluate the effectiveness of M. tuberculosis prevention and control programs, provide
informed insights into TB epidemiology in certain settings, and to define transmission
patterns (Maurer et al., 1984; Bradford et al., 1998; Glynn et al., 1999; Crawford et al.,
2002; McConkey et al., 2002; McNabb et al., 2002; Cronin et al., 2002; Ijaz et al., 2002;
Miller et al., 2002; Murray and Nardell, 2002; McNabb et al., 2004). Several genotyping
methods have been successfully applied to characterize M. tuberculosis strains. The
methods used have included IS6110-based typing, spoligotyping, MIRU and VNTR
(variable number tandem repeat) typing, multilocus sequence typing, single nucleotide
polymorphism (SNP) typing, deligotyping and genomic deletion analysis (Theirry et al.,
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1990; van Embden et al., 1993; Kamerbeek et al., 1997; Supply et al., 1997; Maiden et al.,
1998; Gutacker et al., 2002; Mostowy et al., 2002).
1.20.1 IS6110 RFLP typing
IS6110 is a repetitive DNA sequence present in multiple copies in the M.
tuberculosis genome (Thierry et al., 1990). An IS6110 fingerprint pattern can be obtained
by the method of enzyme restriction RFLP and Southern blotting (van Embden et al.,
1993). It carries genetic information pertinent to its active mobility along the genome and
regulation. This transposition probably interferes with gene order leading to genetic
alterations or activation that may affect gene expression (Chandler and Mahillion, 2002;
Safi et al., 2004). The IS6110 elements probably act as parasitic DNA sequences infecting
their hosts or have emerged as sequences, which have a role in adaptive evolution (Blot,
1994; Charlesworth et al., 1994). IS6110 can be used as a tool to distinguish between M.
tuberculosis complex species or strains, for example, genetic variation between the
attenuated M. tuberculosis H37Ra and virulent M. tuberculosis H37Rv strain is related to
the transposition of IS6110 resulting in the loss of RvD2 (deletion 2) in H37Rv (Brosch et
al., 1999; Lari et al., 1999). Strains with identical IS6110 RFLP patterns can be considered
to originate from a common ancestral strain and are taken to represent recent transmission,
whilst those with polymorphic bands denote distant relationships (van Embden et al.,
1993).
Being a mobile element there is some concern that IS6110 may be an unstable
biomarker (Methema et al., 2006). However, this probability has not proved to be true as
shown by a number studies that have documented that IS6110 banding patterns remain
stable (with no genetic alterations) for up to six months for extracted DNAs from in vitro
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broth cultures, four weeks for macrophage cultures and two months following experimental
inoculation in guinea pigs (van Soolingen et al., 1991; Cave et al., 1994). In one study
involving positive culture samples tested at intervals, the half-life of hybridized IS6110
banding pattern was shown to be 3-4 years (Yeh et al., 1998; de Boer et al., 1999); while, a
second study conducted in patients inhabiting an area with high TB incidence showed that
the pattern stayed unchanged for 8.74 years (Warren et al., 2002). Although increased
proportion rates of pattern changes were observed under stress during early stages, the rates
changes decreased in the latency phase of the disease (Warren et al., 2002). Several other
researchers have used the IS6110-RFLP typing to determine patterns of transmission
(endogenous or exogenous) among patients, trace epidemiological links, identify different
clades, mixed and cross-infections, and episodes of the disease (Bishai et al., 1998; de Boer
et al., 1999; Kremer et al., 1999; van Rie et al., 1999; Warren et al., 2002; Douglas et al.;
2003; Hawkey et al., 2003; Shamputa et al., 2004).
The use of IS6110–based analysis in TB molecular epidemiology has several
advantages. It is a standard method and is widely used because patterns can be digitalized
to ease comparison and exchange between laboratories. The biomarker is adequately
polymorphic and stable which warrants its use in examining transmission dynamics and
follow up at a population level. Investigation of 1,072 clinical isolates taken from patients
living in a populated area resulted in the identification of one-third of the tested samples as
unique strains and another third was spilt between multiple groups (Bifani et al., 1999). It
has great resolution power and it has the capability of discriminating between strains
possessing greater than six IS6110 insertions like W/Beijing strains (Bifani et al., 2002). It
can also be used to detect mix infections as it detects excessive bands of variable sizes. In
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addition to molecular epidemiology, it can be applied for phylogenetic analysis,
evolutionary studies and detection of laboratory cross-contamination (Mazars et al., 2001;
Warren et al., 2004). The used membrane can also be re-hybridized with another probe to
conduct a different molecular test. This procedure saves time and reduces costs.
The IS6110 RFLP typing method has several limitations. It requires culturing for a
period of nearly six weeks, highly skilled manpower and considerable amounts of purified
DNA (van Embden et al., 1993; Lee et al., 2002). Another limitation is the difficulty in
interpretation of molecular data, such as genotypic clustering and its association with
conventional epidemiology as well the probability of obtaining fake clusters in the absence
of definable transmission patterns (Barnes et al., 1997; Bishai et al., 1998; Glynn et al.,
1999). The biomarker has poor molecular resolution to distinguish strains with less than
IS6110 copies because the lower the of number copies, the greater the chances for co-
migration of DNA fragments from certain genomic locations leading to false positive
banding patterns (Rhee et al., 2000; Kremer et al., 2005). This resolution defect can be
overcome by using a secondary molecular method, such as spoligotyping (Kremer et al.,
2005). In additional to its inability to discriminate between members of MTBC, the
method is expensive and laborious requiring analyses huge number of patterns and
comparing results obtained from different laboratories (Lee et al., 2002).
1.20.2 PCR-based methods
A range of rapid PCR-based methods, which are reliable and relatively easy to
perform with a small amount of DNA, have been developed for use with DNA extracted
from bacterial cultures or non-viable materials. These include spoligotyping, mycobacterial
interspersed repetitive units (MIRU), and other variable number tandem repeats (VNTR)
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typing (Kamerbeek et al., 1997; Supply et al., 1997; Kremer et al., 1999; Qian et al., 1999;
Fletcher et al., 2003).
i) Spoligotyping
Spoligotyping is a PCR-based method involving amplification of the direct repeat
(DR) chromosomal locus followed by detection of individual DRs. Each DR consists of an
identical 36 bp repeats interspersed with 35 – 41 bp unique spacer sequences (Kamerbeek
et al., 1997). Polymorphisms in the DR region are proposed to emerge due to homologous
recombination between DRs, deletions of a single direct variable repeat (DVR), deletion of
variable spacer DNA sequences between the DRs, or multiple discrete DVRs in the DR
region (Groenen et al., 1993; Kamerbeek et al., 1997; van Embden et al., 2000). Strains
with identical spoligopatterns are considered to have evolved from the same clone and
imply a likelihood of recent transmission. However this judgment should be made with
caution since false patterns could emerge independently from unlinked M. tuberculosis
strains due to ongoing frequent irreversible spacer deletions occurring simultaneously in the
same spacers in the DRs of these strains under the influence of recombination and IS6110
transient mobility events (Warren et al., 2002).
DR spacers are stable markers that have been widely used as tools to track
molecular epidemiology (Sola et al., 2001). Spoligotyping has also been used to
reconstruct M. tuberculosis phylogeny, discriminate between isolates with less than five
IS6110 copies and classify isolates into the previously known groups or strains families
(Fang et al., 1998; Kremer et al., 1999; Soini et al., 2000; Sola et al., 2001). Other
investigators have used spoligotyping and variable IS6110 RFLP profiles to differentiate
M. tuberculosis isolates with primary infection (Garcia de Viedma et al., 2004).
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Complementation of spoligotyping with IS6110 RFLP typing has recently been conducted
in New York to be exploited for global application (Clark et al., 2006). The method can be
applied to detect possible zoonoses with M. bovis and other circulating bacilli, trace
transmission links and determine transmission patterns such as endogenous reactivations
(Gibson et al., 2004). Moreover, the technique is valuable in identifying new clonal
composition of M. tuberculosis isolates in a country, and monitoring TB dynamics and
epidemiological effects due to immigration (Ferdinand et al., 2005; Garcia de Viedma et
al., 2005; Zozio et al., 2005). Spoligotyping, however, is not always informative and
transmission links could not be traced because strains with shared spoligotypes may have
variable matched IS6110 profiles and is not recommended for tracking such strains like
W/Beijing strains specially, in a high prevalent area e.g. China (van Soolingen et al., 1995;
Bifani et al., 2002; Mokrousov et al., 2002; Kremer et al., 2004).
Spoligotyping has considerable advantages over IS6110 typing. It is an easy PCR-
based technique, requires small amounts of DNA and is less technically demanding. It has
the potential to be used directly on clinical specimens, e.g. sputum, without the need for
culture, paraffin embedded specimens and cell culture lysates (van der Zanden et al., 1998;
Driscoll et al., 1999; Qian et al., 1999). The technique is of great value in developing
countries, which have limited resources for culturing facilities and lack technical expertise.
It is a suitable tool for early identification of outbreaks and incidents of laboratory cross-
contamination. Using this technique, large numbers of samples can be processed at one
time and results can be compiled in a computerized bar-coded system for easy reading and
comparison (Mathema et al., 2006). In this respect, two recognized databases, SpolDB3
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and SpolDB4 have been deposited in the international database for the purpose of
comparison and exchange (Brudey et al., 2006; Filliol et al., 2006).
However, spoligotyping is less discriminative than IS6110-based typing (Prodinger
et al., 1997). It is not a suitable tool for strain differentiation if used alone since it involves
analysis of only one locus (Soini et al., 2000; Cronin et al., 2001). Nonetheless, a
combination of spoligotyping and other molecular typing such as MIRU and VNTR can
provide adequate epidemiological information for studying links between isolates that may
help tracing an ongoing transmission (Savine et al., 2002; Kremer et al., 2005).
Interpretation of genetic spoligopattern changes can be misleading since a deleted DVR in
the DR has been demonstrated in a spoligoprofile of M. tuberculosis laboratory strain sub-
cultured from its parental clone (Aranaz et al., 2004).
ii) MIRU and VNTR typing
Mycobacterial interspersed repetitive units (MIRUs) are small tandem repetitive
DNA sequences originally identified within the intercistronic region of the senX3-regX3
operon of M. tuberculosis (Supply et al., 1997). Frothingham and Meeker-O’Connell
(1998) identified 11 VNTRs consisting of five polymorphic tandem repeats plus six exact
tandem repeat (ETR) with sizes extending from 53 bp to 79 bp for differentiation of MTBC
strains. Although they are limited in number, VNTR are useful in typing M. bovis and in
constructing a phylogeny of M. tuberculosis complex isolates (Frothingham et al., 1999;
Kremer et al., 1999).
MIRUs are a class of VNTRs. Three families of MIRUs, comprising repeated
elements of 77 – 101 bp, 46 – 53 bp, and 58 -101 bp, have been identified, covering an
estimated number of 40 - 50 MIRU loci per mycobacterial genome (Supply et al., 1997).
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In mycobacteria, MIRUs have no defined function and are possibly selfish DNA elements
which have multiplied by gene conversion (Supply et al., 1997). However, the location of
MIRUs within operons and open reading frames (ORFs) in the same directional and
transcription orientation with the ORFs of these genes, suggests that they may have a role
in their translation (Supply et al., 1997).
MIRU loci have been used to discriminate between M. bovis BCG and virulent
strains of M. tuberculosis complex due to the presence of the 53 bp MIRU of senX3-regX3
intergenic region (IR) in the latter strains and its absence from the BCG strains (Magdalena
et al., 1998). MIRU typing has been shown to be more efficient than spoligotyping in
subtyping M. bovis strains, where twelve MIRU loci distributed along M. tuberculosis
genome displayed polymorphisms and some MIRU loci, such as 4, 10, 16, 23, 26 and 40,
were found to be more polymorphic than the reminder MIRUs (Kremer et al., 1999). The
presence of such polymorphism differentiated M. tuberculosis complex isolates obtained
from various countries, traced globally the strains causing epidemics and confirmed their
close-relatedness that emerged from common clades and then expanded worldwide (Supply
et al., 2001).
MIRU analysis is highly efficient in tracing patients with chronic infections,
detecting reinfections in a particular setting, and more discriminatory to isolates with fewer
IS6110-hybridizing bands than spoligotyping or IS6110 RFLP (Cowan et al., 2002; Savine
et al., 2002). More unique isolates were identified with high specificity by combination of
MIRU analysis, spoligotyping and IS6110 RFLP typing (Cowan et al., 2002; 2005).
However, MIRU typing complemented with spoligotyping may generate false clustering
among unrelated isolates (Cown et al., 2005). Applying MIRU typing, other researchers
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have characterized M. tuberculosis isolates collected worldwide and with define lineages,
supported the existence of family grouping or showed genetic diversity that verified the
presence of clonal evolution within species (Sola et al., 2003; Supply et al., 2003;
Ferdinand et al., 2004; Mokrousov et al., 2004). In combination with ETRs and VNTR,
MIRU analysis identified M. bovis and vaccine strains, traced zoonoses and indicated its
impact on public health and trading industry (Roring et al., 2004; Hilty et al., 2005). These
markers can be used clinically for diagnostic purposes, to determine transmission links,
identify multiple infections and discriminate between multi drug resistance (MDR) and
non-MDR M. tuberculosis strains (van Deutekom et al., 2005; Garcia de Viedma et al.,
2005; Kam et al., 2005; Shorten et al., 2005). Application of two informative MIRUs,
numbers 10 and 23, as well as other loci was used successfully to rapidly identify M.
tuberculosis strains which had caused an outbreak in a heavily crowded area. MIRU typing
was employed to develop measures taken to control the outbreak and follow-up (Ashworth
et al., 2008). In another study, the use of standardized 24 MIRU loci on a number of
MTBC isolates collected worldwide achieved high allelic diversity, generating more unique
types than other methods and assisted in constructing phylogeny (Supply et al., 2006).
Among the 24 loci, 15 MIRUs were found to be more discriminatory for M. tuberculosis
isolates following standardization and and was more appropriate for tracking transmission
links (Supply et al., 2006). Most recently, MIRU-VNTR plus a database accessible on the
Web has been developed using the 24 MIRU locus format supported by multiple genetic
markers such as spoligotyping (SpolDB4) to help identify M. tuberculosis lineages (Allix-
Béguee et al., 2008).
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Compared to IS6110 typing, MIRU typing is a relatively easy PCR-based
technique, requiring relatively simple equipment and can be used on small amounts of non-
purified DNA and also with non-viable material; it is time-saving with less cost, and
discriminates between M. tuberculosis isolates exhibiting low IS6110 copy numbers
(Cowan et al., 2002). It has a high resolution power for discrimination of MTBC strains in
a manner equivalent to IS6110 RFLP typing and exceeding that of spoligotyping. In
addition, it is a valuable stable marker and can be used to study population genetics and
evolutionary processes. Moreover, it is a suitable tool for distinguishing unrelated strains
and establishing mixed infection. Furthermore, the method is portable, amendable for
automation and data can be organized in a digital numerical format (Supply et al., 2001;
Savine et al., 2002). However there are a couple of drawbacks; the ultimate evolution rate
of 12 loci is extremely slow in exploring endemic strains (Mazars et al., 2001). This may
render the method unsuitable for investigation of strains outbreak epidemics. Similar
MIRU-VNTR patterns sometimes appear in distinct lineages probably as a result of
convergent evolution (Mathema et al., 2006). MIRU typing also has a lower
discriminatory power compared within IS6110 RFLP typing.
1.20.3 Genomic-based methods
i) Multilocus sequence typing (MLST)
MLST is a simple molecular method designed to examine variable alleles in
nucleotide sequences from several housekeeping genes following amplification of DNA
fragments and sequencing. It exhibits gradual accumulation of conserved genes and is a
valuable method in population genetics for distinguishing bacterial clones causing diseases
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and is therefore extremely useful for epidemiological studies (Maiden et al., 1998).
Application of MLST on six gene loci characterized Neisseria meningitidis hyper-virulent
lineages that had caused an invasive disease and facilitated early disease diagnosis and
treatment (Maiden et al., 1998). Significantly, the results obtained by Maiden et al. (1998)
were concordant with those previously shown by multilocus enzyme electrophoresis
(MLEE). The technique has been utilized in several studies including genotyping of
Leptospira (Ahmed et al., 2006), methicillin-resistant Staphylococcus aureus (Cai et al.,
2007), and revealing the population structure of Candida dubliniensis (McManus et al.,
2008). The method has been employed in evolution genetics to demonstrate that M.
ulcerans, the agent of Buruli fever, evolved from M. marinum (Stinear et al., 2007).
The main advantage of MLST is that it detects relatively variable nucleotides in
multiple gene loci (Maiden et al., 1998). Also the technique can be used to determine
population structure and any genetic alterations and obtained data sequences can be helpful
in comparing results and exchanging data between laboratories via internet Web sites. Yet,
the method is less discriminatory showing limited variable data and an inappropriate tool
for investigating disease outbreaks (Maiden et al., 1998).
ii) SNP analysis
Single nucleotide polymorphisms (SNPs) are genetic variations, which emerge from
nucleotide mutation under the influence of selective pressure, recombination or rarely gene
exchange (Reid et al., 2001). Although M. tuberculosis is a clonal organism, genetic
variability in the form of SNP, region deletions or small duplications exist (Sreevatsan et
al., 1997). There are two types of SNPs; a non-synonymous single nucleotide
polymorphism (nsSNP), in which genetic alteration produces a new amino-acid vulnerable
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to selective pressure, and synonymous single nucleotide polymorphism (sSNP) that is a
mere nucleotide substitution that does not affect the translated amino-acid (Baker et al.,
2004). Non-sSNPs mediate drug resistance traits by generating metabolites that render the
drugs ineffective or the products become unsuitable as drug targets (Baker et al., 2004;
Mathema et al., 2006). In addition, these non-sSNPs can assist in monitoring resistant
phenotypes and dissemination of drug resistance in the community at local and global
levels. The sSNPs on the other hand, provide fruitful genetic information relative to TB
epidemiology and evolutionary relatedness of clinical isolates (Ramaswamy et al., 2003).
Based on the occurrence of two-single nucleotide polymorphisms in katG codon 463 and
gyrA codon 95 in the genome of M. tuberculosis, Sreevatsan et al. (1997) grouped M.
tuberculosis complex into three genotypic groups: Group 1 organisms had katG 463 CTG
(leucine) and gyrA95 ACC (threonine); group 2 had katG463 CGG (arginine) and gyrA95
ACC (threonine), while group 3 had kat463 CGG (arginine) and gyrA95 AGC (serine).
Group 1 contains M. africanum, M. microti and M. bovis; group 2 contains M. tuberculosis
CDC1551 strain: while group 3 includes M. tuberculosis H37Rv (Sreevatsan et al., 1997).
Neither of the two mutations are related to drug resistance (Sreevatsan et al., 1997). It has
been proposed that organisms belonging to group 1 and 2 have a higher level of virulence
than those from group 3 (van Embden et al., 1993; Sreevatsan et al., 1997), although this
claim is not supported by all researchers (Rhee et al., 1999). Baker et al. (2004) analysed
katG and gyrA and other mutations in a population comprising UK isolates obtained from
foreign-born patients originating from different countries. The resulting data divided the
isolates into three M. tuberculosis genetic groups, with four lineages (I, II, III and IV),
based on silent or synonymous single nucleotide polymorphisms (Baker et al., 2004).
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These mycobacterial lineages were found to associate geographically with the continent of
birth. For example, lineage I dominated in South-Eastern Asia; lineage II in Europe;
lineage III in the Indian Subcontinent; and lineage IV has universally disseminated. These
findings have been shown to correlate with IS6110 typing, spoligotyping and validate
earlier family group classification (van Soolingen et al., 1995; Sreevatsan et al., 1997;
Kremer et al., 1999; Sola et al., 2001). Persistent SNP-analysis performed on multiple M.
tuberculosis clinical isolates has resulted in splitting principle groups into eight clusters
plus a subgroup (Gutacker et al., 2002; 2006) or six large cluster groups and three
subgroups (Filliol et al., 2006). Further utilities of the SNP analysis have been cited by
other researchers in the section of phylogenetic structure (Fleischmann et al., 2002; Alland
et al., 2003; 2007).
SNP-analysis has several values. Firstly, information provided by it is accurate
because it reflects exact nucleotide sequencing of the strains (Mathema et al., 2006).
Secondly, it can be accomplished by using a few chosen SNPs. Thirdly, it is less liable to
selective pressure which makes it suitable for reconstructing phylogeny, explore drug
resistance-mediating alleles or study regions with genetic variability in association with
virulence and host immune reactions (Schork et al., 2000; Arnold, 2006; Mathema et al.,
2006). Nevertheless, the technique is cumbersome requiring a tedious effort to figure out
several potential loci containing SNPs in different genomes (Mathema et al., 2006).
iii) Deligotyping
Deligotyping is a membrane-based technique hybridized with known covalently–
linked oligonucleotides adapted to screen multiplex PCR products. The released PCR
products from potential strains were detected for the presence or absence of large sequence
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polymorphisms (LSPs). Utilizing this array-based approach, Goguet de la Salmonière et al.
(2004) verified almost all genomic deletions in M. tuberculosis clinical isolates and MTBC
strains that were previously reported by others using Affymetrix DNA microassay and
other techniques with high efficiency and specificity (Behr et al., 1999; Gordon et al.,
1999; Betts et al., 2000; Salamon et al., 2000; Fleischmann et al. 2002). The same method
was shown to be extremely valuable in tracing and monitoring a single M. tuberculosis
strain causing an outbreak among homeless people in a populated area. It eased TB control
measures and conserved health resources (Freeman et al., 2005).
The advantages of deligotyping are: Firstly, deligotyping examines minor
differences in many genes at one time with high resolution without the need for expensive
Affymetix GeneChip microarray analysis (Fleischmann et al., 2002). Secondly, it helps in
the deciphering of potentional LSPs that are probably involved in pathogenecity (Freeman
et al., 2005). Thirdly, it is a highly specific technique for exploring target polymorphism
without any ambiguitiest. Fourthly, the genetic informative data derived from the
technique can be exploited for the understanding of the function of deleted genes and their
roles in subsequent changes in evolution and molecular epidemiology (Mathema et al.,
2006). Nonetheless, the method is slightly less sensitive than microarray-based approaches
(Goguet de la Salmonière et al., 2004).
iv) Genomic deletion analysis
Genomic comparative sequencing by microarray between M. tuberculosis strains
H37Rv and CDC 1551 or M. bovis characterized deletions of LSPs, also termed regions of
difference (RD) and SNPs (Brosch et al., 2001; Gordon et al., 2001; Fleischmann et al.,
2002; Mostowy et al., 2002). These LSP deletions are found in aggregates in M.
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tuberculosis and clinical isolates, particularly in areas abundant with IS6110 insertions and
DR regions. This is probably due to recombination incidents, selective pressure,
transposition or genetic rearrangements that arise in conjunction with other deletions in the
development of genetic diversity (Fleischmann et al., 2002; Alland et al., 2003, 2007).
Ultimately these genomic changes may affect virulence or even induce the development of
drug resistance (Maurelli, 1989; Hacker and Carniel, 2001; Rowe-Magnus et al., 2001).
Such genetic diversity can be detected by genomic deletion analysis such as deligotyping.
Kaeto-Maeda et al. (2001) demonstrated by Affymetrix GeneChip the presence of several
aggregated genomic deletions in M tuberculosis infecting patients presenting with few
pulmonary cavitations and in which transmission was limited. Based on PCR genomic
analysis of RDs and TbD1 regions, Brosch et al. (2002) identified several deletions creating
an evolutionary scenario for MTBC strains. Comparative genomics using the Affymetrix
DNA microarray technique detected 68 genomic deletions that aided in constructing a
phylogeny for 100 clinical isolates of M tuberculosis and uncovered deletions those
incorporatied specific genes that induced hypoxia. Further work employing comparative
genomics helped to locate a number of deletions representing LSPs (Tsolaki et al., 2004;
2005). Yang et al. (2005) have also reported a genomic deletion involving phospholipase
gene D (plcD) located in the IS6110 region in association with extra-pulmonary TB.
1.20.4 Other genotyping methods
The exact tandem repeats (ETRs) locus also identified as a VNTR locus that, has
been employed to segregate MTBC strains (Frothingham and Meeker-O’Connell, 1998).
When applied to isolates with high copy number of IS6110, VNTR analysis elicited large
clusters which were further split by IS6110 analysis (Barlow et al., 2001). But, their
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application in isolates possessing a single or low copy number is discriminate and valuable
as an initial step for a more efficient method such as IS6110 typing. Having enough
genetic diversity, MPTR and PGRs identified M. tuberculosis strains with low or no copies
of IS6110 (Kremer et al., 1999). Utilization of PGRs as a secondary typing method after
IS6110 technique contributed to the determination of the transmission dynamics and helped
in the designing of public health measures for TB control (Maguire et al., 2002).
Amplification of 16S rRNA and mtp40 coupled with sequencing has been used to
differentiate M. tuberculosis complex isolates (Magdalena et al., 1998; Fletcher et al.,
2003).
1.21 PHYLOGENETIC STRUCTURE OF M. TUBERCULOSIS
Phylogenetic analyses are vital since they classify isolates with defined genetic links
into groups, examine evolutionary relationships, strengthen epidemiological investigations,
help identify drug resistance trait and determine virulence factors involved in pathogenicity
(Alland et al., 2003). Several studies have been conducted into the phylogenetic structure
and the relations between M. tuberculosis species (Filliol et al., 2003; Baker et al., 2004).
Analysis of 26 structural genes based on nsSNPs involving global isolates of M.
tuberculosis complex using a combination of only two alleles, 463 and 95 in codons katG
and gyrA respectively, categorized the organisms into three PGGs: 1, 2 and 3 (Sreevatsan et
al., 1997). The study showed that tubercle bacilli in group 1 are descendents of group 2
and bacilli in the latter group have also descended from group 3. Fleischmann et al. (2002)
examined comparative genomic sequencing of two strains of M. tuberculosis, namely,
H37Rv and CDC 1551 that assisted in generating a phyogenetic tree for clinical M.
tuberculosis isolates. In addition, the authors discovered the polymorphic genetic loci
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coding for PE/PPE gene family or phospholipase C genes, which may have a role in
virulence, pathogenicity and host immunological response. Using 77 identified SNPs
among H37Rv and CDC 1551 strains for investigating a group of clinical cases of M.
tuberculosis and M. bovis infection, Alland et al. (2003) produced an evolutionary tree
comprising two main branches at two ends (each end was occupied with a reference strain
i.e. H37Rv or CDC 1551) and 14 secondary branches in between, which were occupied by
the clinical isolates including M. bovis. However, their study involved isolates collected
from patients found in only one location. Two comparative genomic studies; one using 230
sSNPs and the other informative sSNPs for 5,069 M. tuberculosis lineages in three
genomes of M. tuberculosis strains and subsequently to global M. tuberculosis complex
isolates, located eight family clusters annotated as I to VIII representing M. tuberculosis
lineages besides II.A sub-cluster (Gutacker et al., 2002; 2006). In comparison to four
lineages (I-IV), Baker et al. (2004) found that lineage IV is less susceptible to drug
resistance. The lineage findings were consistent with that of the clusters (Gutacker et al.,
2002; Baker et al., 2004; Gutacker et al., 2006). For example, M. tuberculosis lineage IV
which matches cluster I, also belonged to PGG 1 and possesses TbD1 region, thus
supporting the viewpoint that tubercle bacillus is ancestral (Mathema et al., 2006).
Sometimes, however, discrepancies occur between these molecular markers. For instance,
Baker et al. (2004) thought that H37Rv and CDC1551 strains were nearly the same and
both belong to lineage II that is associated with different clusters as opposed to the findings
of others who assigned the former strain to cluster VIII with PGG3 and the latter to cluster
V designated to PGG2 (Fleischmann et al., 2002; Alland et al., 2003; Gutacker et al.,
2006). This distant relationship between the two strains was also observed in comparative
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genome sequences at the level of IS6110 position, orientation and insertion sites (Mathema
et al., 2006). Filliol et al. (2006) utilized 212 SNPs and achieved similar results as
previously documented (Gutacker et al., 2002; 2006) with a few variations. The authors
reconstructed a four-branched phylogenetic tree for the collected isolates, which contained
six cluster groups and three subgroups instead of a three-branched tree and eight groups
plus a subgroup (Gutacker et al., 2006). In addition, Filliol et al. (2006) built a phylogeny
of M. tuberculosis and achieved compatible findings with other researchers using different
modelling methods and programmes. More recently, Alland et al. (2007) has demonstrated
that LSPs are genomic deletions that probably evolved as a source for genetic diversity due
largely to IS6110 transposition events in clinical M. tuberculosis isolates in association
with virulence and transmission rather than as mere phylogenetic markers. However,
others believe that LSPs are valuable genetic markers for molecular epidemiology and
evolution of M. tuberculosis (Mostowy et al., 2002).
1.22 PHYLOGENETIC FAMILY STRAINS
Phylogenetic analysis assists in grouping isolates into family strains. Grouped
isolates must have specific and common properties e.g., deleted spoligotyping spacers, in
order to be designated to a family strain. Although some family strains can be identified by
the use of one molecular marker, combination of molecular markers gives better results.
Depending on the presence and absence of TbD1 region, Brosch et al. (2002) revealed that
M. tuberculosis isolates which have the region are ancestral strains belonging to group 1
(e.g., EAI) while those devoid of it for example, W/Beijing, Africa and Haarlem strains are
modern strains designated to group 2. Equally, Filliol et al. (2003) utilized visual
spoligotyping patterns and grouped M. tuberculosis into seven strain families, namely,
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Beijing, Haarlem, Latin-American Mediterranean (LAM), EAI, S, T and X. Sun et al.
(2004) employed the copy number of repeats in MIRU 24 to place M. tuberculosis isolates
into group 1 with two repeats and those with one MIRU repeat into group 2. Taking these
properties into account, EAI family strains are further characterized by their specific
spoligo-pattern formed of deleted DVRs 29 to 32 and 34 and their assignment to cluster I
and lineage IV by SNP analysis (Filliol et al., 2002; Gutacker et al., 2002; Filliol et al.,
2003; Baker et al., 2004). In addition, the strains possess a distinct MIRU profile with high
copy numbers at MIRU 23 (≥ 6), MIRU 24 (> 1) and MIRU 4 (≥ 3) supporting their
ancestral origin (Sun et al., 2004).
Further classification using spoligotyping alone or in combination with SNP-
analysis and MIRU typing with or without TbD1 region helped to group family strains.
Haarlem strains have emerged with special spoligotype signature consisting of deleted
DVRs 8 and 32 to 35 (Filliol et al., 2002). The strains fall in cluster III or lineage II with
PGG 2 and have retained the TbD1 region (Gutacker et al., 2002; Baker et al., 2004).
Moreover, the strains exhibit a specific MIRU pattern with high copy numbers (6-13) at
MIRU 10 and similar IS6110 profiles (Filliol et al., 2002; Gutacker et al., 2002). The
LAM strains are distinguished by spoligo-pattern consisting of deleted DVRs 21 to 24 and
32 to 35 (Filliol et al., 2002). They are grouped into cluster IV with PGG 2 and show
similar IS6110 profiles (Gutacker et al., 2002). Beijing strains are identified by several
characteristics including their unique spoligo-pattern lacking spacers 1 to 34, designation to
cluster II or lineage I with PGG 1, and high copy number of IS6110 including one in the
origin of replication (oriC), and at least one copy of the insertion in the NTF locus (a base
adjacent to the 3’ end of the flanking IS6110 element in W strain of M. tuberculosis)
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(Glynn et al., 2000; Bifani et al., 2002; Filliol et al., 2002; Gutacker et al., 2002; Baker et
al., 2004; Hirsh et al., 2004).
1.23 BEIJING STRAINS, CHARACTERISTICS, DISTRIBUTION AND PATHOGENESIS
Phylogeographic and clonal structure of M. tuberculosis groups strains to specific
geographical locations and plays an important role in understanding the epidemiology of
TB. Specific phenotypic and genotypic characteristics of M. tuberculosis are identified in
certain countries, for example, the Beijing and Haarlem families (Gagneux and Small,
2007).
The ‘Beijing family’ of M. tuberculosis strains first emerged in China in the mid
1950s (van Soolingen et al., 1995; 2001). The family is well recognized genetically and
has a highly homogenous genotype with unique characteristics including; high similarity of
IS6110 RFLP patterns, unique spoligopatterns and multiple drug resistance (van Soolingen
et al., 1995; 2001; Drobniewski et al., 2002; Tougoussova et al., 2002). In addition, the
Beijing/W strain is characterized by the presence of one or two insertions of IS6110 in the
dnaA-dnaN intergenic region and the NTF region which differentiates between lineages
including, the N family (Kurepina et al., 1998; Milan et al., 2004). Other characteristic
features of these strains are mutations in mutT and increased virulence with the ability to
overcome the immunological protection of the BCG vaccine (van Soolingen et al., 1995;
Lopez et al., 2003; Reed et al., 2003; Werngren and Hoffner, 2003). Infections from this
strain are dominant in Asia where their prevalence ranges from 34-70% (Anh et al., 2000;
Chan et al., 2001; van Crevel et al., 2001; Drobniewski et al., 2002).
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1.24 ACTIVE CASE FINDING AND DIAGNOSIS
Active case finding is a traditional contact searching approach that uses the
presenting clinical symptoms and Mantoux test of an individual, who has remained in
direct contact with an infectious index case and from whom the individual has supposedly
contracted the infection (Clancy et al., 1991). This approach assumes that any harboured
characteristics by the index case, including susceptibility to drugs, will automatically be
passed on to individuals in contact who then act as reservoirs in perpetuating the infection
and any other traits (Burgos and Pym, 2002). Hence, in order to limit transmission and
control TB, contacts should be searched for and rapidly detected using Mantoux test and
chest radiography (Thoracic American Society, 2000). This traditional epidemiological
policy is currently adopted by some industrialized countries in TB control programmes
(Bishai et al., 1998; Thoracic American Society, 2000). Yet, the policy has a couple of
discrepant results. Behr et al. (1999) have cited an account of 30% distinct profiles among
compared paired DNA samples taken from index and contact cases implying the existence
of a third source of infection and have therefore raised doubts about the TB control
programmes.
1.25 EFFECT OF MIGRATION AND IMMIGRANTS ON TB OCCURRENCE
Migration is defined as the movement of a person from one place or locality to
another under pressure from socio-economic, religious, psychological and political reasons
(Davies, 1995; Chemtob et al., 2003). Migration has a great impact on the spread of
infectious diseases, particularly TB (Long et al., 1999), as although many industrialized
countries had succeeded in controlling TB in the last latter part of the last century, the
influx of immigrants originating especially from TB endemic countries and international
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travelling continue to affect the prevalence of the disease in these communities (Enarson et
al., 2000; Talbot et al., 2000; Dale et al., 2005; Chemtob et al., 2003; Dahle et al., 2007).
Immigrants are believed to act as reservoirs, incubating persistent latent M. tuberculosis
infections that may progress to active disease after several years (Heywood et al., 2003).
More than 50% of TB cases reported in many Western countries result from immigrants
(Schwoebel et al., 1999; Talbot et al., 2000). For example, in Denmark, a country with low
TB prevalence, 74.9% of Somali immigrants were found to be incubating dormant M.
tuberculosis on arrival into the country (Lillebaek et al., 2001). In The Netherlands only
17% of TB cases among native Dutch have been attributed to foreign-born residents
(Borgdorff et al., 1998). However, low levels of cross infection from immigrants to local
populations have been reported in several countries with low prevalence (Lillebaek et al.,
2001; Chemtob et al., 2003; Dale et al., 2005) even though prevalence and incidence of the
disease among immigrants in these communities showed an increase because many people
from different ethnic immigrants harbour latent infection and stick togther (Lillebaek et al.,
2002). Lillebaek et al. (2001) also observed a high proportion of clustered isolates
(55.2%), reflecting ongoing transmission among immigrants in a country with low TB
incidence. Conversely, others reported that imported TB has little effect on native
populations in some countries with similar incidence of the disease (Dahle et al., 2007).
1.26 PREVALENCE OF TB IN GULF COUNTRIES
Epidemiological studies of TB are important in evaluating the occurrence,
determinant, distribution and control of the disease within populations (Narayanan et al.,
2004). There is limited information regarding the prevalence of TB in the Arabian Gulf
countries, which include Saudi Arabia, United Arab Emirates (UAE), Kuwait, Oman, Qatar
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and Bahrain. In one study Al-Hajoj et al. (2007) analyzed 1505 clinical isolates of M.
tuberculosis using molecular typing in Saudi Arabia and identified nine internationally
circulating clades. In addition, they reported the presence of single drug resistance in 20%
of strains and 4.5% of multiple drug resistance (Al-Hajoj et al., 2007).
1.27 PREVALENCE OF TB IN THE UAE
United Arab Emirates (UAE) has a population of approximately 4.95 million, the
majority of which are immigrant expatriates equipped with knowledge and skills important
to the UAE economy (Annual Statistical Reports, UAE, 1981-1998; 2003; UAE Interact,
2007). Following the increase in oil revenues during the period from 1973 to 1979, the
country experienced a rapid economic development, which was very quickly transformed
into a market economy (Annual Statistical Reports, UAE, 1981-1998; 2003; UAE Interact,
2007). The government implemented various infrastructure developmental projects, which
attracted foreign workers from all over the world, particularly Southeast Asia and Northern
America to fill both the professional and the labour job markets. Indeed, early reports
indicated that TB-infected immigrants who came to the Gulf countries after the era of oil
exploration were responsible for the introduction and spread of the disease (Annual
Statistical Reports, UAE, 1981-1998; 2003; UAE interact, 2007).
Epidemiological data from tuberculosis control and treatment centres in the UAE
have revealed an increase in the incidence of TB (Annual statistical Reports, UAE, 2003).
About 85-95% of the TB clinical cases in the UAE were reported from patients from TB-
endemic countries, including India, Pakistan and Bangladesh (WHO, 2002). Analysis of
incidence rates for the period 1997-2003 showed an increase in the number of new cases
from 23 cases to 85 cases/100,000 population identified respectively among UAE nationals
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with a parallel decline in incidence rate among imported cases from 18% in 1995 to 2% in
2000 (Dissanayake et al., 2001). The same authors reported the presence of indigenous
strains and the foci of local transmission of M. tuberculosis in the UAE. Suppositions
surrounding the presence of unique strains have been supported by the findings of distinct
IS6110 patterns after genotypic analysis of M. tuberculosis isolates that did not fit more
than 4000 global patterns and the presence of unique signs in UAE natives superimposed
by extra-pulmonary TB form (Dissanayake et al., 2001). Likewise, increased rate of
multiple drug resistant cases from 1.4% to 8.5% has been reported in UAE TB patients
(Bener et al., 1996; Dissanayake et al., 2001). The conflicting epidemiological data may be
due to the fact that the data has emanated from different sources and bodies that are
coordinated or integrated.
1.28 UAE DEMOGRAPHIC POPULATION AND SOCIAL CHANGES
UAE is a federal country composed of seven emirates; Abu Dhabi has the largest
population making up 39% of overall UAE total population, followed by Dubai 29%,
Sharjah 17%, Ras-al-Khaima 6%, Ajman 5%, Fujairah 3% and Um-al-Quiwain 1.5% (AL-
Awadhi, 2007; Looklex, encyclopaedia, 2007). The political system of the country is
represented by the ruler in Abu Dhabi who is also the president of the country; while the
ruler of Dubai, a commercial centre for the UAE, acts as a Vice President and Prime
Minister (AL-Awadhi, 2007; Interact, UAE, 2007). The General Authorities of Health
Services (GAHS) stationed in Abu Dhabi is responsible for providing health services and
management; while in the remainder emirates, the Ministry of Health (MoH) does the job.
The Preventive Medical Department (PMD) which is also found there investigates
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infectious diseases including TB and cares for community-based services, and only PMD
representative units are found in other emirates.
The country has a diverse population the majority of which are immigrant
expatriates (Annual Statistical Reports, UAE, 1998; 2003; UAE Interact, 2007). Non-
nationals constitute about (81%) of population with natives forming only 19% (UAE
interact, 2007). There are different ethnic groups including Emiratis (19%), Arabs, Iranians
and Baluchi (23%), South Asian (Indians, Pakistani, Bangladeshi and Sir Lankan) (50% of
the whole population) and others, such as Westerners and East Asians (8%) form the other
ethnic groups found in the UAE (AL-Awadhi, 2007; Interact, UAE, 2007). The age
structure comprises 0-14 years (25.3%), 15-64 years (71.1%) and over 65 years (3.6%).
The sex ratio of male to female is 1:1.442.
The dominance of expatriates over the natives has created several demographic and
social changes. Unemployment has flourished among natives with concomitant decrease in
the number of nationals and increased number of immigrants (AL-Awadhi, 2007). The
increased number of young male immigrants in the age group of 20-30 years has also
contributed to the lack of job opportunities among natives. Moreover, nearly more than
60% of the total population, most of whom are non-nationals, are concentrated in only two
emirates, Abu Dhabi and Dubai, this has therefore resulted in a demographic change (AL-
Awadhi, 2007).
1.29 MAJOR EXPORTING COUNTRIES OF LABOUR TO UAE AND PREVALENT
STRAINS
The major countries exporting labour to the UAE are India, Pakistan and
Bangladesh all of which have a high TB prevalence (WHO, 2002). These nationalities
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constitute more than two thirds of the population of the UAE (Khoja, 2002; WHO, 2002).
Other countries serving as important sources of labour to the UAE are Sri Lanka, the
Philippines, Indonesia and Nepal (Khoja, 2002). The overall manpower coming from these
seven countries is estimated to be about 2.5 million with an estimated annual turnover of
20% (Khoja, 2002).
India has the highest prevalence rate in the world of TB (30%) with 1.8 million new
cases of M. tuberculosis infection and about 0.5 million deaths each year (Singh et al.,
2004; Robert, 2007). The average annual TB incidence is calculated as 168 cases per
100,000 of population (van der Werf and Borgdorff, 2007). The impact of the disease on
India has a significant effect as a result of the emergence of HIV epidemic, MDR-TB, and
poor resources (Singh et al., 2004). The predominant M. tuberculosis genotypes found in
India are: the Central Asian 1 type (CAS 1) (22%) reported in association with pulmonary
cases; Beijing (8%) linked with MDR-TB cases, EAI, LAM, Haarlem, Manu, T 1 and X 1
as well as well as some of other MTBC species including M. bovis and M. africanum
(Singh et al., 2004; Brudey et al., 2006; Gutierrez et al., 2006; Shah et al., 2006).
Bangladesh ranks the 6th on the list of countries with high TB risk with ~ 70,000 deaths and
300,000 new cases each year (WHO, 2005; Zaman et al., 2007). Recent studies showed
prevalence rate estimate ranged from 24 to 150 cases per 100,000 of population, and an
annual incidence rate estimated as 229 cases per 100,000 people (van der Werf and
Borgdorff, 2007; Zaman et al., 2007). The most abundant M. tuberculosis genotypes are
Beijing (31%), CAS 1 (17%), along with other strains from epidemic and endemic types
(Banu et al., 2004; Hasan et al., 2006). Like in India, the emergence of the HIV epidemic
and increased MDR-TB cases pose great challenges to TB control efforts in Bangladesh
73
(Banu et al., 2004). Pakistan is graded as the 7th most TB burdened country showing an
incidence rate of 181 cases/100,000 persons (Hasan et al., 2006; The Union World
Conference on Lung and Health, Paris, 2008). Again it is recognised that the deteriorating
TB prevalence in Pakistan is compounded by co-infection with HIV and emergence of
MDR-TB (Hasan et al., 2006; The Union World Conference on Lung and Health, Paris,
2008). The prevalent M. tuberculosis genotypes circulating in the Pakistan region are: CAS
1 (39%), Beijing (6%), EAI, LAM, and T group (Hasan et al., 2006).
1.30 TB SCREENING TESTS FOR IMMIGRANTS
Many developed countries (including the US and UK) with low TB prevalence face
increased TB incidence resulting from the flow of new immigrants and foreign-born
residents who may transmit infection to the native population (Bloom, 2002; Laifer et al.,
2007). On entering a country, most immigrants do not present with clinical signs (Laifer et
al., 2007). To efficiently diagnose and reduce TB infection rates, active and latent cases
need to be detected. Various screening tests routinely used includ chest X-ray, acid fast
staining of sputum smears, sputum culture, and PCR to detect active cases, while Mantoux
test and whole-blood IFN-γ assays are employed for the detection of latent cases (Mazurek 
et al.; 2001; Pai et al., 2004; Dasgupta and Menzies, 2005). Chest radiography has a high
sensitivity but is relatively less specific with a high net cost (Dasgupta and Menzies, 2005).
Mantoux test involves intradermal inoculation of purified protein derivative (PPD) antigen
with measurement of cell-mediated immunity manifested by induration and erythematic
lesion after 48-72 hours to diagnose latent TB (Anderson et al., 2000). The test has a high
sensitivity and low cost but it cross-reacts with NTM organisms and M. bovis BCG
vaccine, and shows variability and subjectivity (Pai et al., 2004). Mantoux test has recently
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been replaced by GIRAS for detection of cases with latent infection among immigrants
throughout Europe (Pai et al., 2004).
1.31 TB CONTROL STRATEGIES
The main goal of TB control is to get rid of the disease through reduction of
transmission by prompt identification of infectious cases and effective treatment (Clancy et
al., 1991). Pioneering attempts to develop effective control of TB were launched by the
World Health Assembly (WHA) resolution in 1991, which aimed to achieve two targets; to
detect 70% of new smear-positive cases and to treat 85% of these cases by 2000 (WHO,
1993). In 1994, the WHO established DOTS strategy that aimed to support the attempts of
WHA. The directly observed short course therapy is composed of five elements namely;
government dedication to support TB control programme, bacteriological detection and
case finding, standardized and supervised therapy, maintained delivery of drugs, and
regular monitoring programme for supervision and assessment (WHO, 1994). DOTS
strategy has been implemented in 182 countries the majority, of which have achieved
successful TB programmes. TB still remains a burden in sub-Saharan Africa due to the
HIV epidemic and poor health care facilities and regions of Eastern Europe region where
poverty flourishes with aggravated low standard of living and other vices (Migliori et al.,
2006; WHO, 2006). These regions still suffer from escalated TB notification rates. As a
result of the continued implementation of the DOTS policy, global incidence and mortality
rates of TB have subsided (WHO, 2006). Out of 20 million treated patients in 2004, 16
million were cured; the policy fulfilled its target for the year 2003 by treating 83% of cases
and detected 53% of new cases by 2005 (WHO, 2005). After a revision of the strategy, the
WHO and technical partners decided to introduce an extended New Stop Strategy for the
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years 2006 to 2015 in further support for DOTS with the aim of facing new challenges in
relation to various social and health changes (WHO, 2006; Zignol et al., 2007). This
strategy was required to break barriers of unjust health care management systems and make
treatment and supervision accessible to vulnerable groups such as the poor, homeless and
marginalized people. Of particular importance, this strategy addressed interaction between
TB and HIV, cooperation between programmes, emergence of MDR-TB and recent XDR-
TB that have worsened the burden of disease and outcome of treatment regimes
(Raviglione et al., 2007). In addition, the new strategy called for more practitioners and
health carers to participate, and procured sustained extra funding and resources in
cooperation with the private sector to establish health care infrastructures and services that
can effectively deal with the needs of patient. The programme also tackled crucial issues
such as enhancing TB research worldwide to explore effective drugs, new vaccines and
rapid diagnostic methods (WHO, 2006). This was to be supported by the establishment of
a web of well equipped laboratories having advanced techniques and dedicated qualified
staff. Moreover, the strategy intended to promote awareness among people in various
communities to alleviate stigma, improve care and enhance political commitment of
governments (Raviglione and Uplekar, 2006; WHO, 2006). In order to fulfil the above
outlined activities, the strategy planners should recognize that an efficient management
system is essential for monitoring and supervision.
1.32 THE UAE HEALTH STRUCTURE AND GENERAL GOVERNMENT POLICY FOR
CONTROL OF INFECTIOUS DISEASES
The UAE public health structure comprises two governmental bodies stationed in
the capital. The MoH providing supervision and GAHS which manages and delivers health
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services to the Emirate of Abu Dhabi. With the exception of the Emirate of Abu Dhabi, the
Emirates fall under the responsibility of the MoH which fully funds and provides medical
services. The health system comprises hospitals, PMD and primary health care centres
(PHCs) (GAHS, 2006). The main office of the PMD is located in Abu Dhabi and
coordinates smaller representative units distributed in the remaining Emirates. It is
responsible for community-based services, carrying out screening tests for TB and other
infectious diseases such as HIV, Hepatitis B and C, BCG vaccination, implementing the
expanded vaccine programme in children and promotion of health and education. Reported
TB cases in hospitals and PHCs are regularly notified to the PMD. Currently, the country
lacks a separate centre responsible for TB control and there is no legislative law that
compels an infected person to take treatment. In addition, the private health sector is not
involved in the strategy of TB control.
The government has implemented a code of practice to manage TB cases among
nationals and a control policy that targets expatriates and non-nationals. Case
ascertainment depends on the diagnosis of TB bases on symptoms and chest radiography of
infected persons at PMD and district hospitals, tracing of contacts, sputum smear
microscopy to demonstrate acid fast bacillus using Ziehl-Nielsen stain. Confirmation of
results was done in the laboratory of Al Ain hospital, where pathological materials were
cultured to determine the MTBC isolates. The government policy for TB control includes a
mandatory chest X-ray to detect active cases. The targets for this policy are new
immigrants and non-national residents with visa renewals. New immigrants are sent to the
PMD to be screened for TB by chest x-ray within three days of arrival. If the radiography
is abnormal, a Mantoux test is performed. If the latter is positive, the patient is deported.
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In case of doubtful results, such as difficulty in interpretation of radiography, the chest X-
ray is repeated and Mantoux test is performed. In some instances, doubtful results are sent
to a designated laboratory in Germany for confirmation. Only immigrants within the age
group of 18-60 years are issued entry visas. Visas are issued on personal basis only and
last for a period of three years. During this time the person may also bring over his family
if his monthly salary exceeds Arab Emirates Dirhams (AED) 5000 (currently £1= 5,25
UAE Dirhams). Once the visa expires, a non-national resident is required to retest for TB
at the PMD. If the tests are positive the person is deported.
As a policy, all live births in the UAE are immunized with the BCG vaccine at birth
as a part of expanded WHO immunization programme. Healthcare workers must wear
gloves and masks during management and movement of cases to reduce airborne
transmission. If a UAE national is infected in a household, he/she is treated as an index
case. The case is immediately notified to the PMD and the patient is isolated in a hospital
ward under supervised treatment and police guard. Close contacts are screened for TB by
chest x-ray and Mantoux test. All individuals who test positive are treated accordingly and
prophylaxis is provided to all contacts.
1.33 LIMITATIONS OF DATA EXPERIENCED DURING THE STUDY
The candidate has encountered several limitations while collecting data and
executing this molecular TB study in Al Ain, which has influenced the outcome of the
study. Firstly, the collected number of samples used in this study was small which
complicated statistical analysis and increased variability. This small number of collected
data was due to logistic problems: of the delayed arrival of samples in the UK from the
UAE, the technical problems of incompetent handling of samples by UAE laboratory staff
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that resulted in reduced number of recovered samples after culture or the failure of growth
specimens. Secondly, demographic and clinical data of TB participants were retrieved
from medical records and official forms, and not obtained by direct interviews of sick
patients. Thirdly, there were no proper formal addresses for TB participants that hindered
traditional contact tracing and accurate determination of transmission links implied by
clustering.
In the present project, different genotypic methods, including MIRU analysis and
spoligotyping, were been employed to type MTBC prevalent strains, identify strain families
and determine transmission chains of TB in association with conventional epidemiological
data among immigrants and native patients in Al Ain, UAE.
1.34 PROJECT OBJECTIVES AND AIMS
i) Background
Epidemiological data from tuberculosis control and treatment centres in the UAE
show an increase in the incidence of tuberculosis (Dissanayake et al., 2001; WHO, 2002;
Annual statistic Reports, 2003; UAE Interact, 2007). Analyses of incidence rates for the
period 1997 - 2003 revealed an increase in new cases from 23/100,000 persons to 85
/100,000 persons among local resident populations as opposed to a parallel striking
decrease rate among immigrants from 18% in 1995 to only 2% in 2000 (Dissanayake et.al.,
2001). There was also increased rate of multiple drug resistant cases from 1.4% to 8.5%
among patients during the period from 1995 to 2000 respectively (Bener et al., 1996;
Dissanayake et al., 2001). Moreover, distinctive TB clinical signs and tropism were
observed between populations that appeared to be reflected in the high level of extra-
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pulmonary cases among the natives. The objective of this study is to determine whether
the strains responsible for these cases are indigenous or exogenous to the UAE. The
speculations surrounding the presence of unique strains have arisen from findings of
distinct IS6110 patterns of M. tuberculosis isolates in infected UAE nationals that did not
match any patterns on available international database (Dissanayake et al., 2001).
Therefore, there was a need to confirm these observation using genotyping studies
in order to assist in developing an improved TB control policy if required or adjust the
existing control programmes.
ii) Aims
The principal aim of this project was to examine the epidemiology of culture-
confirmed cases of tuberculosis from Al Ain, UAE caused by M. tuberculosis infections
between January 2003 and August 2005, using a combination of modern molecular typing
methods in conjunction with clinical, demographic, and contact tracing data.
Furthermore, genotyping of circulating isolates of M. tuberculosis causing the
disease in the country was undertaken to determine their source of origin; as well as to
determine the rate of any cross infections between indigenous (nationals) and exogenous
(immigrant) populations. In addition, the study assessed the discriminatory capacity of the
molecular methods MIRU and spoligotyping to differenciate between clusters and unique
cases in isolates recovered from patients inhabiting Al Ain, UAE.
The following order of investigation was undertaken:
1. Genotypic analysis of 194 UAE clinical M. tuberculosis isolates by MIRU and
spoligotyping; in conjunction with 40 UK DNA samples, which were included to
validate the typing methods. In addition, these techniques were tested in
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combination with other supplementary molecular methods to determine the most
discriminatory method and to validate some of the findings.
2. Analysis of correlation between the genotypic findings and clinical, demographic
and contact tracing information.
3. Investigation of strains causing TB in the UAE, and their source of origin whether
indigenous or exogenous in order to suggest further recommendation to the
currently existing screening and control programmes in the UAE.
4. Determination of the susceptibility of genotyped strains to rifampin using rpoB
sequencing.
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CHAPTER 2 MATERIALS AND METHODS
2.1 STUDY SUBJECTS
2.1.1 TB participants/Sampling materials
This molecular TB epidemiology study was carried out on 327 patients that
presented at three medical health centres in Al Ain, UAE. Al Ain has a population of ~half
a million people comprising of Emirati and 33 different nationalities. Participants consisted
of both non-nationals and nationals, from different age groups, and of both sexes. Medical
records of TB participants were obtained from the health centres. Sputum samples and
other pathological materials were collected for culture to isolate M. tuberculosis. The
paucity of collected samples was due to low TB incidence (25 cases/100,000 population) in
UAE (UAE Interact, 2007) and logistical problems, such as the delay encountered in
shipping DNA samples from the UAE to UK. After culture only 194 UAE samples were
further processed for genotypic analysis, as some of them either failed to produce viable
culture or became contaminated.
2.1.2 Genomic DNA collection
Genomic DNA from 40 UK M. tuberculosis isolates was provided by Professor
Tanya Parish. These UK isolates were included and simultaneously processed as controls
for some genotypic methods and comparison of results. Genomic DNA from 194 M.
tuberculosis complex from Al Ain, UAE clinical isolates from patients diagnosed with TB
in three different health organizations (Tawam hospital, Al Ain hospital, and the PMD)
were obtained from the Microbiology Laboratory of the Faculty of Medicine and Health
Sciences, UAE University, Al Ain.
82
2.2 STRATEGY FOR LABORATORY STUDIES
Initially, the study utilized MIRU typing to identify UAE isolates recovered from
patients in Al Ain and family strains, this method was chosen as published data suggestedit
as appropriate for such a study (Ferdinand et al., 2004). Spoligotyping was applied to
supplement the MIRU typing: to confirm MIRU results and for the reconstruction of
phylogeny. SNP in codons katG 463 and gyrA 95 were used to classify strains to their
principle groups, to confirm the findings of the two genotypic methods, reconstruct real
phylogeny, and to determine virulence and transmission of UAE isolates. MIRU discrepant
results for some UAE Beijing isolates were tested by spoligotyping and the spoligotyping
findings further verified by IS6110dnaA-dnaN analysis. The UAE isolates that were
negative for genotype analysis by MIRU and spoligotype were tested for the presence of
NTM by 16S rRNA and sequencing.
2.3 ALGORITHM FOR INTERPRETING GENOTYPING DATA/ASSIGNATION OF A
CLUSTER AND STRAIN FAMILY
Algorithms for interpreting genotyping data of MTBC isolates from UAE involved
thorough knowledge about MIRU typing and spoligotyping as well as experience in
analysis of data including the help of experts. Secondly, extracted genotypic data including
identified strain families were interpreted in combination with patients’ addresses,
demographic data and clinical signs in order to determine TB molecular epidemiology,
virulence and transmission patterns in Al Ain.
In this study, a cluster is defined as two or more MTBC isolates sharing common
genotypes. Genotypic data by both methods were further processed using certain
bionumeric programmes to classify the isolates into clusters in comparison to a reference
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strain. Clustering was assessed by spoligotyping and MIRU typing, and by combination of
both methods. Clustering rate is indicative of ongoing transmission and is evaluated as
follows:
Clustering rate = (n – c)/n, where n is the total number of clustered cases; c is the number of
clusters, and n is the total number of cases in the sample (Small et al., 1994).
Grouping of isolates by molecular techniques defines strain family. MIRU data of
UAE isolates were processed via a computer programme according to Ferdinand et al.
(2004) to identify strain families. Similarly, spoligotyping assigned the UAE isolates into
strain families by utilizing the seven visual recognition rules (A-F) involving presence and
absence of spacers, and recent international database (SpotlD4) (Filliol et al., 2002; 2006).
The DNA fingerprints were compared to international strain families included as controls.
2.4 MIRU TYPING
Unless stated elsewhere all chemical reagents were purchased from Sigma, UK.
Oligonucelotide PCR primers were synthesised by MWG, UK. Standard primers for each
of the twelve MIRU loci (MIRU 2, 4, 10, 16 20, 23, 24, 26, 27, 31, 39, and 40) were used
as previously described (Supply et al., 2001) (Table 1). For each MIRU allele, two primers
were used in standard PCR amplification. The forward was designated (F1) while the
reverse primer was designated (R1).
MIRU DNA sequences were amplified by PCR as described by Supply et al.
(2001). For MIRU amplifications from H37Rv genomic DNA, PCR reactions with and
without 10% v/v dimethyl sulphoxide (DMSO) were tested. Each reaction mixture
contained, 25 µl of 2X PCR Master Mix (Promega, UK); containing Taq DNA polymerase,
buffer , MgCl2 and dNTPs), 1 ng genomic DNA template, additional MgCl2 as required
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(see below), 5 µl each of forward and reverse primer (80 ng/ml) in a final volume of 50 µl
of sterile distilled water (SDW). Magnesium chloride (MgCl2) stock solutions of different
concentrations (5 mM, 10 mM and 15 mM) were used to adjust the magnesium ion
concentration for the various MIRU allele PCRs. Five microliter of 15 mM MgCl2 was
added for MIRUs 4, 26 and 40; 5 μl of 5 mM MgCl2 for MIRUs 10, 16 and 31; 5 μl of 10
mM MgCl2 for MIRUs 2, 23 and 39; MIRUs 20, 24 and 27 had no extra MgCl2 added. The
MIRU PCR programme used was: initial denaturation at 95οC for 15 min, followed by 40
cycles of denaturation at 95οC for 1 min, annealing at 59οC for 1 min, extension at 72οC for
1 min; and a final extension at 72οC for 10 min.
2.5 AGAROSE GEL ELECTROPHORESIS
Three different concentrations of agarose were used as required; 1.8% for
amplification of MIRUs, katG and gyrA, and rpoB; 1% for 16S rRNA and 0.8% for
IS6110dnaA-dnaA. Molecular biology grade agarose (Roche, UK) was dissolved in TAE
buffer (4 mM Tris, 2 mM acetic acid, 5 mM methlyenediaminetetraacetic acid (EDTA), pH
7.2). Ethidium bromide was added to a final concentration of 0.5 µg/ml to visualize the
bands.
Ten μl of each PCR reaction was mixed with 3 µl Orange G loading buffer (2.5 g/L
Orange G, 30% w/v glycerol) and 10 μl loaded onto a 1% or 1.8% agarose gel and
electrophoresed in 1X TAE buffer at 125 volts, for 45-55 mins. in MIRUs with relatively
small PCR molecular sizes; but in case of higher molecular-sized PCR products, including
16S rRNA and MIRU 16, the gel running time ranged from 1.5-2 hours. 1 Kb and 100bp
ladders (Promega) were included as markers. The DNA bands were visualised on an UV
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transilluminator. The approximate molecular size of each band was determined by
comparison with of 100bp and 1 Kb ladder sized bands.
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Table 2.1 Primer sequences
This table contains all primers used in this study and the sources from where they were
opened. MIRU 16 had more that one set of primers. The original primers were described by
Supply et al. (2001) and others were developed by the researcher using Primer3 website and
the sequence M. tuberculosis H37Rv.
MIRU Primer sequence Reference of source
MIRU 2
MIRU 4
MIRU 10
MIRU 16
MIRU 20
MIRU 23
MIRU 24
MIRU 26
MIRU 27
MIRU 31
MIRU 39
MIRU 40
M 16
M 16
F1 5’-TGGACTTGCAGCAATGGACCAACT-3’
R1 5’-TACTCGGACGCCGGCTCAAAAT-3’
F1 5’-GCGCGAGAGGCCGAACTGC-3’
R1 5’-GCGCAGCAGAAACGTCAGC-3’
F1 5’-GTTCTTGACCAACTGCAGTCGTCC-3’
R1 5’-GCCACCTTGGTGATCAGCTACCT-3’
F1 5’-TCGGTGATCGGGTCCAGTCCAAGTA-3’
R1 5’-CCCGTCGTGCAGCCCTGGTAC-3’
F1 5’-TCGGAGAGATGCCCTTCGAGTTAG-3’
R1 5’-GGAGACCGCGACCAGGTACTTGTA 3
F1 5’-CTGTCGATGGCCGCAACAAAACG-3’
R1 5’-AGCTCAACGGGTTCGCCCTTTTGTC-3’
F1 5’-CGACCAAGATGTGCAGGAATACAT-3’
R1 5’-GGGCGAGTTGAGCTCACAGAA-3’
F1 5’-TAGGTCTACCGTCGAAATCTGTGAC-3’
R1 5’-CATAGGCGACCAGGCGAATAG-3’
F1 5’-TCGAAAGCCTCTGCGTGCCAGTAA-3’
R1 5’-GCGATGTGAGCGTGCCACTCAA-3’
F1 5’-ACTGATTGGCTTCATACGGCTTTA-3’
R1 5’-GTGCCGACGTGGTCTTGAT-3’
F1 5’-CGCATCGACAAACTGGAGCCAAAC-3’
R1 5’-CGGAAACGTCTACGCCCCACACAT-3’
F1 5’-GGGTTGCTGGATGACAACGTGT-3’
R1 5’-GGGTGATCTCGGCGAAATCAGATA-3’
P2a 5’-TCGGTGATCGGGTCCAGTCCAA-3’
P2b 5’-CCCGTCGTGCAGCCCTGGTAC-3’
P3a 5’-CGCCGTGTTGTCACTCAC-3’
P3b 5’-ACCACCTATCGACGGCTCT-3’
P4a 5’-AGGTGTCCAGTAGCCAGTGC-3’
Supply et al. (2001).
Supply et al. (2001).
Supply et al. (2001).
Supply et al. (2001).
Supply et al. (2001).
Supply et al. (2001).
Supply et al. (2001).
Supply et al. (2001).
Supply et al. (2001).
Supply et al. (2001).
Supply et al. (2001).
Supply et al. (2001).
This work.
This work.
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M 16
M 16
KatG463
GyrA95
DR region
dnaA-
dnaN
rpoB
16S rRNA
P4b 5’-TGGTGTGCTGGCTGTTATTG-3’
P5a 5’-GGGTACTGGTGTGGGAGTTG-3’
P5b 5’-CTGTGATGGCGAGTCTAACG-3’
F1 5’-TGCGAGATACCTTGGG-3’
R1 5’-GTCGCTACCACGGAAC-3’
F1 5’-GGTGCTCTATGCAATGTT-3’
R1 5’-GGCTTCGGTGTACCTC-3’
DRa 5’-GGTTTTGGGTCTGACGAC.
DRb 5’-CCGAGAGGGGACGGAAAC-3’
F 5’-CGCATCCGTCAGCGCTCCAA-3’
R 5’-GCCAACTCTTGTCGTAGCCGC-3’
F1 5’-TGGTCCGCTTGCACGAGGGTCAGA-3’
R1 5’-CCCTCAGGGGTTTCGATCGG-3’
F1 5’-GAT CCT GGC TCA GGA CGA-3’
R1 5’-CAC CTT CCG GTA CGG CTA C-3’
This work.
This work.
Sreevatsan et al. (1997).
Sreevatsan et al. (1997).
Kamerbeek et al. (1997).
Milan et al. (2004).
Kapur et al. (1994.
Kirschner and Bottger
(1998).
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2.6 DETERMINATION OF PRINCIPLE GENETIC GROUPS
PCR amplification of katG and gyrA alleles were performed according to
Sreevatsan et al. (1997) using previously reported primers designed to amplify the katG
codon 463 and gyrA codon 95 of the gene (Table 2.1). PCR reactions contained 25 µl of
2X Master Mix (Promega), 1ng DNA template, and 5 µl of each forward and reverse
primer (80 ng/ml) and SDW to a final volume of 50 µl. The PCR programme was as
follows: denaturation at 95οC for 15 min, 40 cycles of denaturation at 95οC for 1 min,
annealing at 59οC for 1 min, extension at 72οC for 1 min. and a final extension at 72οC for
10 min. PCR products were purified and sequenced.
The polymorphism of both katG and gyrA was utilized to group the various M.
tuberculosis isolates into three evolutionary groups as previously stated (Sreevatsan et al.,
1997). Organisms with genotypic polymorphism encompassing katG463 CTG and gyrA95
ACC were assigned to group 1; those with katG463 CGG and gyrA95 ACC to group 2, and
group 3 organisms had katG463 CGG and gyrA95 AGC (Fig. 2.1) (Sreevatsan et al., 1997).
2.7 AMPLIFICATION OF IS6110dnaA-dnaN INTERGENIC REGION
PCR was performed as described by Milan et al. (2004), using IS6110dnaA-dnaN
primers (Table 2.1). PCR mixture contained 25 µl 2X PCR Master Mix (Promega), 5 µl of
1.5 mM MgCl2, 1ng DNA template, 5 µl of each forward and reverse primer (80 ng/ml),
and made up to 50 µl SDW. The PCR programme was performed at 94oC for 4 min
followed by 30 cycles of 30 s at 94oC, 30 s at 60oC, 2 min at 72oC, and a final extension of
72oC for 7 min.
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2.8 AMPLIFICATION OF rpoB AND RIF RESISTANCE STATUS
PCR reaction was performed as described by Kapur et al. (1994), using rpoB
primers (Table 2.1). Two different PCR optimization reactions were carried out: 1) Taq
polymerase reaction mix consisted of: 10 µl 2X PCR Master Mix (Promega), 2 µl DMSO,
2 µl of each forward and reverse primer (80 ng/ml), 1ng genomic DNA in a final volume of
20 µl. 2) Pfu reaction mixes containing: 2 µl 10X Pfu buffer (Promega), 2 µl DMSO, 2 µl
of each forward and reverse primer (80 ng/ml), 1 µl genomic DNA (1 ng/µl), 1 µl dNTPs
and 1 U Pfu polymerase (Promega) in a final volume of 20 µl with SDW. DNA from the
laboratory strain H37Rv was included as a positive control for amplification of rpoB and
for comparison of nucleotide sequence alignment.
The PCR conditions for amplification of rpoB were: denaturation at 95oC for 12
min, 30 cycles of denaturation at 95oC for 1 min, annealing at 50.5oC for 1 min and
extension at 72oC for 2 min, and a final extension at 72oC for 10 min. PCR products were
purified as described in section 2.8 and prepared for sequencing as described in 2.9.
The generated nucleotide sequences of rpoB product codons 511 to 533 were
aligned and compared with the corresponding gene region involving nucleotides 761094
and 761160 sequence respectively, in M. tuberculosis H37Rv strain included as a control to
identify any mutations related with RIF–resistance using Tuberculist website
(http://genolist.pasteur.fr/TubercuList/index.html tuberculist) and Kapur et al., 1994.
Anti-mycobacterial sensitivity test (AST) for RIF was performed using the
BACTEC TB-960 (Becton Dickinson, Spark, USA) method as described by Marttila et al.
(2003) following manufacturer’s instructions. BACTEC tests were carried out by technical
staff in Al Ain laboratory. Results were sent to the UK for comparison purposes with the
molecular results.
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2.9 SPECIES IDENTIFICATION USING 16S rRNA
PCR reactions were prepared according to Kirschner and Bottger (1998) using 16S
rRNA primers (Table 2.1). The optimized reaction was formed from the following
constituents: 2 µl Pfu buffer (Promega), 2 µl DMSO, 2 µl for each forward and reverse
primer (80 ng/ml), 1 µl dNTPs, 1U Pfu polymerase (Promega) and SDW to a final volume
of 15 µl. The contents were mixed well and 5 µl (1 ng/µl) sample DNA were added. The
mixtures were dispatched in 20 µl tube. The tubes were placed in a thermocycler and
heated for 72oC. The contents were subjected to the following PCR cycling conditions: 40
cycles of denaturation at 94oC for 1 min, annealing at 46.5oC for 2 min and extension at
72oC for 2 min with a final extension at 72oC for 5 min. The PCR cycling conditions were
performed according to Kirschner and Bottger (1998) except the annealing temperature,
which was raised to 61oC.
2.10 PURIFICATION OF PCR PRODUCTS
PCR products were purified using the High Pure PCR Product Purification Kit
(Roche) as follows: 500 µl of binding buffer was added to 50 µl of PCR reaction, mixed
well and the mixture applied to a High Pure Filter tube, centrifuged at 13,000 X g for 30-60
seconds and the flowthrough discarded. After the addition of 500 l of washing buffer, the
mixture was centrifuged at 13,000 X g for 1 min and the flowthrough discarded. The wash
step was repeated using 200 µl of the washing buffer. The column was transferred to a
fresh tube and DNA eluted with 50 µl elution buffer to collect the purified DNA. 5 µl of
the purified product was run on a 1.8% agarose gel to assess the presence and quality of the
DNA.
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For the purification of rpoB and 16S rRNA, the PCR products were excised and
purified using the GenEluteTM Minus EtBr Spin Columns (Sigma). The spin column was
placed into a collection tube and pre-washed with 100 µl 1 X TE buffer (10 mM Tris-Cl,
(pH 7.5), 1 mM EDTA). The spin column was then transferred to fresh collection tube.
The excised gel band slice was loaded onto the pre-washed spin column and centrifuged at
13,000 X g for 10 min. DNA concentration was determined and sent for sequencing
(MWG Biotech) with the corresponding forward primer.
2.11 PCR SAMPLE DETERMINATION, SEQUENCING AND SEQUENCE ANALYSIS
PCR products were quantified using a Nanodrop ND-1000. Prior to measuring the
ND-1000 pedestal was cleaned with sterile distilled water and then blanked using the
solution that the DNA was dissolved in. With the sampling arm open 1.2 μl of DNA
sample was placed on the measurement pedestal, the sampling arm was then closed and the
reading taken. The concentration of the DNA was determined.
Purified PCR products (30 ng/µl for each 100 bp) were sent to MWG Biotech,
Ebersberg, Germany, with 10 μl of the forward or reverse primers, as required, for
sequencing. Sequences were compared with the H37Rv genome sequence database using
the Tuberculist website (http://genolist.pasteur.fr/TubercuList/index.html).
2.12 SPOLIGOTYING (SPACER OLIGOTYPING)
Spoligotyping was carried out according to the method of Kamerbeek et al. (1997)
using DR region primers (Table 2.1) as follows: PCR amplification using reaction of 50 µl
DMSO, 200 µl of 10 X buffer (Isogen), 4 µl of each dATP, dGTP, dCTP and dTTP, 60 µl
of 50mM MgCl2 and 100 µl of each forward (DRa) and reverse primer (DRb) (20pmol).
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Mixtures were topped up with 475 µl SDW to a volume of 1000 µl and 5 µl of Taq
polymerase (Isogen) were added. Two µl of purified DNA were added. H37Rv strain and
M. bovis BCG were included as positive controls.
The PCR programme used included an initial denaturation step at 94oC for 5 min
and 30 cycles of 94oC for 30 seconds, 55oC for 1 min, 72oC for 1 min, with a final step at
72oC for 5 min.
Twenty microliters of amplified PCR product was diluted in 150 µl of 2 X SSPE (3
M sodium chloride, 200 mM sodium phosphate and 20 mM EDTA) in 0.1% SDS (Sodium
Dodecyl Solution), heat denatured at 100oC for 10 min and immediately placed on ice to
cool down. The membrane (Biodyne C, Isogen Life Science, The Netherlands) had 43
immobilized oligonucleotides-covalently bound to it in parallel lines, and was prepared for
blotting by washing once with 250 ml of 2 X SSPE in 0.1% SDS at 60oC for 5 min. The
membrane and support cushion were placed in a mini-blotter apparatus in such a way that
the channels of the apparatus were at a 90o angle to the line patterns of precipitated
oligonucleotides. Residual fluid was aspirated from the slots. Slots were filled with 160 µl
diluted PCR product. The slots were loaded in the following order; the first well was filled
with 160 µl of 2 X SSPE in 0.1% SDS (negative control); the second and third wells were
filled with extracted DNA from H37Rv and M. bovis BCG (positive controls); the fourth
and fifth wells were filled with 2 X SSPE in 0.1% SDS buffer (negative controls); and the
sixth well was filled up with a clinical sample. The top and bottom openings of the slots
were sealed to safeguard against evaporation. The contents were left to hybridise for 90
min at 60oC on a horizontal surface without shaking.
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After hybridisation, the membrane was washed for 10 min in 250 ml of 2 X SSPE in
0.5% SDS at 42oC and then once in 250 ml of 2 X SSPE for 5 min at room temperature.
The membrane was incubated in 5 µl streptavidin-peroxidase conjugate (500 U/ml) added
to 20 ml 2 X SSPE in 0.5% SDS for 60 min at 42oC.
The membrane was washed and rinsed several times as before. Two µl DNA was
detected using the chemiluminescent (ECL) (Amersham) detection fluid for 1 min at room
temperature. The membrane was exposed to X-ray film (Kodak hyper film, Amersham) in
a dark room for typically 30-90 min, and in some cases overnight.
For repeated use of the membrane, the membrane was washed twice in 1% SDS at
80oC for 20 min, and incubated in 20 mM EDTA at room temperature for 10 min. The
membrane was placed in a sealed plastic box and stored at 4oC.
2.13 QUALITY CONTROL MEASURES OF THE STUDY
Ten percent of MIRU tests were randomly repeated and the results were consistent,
although new primers were ordered for quality control purposes. Abnormal results
generated due to MIRU 16 and NTM were also checked more than once in two different
laboratories; the HPA and MRU at Queen Mary’s University. Spoligotyping was
monitored by the HPA and MRU, and data were checked by available personnel with their
database. The HPA offered five runs for this test including, positive and negative controls,
which were enough for 200 isolates. NTM isolates detected by 16S rRNA in this study
were also sent to the MRU for cross-identification using microarray and both results
confirmed the presence of M. kansasii. The variability in spoligotyping results was limited
because the technique involved only one locus. However, the researchers encountered faint
spacers on two occasions, which were confirmed by repeated testing. The appearance of
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the faint spacers could be due to low primer affinty, low amount of DNA or overused
membrane.
2.14 CLASSIFICATION OF M. TUBERCULOSIS STRAINS
The clading programme used in this study is a Microsoft Access computer
programme that was developed to define M. tuberculosis families based on MIRU dataset
and alleles according to the rules laid out by Sola et al. (2003) and Ferdinand et al. (2004).
MIRUs 23 and 24 were the most informative in this respect. Other MIRUs were also
utilized to group strains into their corresponding families. The MIRU databases of these
workers were used as a reference for our computerized clading programme.
Phylogenetic analysis of MIRU alleles and spoligopatterns of 194 UAE M.
tuberculosis complex clinical isolates were carried out using bioinformatics specialized
software (developed by the researcher using the clading proposal suggested by Ferdinand et
al. (2004). Clustered isolates by MIRU typing and spoligotyping were determined and
families were defined by both methods.
Spoligotype strains belonging to 13 major international families of M. tuberculosis
complex as well as the work of others were utilized as reference for spoligotyping profiles
(Goguet de la Salmoniere et al., 1997; Kremer et al., 1999; Cowan et al., 2002; Filliol et
al., 2002; 2003; Sola et al., 2003; Ferdinand et al., 2004; Brudey et al., 2006). Spotclust
website was used to identify family of strains using their spoligopatterns
(http://cgi2.cs.rpi.edu/~bennek/Run.html) (Vitol et al., 2006).
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2.15 CLINICAL AND DEMOGRAPHIC DATA COLLECTION
Proforma covering clinical, demographic, and social factors of culture-confirmed
TB cases was designed in this study. Information pertinent to this study and proforma was
conducted with confidentiality. An ethical approval form was submitted and approved by
the research committee of the Faculty of Medicine and Health Science of the UAE
University (Appendix 1). In addition, patients were informed in a written form that their
data will be held in strict cnfidence (Appendix 2). The retrospective study included 327
patients with suspected TB in Al-Ain, UAE. Of these, only 194 patients had positive
cultures and were included in this study. The study, which spanned a period of two and
half years included adults and children of both sexes.
Relevant information contained in the proforma was retrieved from patients’
medical record, notification (Appendix 3) and laboratory forms. Information obtained
included age, sex, nationality, marital status, place of residence, number of people in the
household, monthly income, place of diagnosis, presenting symptoms and reason for
seeking health attention (for immigrants only), type of tuberculosis (pulmonary or extra-
pulmonary or combined), past medical history of similar incidence, BCG vaccination,
history of TB in the family, travel history, history of drug consumption, smoking,
alcoholism and drug abuse, patients residence address, presence of chronic conditions such
as diabetes mellitus hypertension and others, signs noticed at presentation, general
examination findings, chest radiographic findings, laboratory findings which included
sputum smear, culture, and biopsy findings (Appendix 4). In addition, the association of
these symptoms with other illnesses were examined. If cough was clinically diagnosed, the
duration, type (productive or non-productive), and colour of the sputum (white, yellow,
green or tinted with blood) were included. Presence of similar TB symptoms and signs in
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family members, previous drugs taken, or example, antibiotics, antipyretics, cough syrups,
herbal or others were noted, as was the source of these medications , i.e. government
hospital, private clinic or pharmacy. Moreover, information about haemoglobin and
erythrocyte sedimentation rate (ESR) was included. It is worth noting that patient’s were
interviewed and diagnosed by the treating doctors in Al Ain hospitals (Appendix 4).
2.16 STUDY POPULATIONS
Participants of this study were culture-confirmed M. tuberculosis cases from three
different health organizations in Al Ain, namely, Preventive Medical Department (PMD),
Tawam and Al Ain Hospitals. Three hundred and twenty seven patients were diagnosed
with tuberculosis from January 2003 to August 2005. In these health institutions, non-
nationals (immigrants) were diagnosed during their entry into the country and were being
health checked as part of the requirement for visa applicants. Some of the non-nationals
participants were Al Ain residents who were diagnosed during examination for visa
renewals. Adults and children of both sexes were included during the 2.5 year period of
study. Adult patients were distributed into age groups of 13 - 20, 20 - 30, 30 – 40, 40 – 50,
50 – 60 and > 60 years; children were grouped into < 3 years old, then from 3 – 5, 5 – 7, 7
– 9, 9 – 11 and 11 – 13 years.
2.17 AREA OF THE STUDY AND PARTICIPANTS’ ADDRESSES
Patients were distributed in eight districts: Al Jimi, Al Maqam, Al Markhaniya, Al
Masoudi, Hili, Industrial Area, Zakhir and Mezyad. In the UAE, there is no formal address
system. Therefore, addresses of patients were obtained from two main governmental
sources. UAE nationals’ addresses were obtained from the municipality; immigrants’
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addresses were obtained either from an employer’s address, or from the Immigration
Department. In addition, attempts were made to llocate addresses of nationals by retrieving
the site map of the districts where affected cases were identified, and counting the number
of buildings or sites and comparing them with all buildings owned by sponsors of the
patient using the name of the sponsor and family residing in the premises to identify
address of expatriates working in the houses. Each patient was then grouped by his district
of residence and labelled with the first initials of the district and a number corresponding to
his building number. Patients working in the industrial area were by far more difficult to
trace because work and not residential addresses are required for all official documents. A
working site like the industrial area is used by many workers most of whom are foreigners
and who typically live among other non-nationals and might have latent TB infection.
Such sites may be considered as a suitable environment for transmission of the disease from
infected individuals to susceptible ones.
2.18 STATISTICAL ANALYSIS
Statistical analysis is an important tool in any research or study. Accurately
evaluating the probability of the association is a major determinant of the quality of
research and the results obtained. This could be determined by different statistical tests
such as P value, proportion method, confidence interval and Chi square statistical power
and others (Houle et al., 2005).
In this study P-value, proportion method, confidence interval and Chi square were
used to analyse data that included form of the disease, fever and coughs as prominent
presenting symptoms of TB and radiographic chest abnormalities (fibrosis, cavitations,
calcifications and pleural effusions) and find their association among nationals and
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immigrants (Chapter 4). The association between TB family strains and symptoms of
(pulmonary, extra-pulmonary and coughs), and cavitations was assessed (Chapter 4). The
correlation between some dominant TB family strains (CAS, T, EAI and F33) and patient’s
place of origin was also evaluated (Chapter 4). The small size of the sample has caused
statistical bias.
2.19 FIELD STUDY TO DETECT THE MISUSE OF DRUGS FOR TREATMENT IN THE
UAE
A field study to determine the code of practice in the UAE and define the extent of
antibiotic consumption without prescrition and anti-tuberculous drugs was conducted. The
idea of such field project was recommended by Professor, Francis Drobniewski in order to
collect some data about the drug practice in Al Ain, UAE. This study was approved by the
local ethical committee in Al Ain University and done in collaboration with Professor
Dissanayake and Asad. The subjects and materials used were standardized as follow:
i) Two investigators, a national (the researcher) and a non-national (an Indian).
ii) Pharmacies. There are four pharmacies in the Industrial Area in Al Ain and all the
pharmacies were approached by the two investigators at different timings.
iii) Standardised questions were used by both investigators for describing a health condition
and requesting specific drugs for their teatment.
For the purpose of this field study, the investigators had approached all four
pharmacies located in the Industrial Area, and in the town centre of Al Ain. The national
investigator presented to the pharmacists that he had fever, productive cough and nasal
discharges, and requested medication that the pharmacist felt would be curable for the
condition. These same complaints and requests were presented by the non-national
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investigator. The two investigators were diagnosed, prescribed and supplied with similar
drugs from all the pharmacies visited. Requests of anti-tuberculous drugs and steroids were
also made by both investigators.
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CHAPTER 3 MIRU TYPING AND SPOLIGOTYPING ANALYSIS OF UAE M.
TUBERCULOSIS COMPLEX CLINICAL ISOLATES
3.1 INTRODUCTION
Molecular epidemiology is defined as the study of determinants and distributions of
a particular disease using molecular techniques within a specific population (Narayanan et
al., 2004). TB research entered a new era after the publication of the complete M.
tuberculosis sequence (Cole et al., 1998). Molecular studies showed that the M.
tuberculosis complex was highly conserved genetically, yet limited genetic differences
were identifiable in specific loci scattered throughout the genome (Frothingham et al.,
1994; Sreevatsan et al., 1997; Musser et al., 2000; Brosch et al., 2002; Fleischmann et al.,
2002; Gutacker et al., 2002).
These genetic variable regions were targeted for study on clonal relatedness,
transmission dynamics, identifies emerging strains, and for defining the biogeography of
specific phenotypic strains or traits of M. tuberculosis complex (Gagneux and Small, 2007).
Different methods have been used to genotype M. tuberculosis strains but in this chapter,
three typing methods were used: MIRU typing, spoligotyping and grouping strains
according to their principle genetic groups of 1, 2 and 3 using katG463/gyrA95 typing
(Groenen et al., 1993; Sreevatsan et al., 1997; Kamerbeek et al., 1997; Supply et al., 1997;
2001).
Genotypic methods have been widely used in TB epidemiology based studies.
Several limitations have been observed throughout extensive application of these genotypic
methods (McNabb et al., 2004). Difficulties in comparing strain patterns with the available
genotypic databases and the evolutionary nature of these data, such as clusters represent a
potential challenge to investigators (de Boer and van Soolingen, 2000; Cowan et al., 2002;
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Rosenblum et al., 2003). In addition, interpretation of this information must be well
established in terms of time and relevance specifically in population based studies (Glynn
et al., 1999; Vynnycky et al., 2001).
There is a paucity of research information concerning the prevalence of TB in the
Arabian Gulf countries although it has been claimed that immigration has introduced and
perpetuated the disease (Annual Statistical Reports, UAE, 2003; Al-Hajoj et al., 2007). In
this context, the UAE is not exceptional since two thirds of its population originate from
regions which are endemic for TB (Annual Statistical Reports, 1981-1998; 2003).
However, there is a continuing debate over the presence of unique circulating strains
indigenous to the UAE and responsible for the spread of the disease between nationals
(Dissanayake et al., 2001).
3.1.1 MIRU typing
A common genotyping methodology is to amplify specific polymorphic loci on the
chromosome by PCR. One of these methodologies is mycobacterium interspersed
repetitive units (MIRU) typing (Supply et al., 1997). MIRUs are small DNA elements of
VNTRs located around the genome of M. tuberculosis genome (Supply et al., 1997).
MIRUs are a specific subclass of VNTRs with exact tandem repeats (Supply et al., 1997;
Frothingham and Meeker-O’Connell, 1998). Three families of MIRUs, comprising of
elements of 77-101bp, 46-53bp and 58-101bp, have been identified and found scattered
throughout the M. tuberculosis genome. Their function remains unclear, although some
researchers believe that they may play a role in chromosome structure, chromosome
arrangement, differential translation of genes and tandem replication (Supply et al., 1997).
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MIRU typing is known for its high efficiency in molecular epidemiological studies
of TB (Sola et al., 2003; Mathema et al., 2006). Among several MIRU loci, 12 specific
MIRU loci were found to discriminate between M. tuberculosis isolates collected from
different countries due to their short and repetitive nature (Supply et al., 1997; 2001). The
degree of discriminatory power of MIRUs varies and has been used to group MIRUs into
low, moderate and high variability (Supply et al., 2001; Sola et al., 2003). For instance,
MIRUs 10, 16, 23, 26 and 40 were grouped as having a high variability, while MIRUs 4,
16, 24 and 39 were moderately variable (Sola et al., 2003). MIRUs 2, 20 and 27 were
considered to be the most stable and with the lowest variable MIRU loci. Use of such
variation is of great importance in tracing strains with epidemiological links (Sola et al.,
2003). Strain differentiation is comparable to that of IS6110 RFLP typing for strains with
low copy numbers and considered a reliable method in detecting chronic cases, and more
efficient than IS6110 RFLP in detecting re-infection cases as it is highly sensitive to any
genetic alterations (Lee et al., 2002; Savine et al., 2002). Being a relatively stable marker,
MIRU typing is used for tracing strains causing global epidemics, laboratory cross-
contamination and in studying evolution and genetic diversity among M. tuberculosis strain
populations (Supply et al., 2001; Mazars et al., 2002; Savine et al., 2002; Warren et al.,
2002; Supply et al., 2003; Fabre et al., 2004). Furthermore, MIRU typing has been used in
epidemiological and phylogenetic studies (Sola et al., 2003; Ferdinand et al., 2004).
Using MIRU typing and spoligotyping and with the help of software for example,
Bionumerics (Applied Maths, Ghent, Belgium), Sola et al. (2003) succeeded in
reconstructing a phylogeny tree on a worldwide collection of M. tuberculosis complex
isolates that showed that M. canettii was first to diverge from a common ancestor of M.
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tuberculosis complex followed by EAI that preceded the M. africanum- M. bovis
divergence. Similar results have more recently been demonstrated by Gutierrez et al.
(2005), who proposed that M. tuberculosis probably emerged from a common ancestor,
termed M. prototuberculosis including M. canettii in East Africa a few million years ago.
These findings supported earlier family groupings suggested by Kremer et al. (1999).
However, the system disagrees to a certain degree with the findings of Brosch et al. (2002),
who suggested that EAI is the root of the ancestral family followed by Africanum and
Bovis.
MIRU 24 is considered a valuable tool in providing epidemiological information
pertinent to the phylogenetic relationships between M. tuberculosis strains (Thorne et al.,
1998; Ferdinand et al., 2004; Sun et al., 2004). Ferdinand et al. (2004) discussed the
applicability of MIRU typing for identifying circulating strains of the global M.
tuberculosis complex and categorized isolates into eight international clades namely,
Beijing, Haarlem, and LAM, EAI, X, T, Africanum and Bovis, based on MIRU 24.
3.1.2 Spoligotyping
Spoligotyping is a PCR based method that requires the amplification of the DR
locus which is a highly polymorphic region in the mycobacterial genome. Spoligotyping
exploits polymorphism encountered in the spacer sequences in the genomic DR region of
M. tuberculosis complex strains for their differentiation by determining the presence or
absence of the 43 interspersed spacers (Kamerbeek et al., 1997). Results are highly
reproducible, binary (based on the absence or presence of spacers within the DR region),
and so data can be computerized and exchanged between laboratories. Spoligotyping
requires less DNA template and yields results faster in comparison with IS6110 RFLP
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(Groenen et al., 1993; Kamerbeek et al., 1997; van Embden et al., 2000). Although
IS6110-RFLP typing is an ideal genetic marker, difficulties arise in the interpretation of
results of complex patterns or identification of strains with a few copies of IS6110 elements
(Chaves et al., 1996). Spoligotyping distinguishes between M. tuberculosis clinical isolates
to the subspecies (family strain) level, which is an essential tool in studying TB
epidemiology in a community and in tracing outbreak episodes that ultimately help with the
development of measures to control the disease (Sola et al., 2001).
A number of DNA fingerprinting methods including IS6110 RFLP typing,
spoligotyping and MIRU typing have been used to study TB molecular epidemiology
(Supply et al., 2001; Warren et al., 2002; Durmaz et al., 2003; Mathema et al., 2006) but
because of its slower molecular clock (the term molecular clock implies any degree of the
rate of genetic alteration expressed by fingerprinting profile of the strain that could be fast
or slow as time goes on), spoligotyping has been most efficiently used to identify
worldwide clades (Kremer et al., 1999; Prodinger, 2007). Based on visual recognition of
spoligotype patterns, Sebban et al. (2002) classified M. tuberculosis complex isolates into
various families. The identified families were allocated to different geographical locations
using the observed differences in the clonal population structure of M. tuberculosis,
A two-step strategy using MIRU typing in association with spoligotyping has been
demonstrated to be discriminative and is an alternative to IS6110 RFLP analysis for typing
unknown M. tuberculosis complex strains (Sola et al., 2003). Genotyping of remnant
mycobacterial DNA extracted from ancient anthropological materials showed the existence
of modern bacilli of PGG 2 or 3 suggesting that M. tuberculosis evolved most probably
from M. africanum, a progenitor of the complex (Zink et al., 2003).
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Although spoligotyping is clinically valuable for differentiating relapse cases from
exogenous re-infection, assessing follow-up treatment of cases and detecting transmission
of strains harbouring MDR trait, it overestimated clustered isolates and did not distinguish
between M. tuberculosis and NTM isolates (Gori et al., 2005). Even though spoligotyping
is less discriminatory than IS6110 fingerprinting, combination of spoligotyping and several
MIRU-VNTR loci reduced clustering rate of isolates and helped in detecting transmission
links (Oelemann et al., 2006). Deletions of the DR region can occur in a rapid and
independent manner in unrelated strains, resulting in identical spoligopatterns and DR
regions representing less than 0.1% of the M. tuberculosis genome (Mathema et al., 2006).
Spoligopattern of M. tuberculosis has been used to determine the family of species
by comparing their patterns with the internationally recognised reference species patterns
(Filliol et al., 2002; Sola et al., 2003; Ferdinand et al., 2004; Brudey et al., 2006).
Spoligotyping data were processed by Bionumerics for phylogenetic family reconstruction.
The families identified by spoligotyping were compared to the MIRU-generated phylogeny.
3.1.3 Principle genetic grouping
KatG463 and gyrA95 SNPs have been used to reconstruct real phylogeny by
classifying strains into the PGGs 1, 2 and 3 to determine lineages of strains (Sreevatsan et
al., 1997). This classification provides basic understanding of genetic evolutionary
relationship between different strains and aid in examining the relationship between
different lineages and their abilities to exhibit different epidemiologies in different
populations (Alland et al., 1994; 2003; Baker et al., 2004; Mathema et al., 2006). These
principal genetic groups influence the degree of virulence and determine the lineages of
these strains. PGG 1 and 2 have been associated with more virulence and old lineages of
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M. tuberculosis strains, while PGG 3 is associated with more recent and less virulent
strains. PGG 2 strains have also been found to be involved in recent transmission of M.
tuberculosis (Dolzani et al., 2004).
3.1.4 Genotypic characteristic of Beijing strains
The Beijing family of M. tuberculosis strains are hyper-virulent organisms
spreading worldwide (Glynn et al., 2000). Beijing family is well recognized genetically as
a highly conserved and homogenous genotype with unique characteristics, which assist in
their identification. Beijing strains show a high similarity of multi-banded IS6110 RFLP
patterns and identical spoligotypes hybridising to nine (35-43) spacers in the DR region of
the genome (Bifani et al., 2002). In addition, the Beijing/W strains are characterized by the
presence of two insertions of IS6110; one is located in the dnaA-dnaN intergenic region of
the origin of replication while the other is in the NTF region which can be demonstrated by
region RFLP or multiplex PCR (Bifani et al., 2002; Milan et al., 2004). Beijing strains
have one IS6110 insertion, whereas W strains have two IS6110 insertions in head to tail
orientation (Kurepina et al., 2005). On the other hand, the N family, a close relative to
W/Beijing family, lacks the presence of IS6110 insertion in NTF region but has similar
IS6110 RFLP pattern (Milan et al., 2004). Another characteristic feature of these strains is
the presence of acquired mutations in the mutT gene, which enable the organisms to adapt
to hostile environment including, resistance to treatment by anti-tuberculosis drugs (Rad et
al., 2003). The strains were found to be statistically strongly linked with drug resistance in
some regions such as New York, Cuba, Estonia and Vietnam (Glynn et al., 2000). Yet, in
some regions such link is weak or does not exist. A further distinctive feature of the
Beijing/W strains is their ability to resist the immunological effect of the BCG vaccine
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causing insufficient protection (van Soolingen et al., 1995; Lopez et al., 2003). Their
spread has often been associated with BCG vaccination, and increased proportions of
patients infected with Beijing strains had in Indonesia and Vietnam have had BCG scars
(Glynn et al., 2000). The increased virulence could be related to the production of a
polyketide synthase-derived phenolic glycolipid (PGL), believed to lower the level of
cytokines responsible for the induction of Th1 immunity (Reed et al., 2003). This was
further supported by murine experiments in which Beijing strains elicited significantly
higher bacterial load in the lungs leading to the death of all infected mice in comparison to
other virulent strains (Castanon-Arreola et al., 2005). The presence of RD105 deletion and
polyketide synthase (pks) 15/1 region are specific to Beijing/W strains and differentiate
them from non-Beijing/W strains (Tsolaki et al., 2005).
IS6110 dnaA-dnaN typing is frequently used in countries with high Beijing
prevalence such as Russia, to differentiate Beijing from and non-Beijing strains (Bifani et
al., 2002; Milan et al., 2004).
3.1.5 Non-tuberculous mycobacteria (NTM) identification
In the 1960s, a conserved genetic region termed the 16S rRNA gene sequence was
observed in Bacillus spp. (Dubnau et al., 1965) and later used by others for identification of
bacteria and for taxonomical purposes (Woese et al., 1985; 1987). Sequence determination
of 16S rRNA is by far the most used method in NTM identification as rRNA genes are
found in all organisms (Bottger, 1989; 1992; Palys et al., 1997; Kirschner and Bottger,
1998; Kolbert and Persing, 1999; Garrity and Holt, 2001; Tortoli, 2003; Harmsen and
Karch, 2004). In addition, 16S rRNA sequence of species is stable at species level although
there are hypervariable regions between different species. However, the exact rate of
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change in this gene sequence remains to be determined. This aids the determination of
evolutionary relations that may exist (Kimura, 1980; Pace, 1997; Thorne et al., 1998;
Harmsen and Karch, 2004). The 16S rRNA gene is ~ 1,550bp in size and is used to
identify NTM with reference to known GenBank Database of M. tuberculosis complex 16S
rRNA sequences (Chen et al., 1989; Kirschner and Bottger, 1998; Relman, 1999).
In this chapter, a panel of 40 UK and 194 UAE DNA samples extracted from
clinical isolates of M. tuberculosis were examined epidemiologically and phylogenetically
using MIRU analysis. This information was then utilized to determine various
discriminative MIRUs in the process of studying TB epidemiology in Al Ain, UAE. Other
genotypic methods were also attempted to verify the results or identify other M.
tuberculosis complex strains.
3.2 RESULTS
3.2.1 Validation of the standard primers for MIRU amplification
Standard primers described by Supply et al. (2001), were used for the amplification of 12
MIRU loci. The primers were first validated by using the control strain H37Rv. The
primers described in Supply et al. (2001) were used to amplify the 12 MIRU loci (2, 4, 10,
16, 20, 23, 24, 26, 27, 31, 39 and 40) from H37Rv. The PCR products were then
electrophoresed on a 1.8% agarose gel and the sizes of the MIRU amplification products
estimated (Fig. 3.1). The PCR products were then purified and sent for sequencing to
confirm that the correct MIRU sequence and locations had been amplified. Sequence
results were aligned (blasteded) in the Tuberculist website to match with the H37Rv
sequence, to identify the starting point of each sequence and to determine its location. The
sequences of all MIRUs were confirmed as expected (Supply et al., 2001).
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Expected size (bp) 352 437 407 642 670 650 507 464 645 590 446 656
Product size (bp) 350 450 400 650 650 650 500 450 650 600 450 650
Fig. 3.1 PCR-amplified MIRU products of H37Rv strain
Standard primers were used to amplify the 12 variable MIRU loci from H37Rv; lane M,
100bp marker; lanes (2-13) MIRUs group A, 4, 26 and 40 group B, 10, 16 and 31, group C,
2, 23 and 39, group D, 20, 24 and 27 respectively. The lower band seen in line 13 with
molecular size of approximately 450bp is not significant as it is lower than the expected
size of MIRU 27 in the H37Rv strain and presence could be either due to the high affinity
of MIRU 27 primers to anneal that more optimization might be needed.
500bp
1000bp
M 2 3 4 5 6 7 8 9 10 11 12 13 M
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3.2.2 Molecular typing of UK isolates
PCR products of eight TBM clinical isolates were electrophoresed, the sizes of the
PCR products were determined and the repeat numbers for each MIRU were calculated
with reference to the corresponding size and number of repeats for each MIRU in strain
H37Rv (Supply et al., 2001). The presence of secondary bands in some gels was thought to
be artefacts that disappeared on optimization of the PCR reactions #1. For each strain a
single 12 digit MIRU profile was obtained. This 12 digit represented the number of repeats
of MIRUs in this order: 2, 4, 10, 16, 20, 23, 24, 26, 27, 31, 39 and 40 (Fig. 3.2; 3.3).
Similarities and differences of MIRU number of repeats between isolates were determined.
The presence of small bands at lower levels probably represented primer dimers. The
possibility of contamination and mixed infections could however not be excluded.
From the TBM MIRU types, classification of individual MIRU alleles into low,
moderate and high variables was carried out in two stages; first the difference in the
number of repeats in each MIRU locus (variability) was determined and then the Hunter-
Gaston discriminatory index (HGDI) was calculated (Hunter and Gaston, 1988; Supply et
al., 2001; Sola et al., 2003). Depending on the HGDI, the TBM MIRU 26, 10 and 31 were
assessed as being highly discriminatory; showing values of 0.50, 0.68 and 0.70
respectively; MIRU 39, 4, 40 and 23 were moderately discriminate with values of 0.32,
0.47, 0.47 and 4.8 respectively; MIRUs 2, 16, 24, 27 and 20 had low discriminatory values
of 0.11 for each of the first four MIRUs but a value of zero for MIRU 20 (Hunter and
Gaston, 1988). Analysis of all eight TBMs is represented by lines (TBM 1-8) (Table 3.1).
On this panel of TBM isolates, MIRUs 4, 10, 16, 23, 26, 27, 31 39 and 40 had a relatively
moderate variability in their product sizes (Table 3.1). MIRUs 2, 20 and 24 were not
variable since most isolates had the same number of repeats.
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The small variation in MIRU repeats between TBM isolates revealed a close
relationship between the strains, which had been observed earlier by other researchers
(Personal communication with Professor Tanya Parish).
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MIRU 2 MIRU 4
MIRU 10 MIRU 16
MIRU 20 MIRU 23
Fig. 3.2 PCR amplified MIRU products of UK TBM of MRU, 2, 4, 10, 16, 20 and 23
Standard primers were used to amplify 12 MIRUs (i.e. 2, 4, 10, 16, 20, 23, 24, 26, 27, 31,
39 and 40) in the UK TBM isolates. MIRUs 2, 4, 10, 16, 20 and 23 are shown in this
figure. The PCR products were electrophoresed on a 1.8% agarose gel. Lane, M, 100bp
ladder; lanes (1-8) represent the MIRU products for each MIRU in the eight UK TBM
isolates. Multiple bands were visualized in MIRU 4; these bands disappeared after
increasing the annealing temperature.
500bp
M 1 2 3 4 5 6 7 8 M
500bp
M 1 2 3 4 5 6 7 8
1000bp
1000bp
M 1 2 3 4 5 6 7 8 M
500bp
500bp
1000bp
500bp
1000bp
1000bp
M 1 2 3 4 5 6 7 8 M
1000bp
500bp
M 1 2 3 4 5 6 7 8 MM 1 2 3 4 5 6 7 8 M
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MIRU 24 MIRU 26
MIRU 27 MIRU 31
MIRU 39 MIRU 40
Fig. 3.3 PCR amplified MIRU products of UK TBM, MIRUs 24, 26, 27, 31, 39 and 40
Standard primers were used to amplify 12 MIRUs (i.e. 2, 4, 10, 16, 20, 23, 24, 26, 27, 31,
39 and 40) in the UK TBM isolates. MIRUs 24, 26, 27, 31, 39 and 40 were shown in this
figure. The PCR products were electrophoresed on a 1.8% agarose gel. Lane, M, 100bp
ladder; lanes (1-8) represent the MIRU products for each MIRU in the 8 UK TBM isolates.
500bp 500bp
M 1 2 3 4 5 6 7 8 M M 1 2 3 4 5 6 7 8 M
500bp
1000bp 1000bp
500bp
1000bp
500bp
1000bp
500bp
1000bp
1000bp
M 1 2 3 4 5 6 7 8 M M 1 2 3 4 5 6 7 8 M
M 1 2 3 4 5 6 7 8 M M 1 2 3 4 5 6 7 8 M
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Thirty two UK strains were genotyped, strains were collected previously from
pulmonary and extra-pulmonary cases in an expected diverse population represented by the
different population groups in the UK (Dale et al., 2005), although no demographic and
clinical data was available. Comparison of UK with UAE data stemmed from the fact that
both countries have low TB prevalence and contain a diverse population including many
Asian immgrants that could reflect the type of imported foreign strains and possible
transmission patterns (Dale et al., 2005). In addition, amplified MIRUs from UK isolates
were used as standard for amplification of UAE clinical isolates. However, definite
conclusion could not be withdrawn as demographic data of the isolates were lacking.
Twelve MIRU loci were amplified from each of the UK isolates using standard
MIRU primers and the number of repeats was determined simultaneously (Supply et al.,
2001) (Table 3.1). MIRU alleles were amplified and PCR products were obtained from
majority of isolates. However, three isolates (#1, #14 and #24) gave no MIRU 16 product
even after repeated and optimized amplifications (Table 3.1).
On this panel of UK isolates, MIRUs 10, 16, 23, 26, 31 and 40 had relatively high
variability with a minimum copy repeat number of one and a maximum number of 10
(Table 3.2). MIRUs 27 and 39 had moderate variability with a repeat number of 1-4 and 2-
6 respectively. The remainder of the MIRUs (2, 20 and 24) had a lower variability power
with a minimum repeat number of one and a maximum number of two repeats (Table 3.2).
As expected, no identical MIRU profiles were found in the UK panel. The degree of
variability between MIRU alleles was expressed in the allelic diversity index (Hunter and
Gaston, 1988; Supply et al., 2001; Lee et al., 2002; Sola et al., 2003).
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3.2.3 Allelic diversity of MIRU loci in UK
Allelic diversity is an indirect index for measuring heterogeneity of M. tuberculosis
samples and it differs between high and low TB endemic countries (Hunter and Gaston,
1988; Sola et al., 2003; Nguyen et al., 2004). It is a more accurate index for detecting the
discriminatory powers of MIRU loci and the differentiation potential of MIRUs.
Furthermore, it can indicate whether transmission or reactivation is occurring; a high allelic
diversity index in a low incidence country would generally be attributed to reactivation
rather than transmission, although this relation is an indirect relationship (Tazi et al., 2004).
The allelic diversity (h) for each MIRU allele for the 40 UK and 194 UAE isolates was
calculated (Table 3.2).
Previous work using allelic diversity, segregated MIRU loci according to their
different number of repeats in each MIRU allele with the results being expressed in index
figures; a figure of (h ≤ 0.3) possesses a poor discriminatory value; a figure ranging
between h ≥ 0.3 to h ≤ 0.6 is moderately discriminatory, while a figure of h > 0.6 is
considered highly discriminatory (Supply et al., 2001; Sola et al., 2003). For the UK panel,
MIRUs 10, 16, 23, 26 and 39 were highly discriminatory; MIRUs 4, 24, 27, 31 and 40 were
moderately discriminatory while MIRUs 2 and 20 were poorly discriminatory (Table 3.2).
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Table 3.1 MIRU type of UK clinical isolates
Thirty two non-TBM and eight TBM isolates from the UK were typed. MIRU profiles
were arranged in 12-digit numbers. MIRU 10 amplification produced 10 numbers of repeat
and was represented by letter A, in isolate #6. Sympol ∆ indicates the presence of deletions
in these MIRUs.
Isolate MIRU profile
# 1 224∆27224544
# 2 255428224514
# 3 254327224544
# 5 224426154335
# 6 22A33216433
# 7 223226154533
# 8 224526154544
# 11 223516154334
# 12 224516154321
# 13 224427224531
# 14 223∆25154543
# 15 227423234522
# 16 226425224523
# 17 225425174532
# 18 223325154321
# 19 223325154523
# 21 242425153325
# 22 254427223534
# 23 125425163323
# 24 224∆26173534
# 25 225526123523
# 27 254426223514
# 28 254426221531
# 29 223415153324
# 30 226525153634
# 31 225425153325
# 32 226425154324
# 33 225426163334
# 34 245426223333
# 35 224226143325
# 36 224326151325
# 37 225526153325
TBM.1 226425183533
TBM.2 223325173543
TBM.3 232324253322
TBM.4 224323153323
TBM.5 224325154322
TBM.6 233327123425
TBM.7 332325153222
TBM.8 233325153423
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3.2.4 Identification of the proposed deletion end points of MIRU 16 in three UK isolates
Using standard MIRU primers, MIRU 16 was not positively amplified from three
UK isolates (#1, #14 and #24). Several attempts were then made to amplify the flanking
regions (upstream and downstream) of the assumed deletion of MIRU 16 locus to locate the
deletion endpoints. Standard MIRU 16 primers, which flanked the MIRU locus, were
designed according to Supply et al. (1997) (Fig. 3.4). After several attempts, these primers
failed to amplify any products in these isolates. Primer sets (P2 and P3; Fig 3.4) designed
to amplify the upstream and downstream regions of the assumed deletion of MIRU 16
locus, were designed but no products were amplified from the three isolates.
A second strategy used involved determining the presence of two primer sets
flanking the upstream and down stream regions (Fig. 3.4) to to approach the deletion end
points. The first set (P4; Fig 3.4) did not work in any of the isolates although it was
amplified in the wild type after several attempts, while the other set (P5; Fig 3.4) amplified
220bp region in Rv1459c gene in all three isolates. Further work is required to locate this
endpoint that may extend to the next gene (Rv1458c). The work was discontinued because
of difficulties in obtaining fresh cultures and shortage of DNA extracts.
The absence of MIRU 16 in the UK isolates #1, #14 and #24 was an interesting
finding since, to our knowledge it is the first report of such deletion to be documented.
Failure to amplify MIRU 16 could probably be due to DNA contamination, problems
related to PCR reactions and primers or permanent absence of the MIRU. A permanent
absence of MIRU 16 may be an indication of a deletion that exists and probably emerged
evolutionarily to confer a selective advantage or role in the organism’s pathogenesis and
survival. This warrants further investigation. MIRU 16 is located between two genes,
namely Rv1458c and Rv1459c (Fig. 3.3) generally considered as ABC drug transporters
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(Cole et al., 1998). Accordingly, the deletion of this region in these isolates may contribute
to the intracellular accumulation of drugs leading to the development of drug susceptibility
phenotypes. On the other hand, the presence of such a deletion in some isolates may lead
to drug efflux from the interior to the exterior of the bacterial wall and create possible drug
resistant phenotypes.
3.2.5 Molecular typing of UAE isolates
One hundred and ninety four M. tuberculosis DNA samples were collected from
culture-confirmed pulmonary and extra-pulmonary cases in Al Ain, UAE, diagnosed
between January 2003 and August 2005. The strains were MIRU-typed and the MIRU
profiles of all the UAE isolates determined (Appendix 5).
The majority of the isolates gave products with all MIRU primer sets, although
some MIRUs were not detected in a few isolates. For example, MIRUs 2 and 10 were not
amplified in two isolates (#2 and #6) (Fig. 3.5).
A 70bp deletion was found in MIRU 40 of isolate #2 (Fig. 3.6). Multiple DNA
bands in MIRU 4 were also detected, but these bands disappeared when the annealing
temperature was raised by 0.5oC, indicating the importance of optimising PCR conditions
(data not shown). Optimization of PCR reactions using different concentrations of MgCl2
and temperatures increases fidelity of PCR and reduce smearing and multiple banding
patterns. With the exception of MIRU 26 and 31 alleles of isolate #105 whose amplications
were difficultand produced multiple weak bands, the remaining MIRUs produced sizable
products. (Appendix 5)
The majority of MIRUs did not amplify in isolate #6 and isolate #2, possibly as
result of DNA degradation during the extraction of DNA. In a few isolates, only some of
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the MIRUs were amplified, for example, only MIRUs 2, 24, 27, 31 and 39 could be
amplified in isolate #162. Isolate #174 had no MIRUs 10, 23, and 27 and, isolate #181 did
not have products for MIRUs 10, 16, 23, 26 and 40. Isolates #182 and #184 had no MIRU
products in loci 4, 16, 20, 26 and 40.
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Fig. 3.4 Diagrammatic representation of strategies used to determine the size of the MIRU16
deletion
This figure identifies the two genes Rv1458c and Rv1459c and the MIRU 16 location
between them. The expected size of MIRU 16 is 670bp in H37Rv (Supply et al., 2001).
The primers P1a, b labeled with * were the original MIRU primers (Supply et al., 2001).
The remaining primers were designed from the corresponding MIRU 16 location in H37Rv
using the Primer3 website.
MIRU16
P2b
P1b*
P3bPlan II
P4b
670bp
1.5kbp
1kbp
220bp220bp
Rv1459c geneRv1458c gene
Plan 1
P5b
P1a
P2a
P3a
P4a
P5a
MIRU16
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Isolate #185 failed to give products using primers for MIRUs 2, 10, 16, 23, 26, 27,
31 and 40. MIRUs 4, 26, 27 and 31 were not amplified from isolate #186 and isolate #188
produced no products from MIRUs 16, 26 and 40. Interestingly, most of these isolates
were obtained from cases diagnosed in 2005 possibly indicating a common problem with
factors such as sample contamination, preparation and extraction of DNA.
Based on the variability of the copy number of repeats in the UAE isolates, MIRUs
10, 16, 23 and 26 had high variability with a minimum of one and a maximum of nine
numbers of repeats (Appendix 5). MIRUs 31, 39 and 40 had moderate variability with a
minimum of one and a maximum of seven numbers of repeats. MIRUs 2, 20 and 24 had
low variability with a minimum of one and a maximum of three numbers of repeats.
A comparison of loci variability in the UK and UAE isolates showed differences.
The UAE isolates had six highly variable MIRU alleles, while the UK TBMs had only four
variable alleles possibly indicating less diversity in the latter isolates. MIRUs 2 and 4 for
UK and UAE isolates had a higher variability in comparison with others (Cowan et al.,
2002; Sun et al., 2004), while MIRU 2 in the UK isolates had a low variability and MIRU 4
was of moderate variability. MIRU 27 was of low variability in the UAE isolates, while it
was of moderate value in the UK isolate panels. This result will be supplemented in a later
section using HGDI which is a more accurate measure of allelic diversity (Sola et al.,
2003).
Although some of the UAE isolates had identical MIRU profiles, the majority were
found to be unique. This was significant as it confirmed the presence of ongoing TB
transmission in Al Ain. Identical MIRU profiles denote recent transmission but a
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contribution can come from reactivation of cases with latent infection that gave different
profiles.
3.2.6 Identification of proposed deletion end points of MIRU 40 in UAE isolate #2
Amplification of MIRU 40 in UAE isolate #2 gave a product with a reduced band
size (Fig. 3.5, 3.6), which was purified and sequenced with both forward and reverse
primers leading to the detection of a small deletion of 70bp (Fig. 3.5, 3.6). The sequenced
MIRUs were compared with strain H37Rv sequence by matching the nucleotide base pairs
and blasting the sequence results into Tuberculist website.
Deletion endpoints were identified by blasting the sequence of the region spanning
the region from 802199 to 802431 with the reverse primer. The region spanning (80501-
80254) was sequenced with the forward primer and similarly blasted and compared with
H37Rv. The deletion was located between rplW and rplB genes. The identification of this
deletion is an indication of how sensitive MIRU typing is in detecting minor genetic
alterations among strains (Cole et al., 1998; Savine et al., 2002).
This deletion has not been documented in the literature and is of unknown
functional significance. Clinical and demographic data in later sections of the study did not
assign any clinical significance to this deletion as there were no peculiar signs presented by
the infected patient involved.
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MIRU 2
MIRU 10
MIRU 40
Fig. 3.5 PCR amplification of MIRU products in the UAE clinical isolates
Standard primers were used to amplify 12 MIRUs (i.e. 2* (with small band), 4, 10, 16, 20, 23, 24,
26, 27, 31, 39 and 40) in the UAE isolates. The PCR products were electrophoresed on a 1.8%
agarose. Lane, M, 100bp ladder; lanes (1-22) represent MIRU products for each MIRU locus in the
22 UAE isolates. MIRU 2 gel shows absence of bands in lines 2 and 6 and a very weak band signal
in line 15. MIRU 10 amplifications produced no band in lines 2 and 6 and weak bands in lines 18
and 20.
1000bp
500bp
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17.18 19 20 21 22
1000bp
500bp
M 1 2 3 4 5 6 7 8 9 10 1112 13 14 1516 1718 19 20 2122
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∆ 70bp in MIRU 40 of isolate 2
Fig. 3.6 A 70bp deletion in MIRU 40 identified in UAE isolate #2
The 70bp deletion endpoints were identified by blasting the sequence of the region
spanning from (802199-802431) with the reverse primer and blasting the sequence into
Tuberculist. The region spanning (80501-80254) was sequenced with the forward primer
and similarly blasted and compared with H37Rv. MIRU 40 sequence 1- 40 corresponded
to regions 80501 - 80540 and 52 - 284 which matched the region spanning 802199 -
802431 in H37Rv.
H37Rv strain
802540 802501 802431 802199
1 41 52 284
Tested isolate 2
rplWrplB
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3.2.7 Cluster analysis of UAE isolates using MIRU data
A cluster is defined as two or more isolates recovered from different patients
displaying identical genotypes (Small et al., 1994). The general assumption is that, isolates
derived from a common ancestor produce similar biological markers (Nguyen et al., 2004).
Hence, isolates with identical fingerprints cluster together and when isolates produce
unique DNA typing patterns they are normally attributed to probable reactivation of
infection. Cluster analysis identifies and detects conventionally undetected cases. At the
same time, it identifies unknown ongoing transmission within a population (McNabb et al.,
2004). Thus, it improves the ability of M. tuberculosis prevention and control in active and
latent cases (McNabb et al., 2004). It is worth noting however, that, clusters do not always
represent transmission (de Boer et al., 2000; Barnes and cave, 2003; Mathema et al., 2006).
Cluster analysis of all 194 isolates was conducted to determine TB transmission
between patients in Al Ain through matching identical MIRU profiles between strains.
Clusters were identified using MIRU typing and the clustering rate was calculated as
follows: Clustering rate = (nc – c)/n, where nc is the total number of clustered cases; c is the
number of clusters, and n is the total number of cases in the sample (Small et al., 1994).
Eight MIRU clusters containing 19 isolates were identified with a clustering rate of 5.6%.
Clusters ranged from two to four isolates in size. This finding in the UAE clinical panel
indicates a low degree of possible transmission within the community. The remaining 175
isolates had unique MIRU types.
3.2.8 Allelic diversity of UAE and UK MIRU alleles
In the UAE isolates, MIRU loci 10, 16, 26, 31, 39 and 40 were highly
discriminatory, MIRU 23, 24 and 27 were moderately discriminatory, and MIRU 2, 4 and
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20 were poorly discriminatory (Table 3.2). For the UK isolates, MIRUs 10, 16, 23, 26 and
39 were highly discriminatory, MIRUs 4, 24, 27, 31 and 40 were moderately discriminatory
while MIRUs 2 and 20 were poorly discriminatory (Table 3.2).
Differences between the MIRU loci of each group also existed in both the UK and
the UAE samples. For example, MIRU 2 which had a low discriminatory value in both
samples was still more discriminatory in the UAE sample than in the UK isolates with
HGDI values of (0.17) and (0.07) respectively. The highest allelic diversity power was
(0.84) with MIRU 26 in the UAE as compared to MIRU 10 in the UK samples (0.76).
Six MIRU loci were identified to be highly discriminatory in the UAE isolates,
while five MIRUs were highly discriminatory in the UK isolates. In the UAE samples,
MIRU 4 had a low discriminatory value as determined by allelic diversity (HGDI) while it
was of moderate discriminatory value in the UK isolates. With the exception of MIRU 2,
4, 20 and 24 among the UAE isolates, the allelic diversity of all the UAE isolates ranged
from moderate to high and ranged from 0.49-0.84. The allelic diversity of the UK isolates
was classified as low, moderate and high.
MIRU allelic diversity is a reliable indicator of the degree of heterogeneity of the
population. The presence of differences between the UK and the UAE M. tuberculosis
samples indicates that the isolates were obtained from diverse populations in the UK with
no cross-infection. The diversity observed in all the MIRU loci of the UAE clinical
samples is probably due to the fact that a more heterogenic population was sampled and a
large number of immigrants were included in this study. It also suggests that the UAE
sample included a large number of cases that had arisen due to reactivation of latent
infections with a minimum degree of ongoing transmission in the UAE community. These
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factors were absent in the UK samples, as no identical MIRU were detected. These
differences between the UK and UAE samples could also be attributed to the large
difference between the two populations sample sizes where UAE isolates (194) contributed
to 0.04% of Al Ain total population; the UK samples contributed to 6.7 X 10-5 %).
3.2.9 Identification of M. tuberculosis circulating clades in UK and UAE clinical isolates
Assigning strains to their corresponding families can be carried out according to the
degree of similarity between strains, i.e. isolates that share common genetic properties and
markers may have a common ancestor. Strain families may be elucidated by shared
specific genetic properties that are common to each family (Mathema et al., 2006). Nine
distinct lineages of M. tuberculosis are presently known (Gutacker et al., 2006).
Identification of M. tuberculosis strain families and grouping them according to their
geographical origin is an important aspect of TB epidemiology. Determining the
phylogeographic population structures and clonal properties of M. tuberculosis strains can
aid in the understanding of the geographical distribution of specific epidemiologically
important strains (Gagneux and Small, 2007). It is particularly important to identify the
circulating M. tuberculosis complex strains in Al Ain, UAE in order to define the
geographical origins of the strains and to identify any cross-infection between the two
population groups of nationals and expatriates in the UAE. Furthermore, this method will
reveal the most dominant strains of the M. tuberculosis complex present in the country and
discover the degree of epidemic and outbreak potentials of these strains (Gutacker et al.,
2006).
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Table 3.2 Allelic diversity of the UK and UAE clinical isolates
________________________________________________________________________
MIRU locus
2 4 10 16 20 23 24 26 27 31 39 40
_______________________________________________________________
_______________________________________________________________
MIRU allelic diversity for UK and UAE isolates of 12 different MIRU loci was calculated
using this equation: h = 1 - ∑X2i [n/(n-1)], where h represents the allelic diversity; ∑ is
sigma, n is the total number of isolates, X2i is the frequency of ith allele of a locus.
Variability between the two settings was compared (Hunter and Gaston, 1988; Ferdinand et
al., 2004).
UAE 0.17 0.22 0.60 0.73 0.19 0.57 0.31 0.84 0.49 0.71 0.72 0.73
UK 0.07 0.33 0.76 0.69 0.11 0.66 0.38 0.64 0.51 0.58 0.61 0.48
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Through the extensive application of MIRU in genotyping M. tuberculosis the
ability to use the 12 digit MIRU typing to construct a phylogeny of M. tuberculosis strains
has previously been described (Ferdinand et al., 2004). In this work M. tuberculosis strains
were first genotyped using spoligotyping. The isolates were then MIRU typed and grouped
using the number of repeats in selected MIRUs 24 and 23. MIRU 24, with two or more
copies was found to belong to principal PGG 1 (Sreevatsan et al., 1997) whilst strains with
only one copy were in PGG 2 and 3. Further subclassification of isolates was performed
with MIRU 23. MIRU alleles with moderate to high variability were further used to
classify strains into clades as defined by spoligotyping. This method was used to identify
the circulating TB strain families prevalent in the UK and UAE after MIRU typing and to
trace UAE isolates to their geographical sources. The MIRU profiles of UK and UAE
clinical isolates were used to classify the circulating strains into clades or superfamilies.
The UK isolates were differentiated into seven clades, namely, Haarlem (13
isolates) which was the most predominant strain family, LAM (12 isolates), EAI (8
isolates), Beijing (one isolate), Bovis (one isolate), T (2 isolates) and X (one isolate)
(Appendix 5). The remaining two isolates were not classified.
One M. bovis strain was recovered from a UK patient with TBM. M. bovis is a
member of M. tuberculosis complex, however it can be identified by the presence of two
copies in MIRU 24, three repeats (without the insertion of 53bp in clinical strains) in MIRU
4 that releases a PCR product size of 352bp (Cowan et al., 2002). M. bovis can also be
differentiated from M. tuberculosis by the demonstration of a 500bp PCR fragment and the
absence of pncA, which encodes for the pyrazinamide enzyme in M. bovis (Shah et al.,
2002). The identification of M. bovis was further confirmed by PCR amplification of the
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region of difference (RD1) (Data not shown). This region encompasses the Rv3877 and
Rv3878 genes and is absent from M. bovis BCG, thus differentiating between the two
species (Haurd et al., 2003). The recovery of M. bovis raises the question about the source
of the infection. Interestingly, no M. bovis strains were identified in the UAE isolates in
spite of the fact that the largest cattle farms in the UAE are found in Al Ain where the
isolates were recovered from. The confirmation of this isolates was done in order to assess
the ability of MIRU typing to differentiate between M. bovis and BCG strains.
Only one sample recovered from a TBM UK patient, was found to be a Beijing
strain. Many of these strains are associated with MDR and reported to be more virulent in
younger than older individuals in some countries e.g. Vietnam, although this association is,
yet to be confirmed (Anh et al., 2000). The remaining isolates were identified as belonging
to families commonly found in Europe and Asia.
The UAE isolates were classified into six clades, namely, EAI (38 isolates),
Haarlem (33 isolates), LAM (18 isolates), T (18 isolates), X (19 isolates) and Beijing (14
isolates). Fifty-four isolates were not classified.
3.2.10 Molecular typing of UK and UAE isolates using katG463 and gyrA95 polymorphism
Principal genetic groups (PGGs) 1, 2, and 3 as defined by SNP in katG and gyrA
provide basic understanding of genetic evolutionary relationships between different strains
and help in examining the relationships between different lineages and their abilities to
exhibit different epidemiologies in different populations (Sreevatsan et al., 1997; Alland et
al., 2003; Baker et al., 2004; Mathema et al., 2006).
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The regions in both genes were amplified and sequenced in all the UK and UAE
isolates. Genomic H37Rv DNA was included as control. Both amplicons were identical to
published sizes and sequences (Sreevatsan et al., 1997).
No katG463 or gyrA95 deletions were found in the UK and UAE clinical panels.
Forty UK isolates were grouped using katG463 and gyrA95 as follows: 22 isolates were
grouped as PGG 1, 15 as PGG 2 and three isolates as PGG 3. By comparison, 140 out of a
total of 194 UAE isolates were PGG 1, 40 were PGG 2 and 14 isolates were PGG 3
(Appendix 5). In both the UK and the UAE samples, isolates designated PGG 1 were more
prevalent, forming 55% and 72% of the total respectively, while PGG 2 comprised 38%
and 21% of the UK and UAE samples respectively, indicating that ancestral strains
dominated in both groups. The finding of both PGG 1 and 2 which are of the ancient
variety of bacilli and are more virulent than their PGG 3 counterparts of the modern variety,
indicates the presence of fewer modern strains in both populations. The prevalence of more
virulence strains in the UAE was evidenced by the fact that they formed approximately
91% of the isolates, i.e. PGG 1 and 2 isolates; a similar M. tuberculosis complex picture to
that of the home countries of immigrants and indicating their dominance in the study
sample (Singh et al., 2004; Ali et al., 2007).
Comparing these results with PGGs to assess the reliability of the method of
Ferdinand et al. (2004) yielded the following results: of the 33 isolates identified as
Haarlem family, 25 were classified as PGG 1, seven isolates as PGG 2 and one isolate as
PGG 3. The second family of EAI was made up of 38 isolates. Thirty four of these isolates
were classified as PGG 1, three isolates as PGG 2 and one isolate was designated PGG 3.
In the T family, six isolates were PGG 1, nine were PGG 2 and four were PGG 3. Of the
132
LAM group of 18 isolates, nine of which were PGG 1, five were PGG 2 and three isolates
were PGG 3. The fifth was the X family comprising 19 isolates, of which 11 isolates were
classified as PGG 1, seven isolates as PGG 2 and one isolate was assigned to the PGG 3
group. The sixth family was of the Beijing family and comprised 14 isolates. Of these, 11
were classified as PGG 1, two isolates were designated PGG 2 and one isolate was PGG 3.
These results revealed some inconsistencies in the MIRU clading. For example, the
Haarlem family is known to be restricted to PGG 2 and 3 (Mathema et al., 2006; Gagneux
and Small, 2007), whereas Haarlem strains identified by MIRU typing fell into PGG 1, 2
and 3. Nevertheless, MIRU typing showed some indication of phylogenetic conservation
in certain conserved strains family, for example, EAI (Sola et al., 2003; Baker et al., 2004;
Sun et al., 2004; Mathema et al., 2006; Gagneux and Small, 2007). Strains identified in the
EAI family were designated PGG 1, 2 and 3 in contradictions to previous work, which
designated the EAI family to PGG 1. Also, the Beijing family, which is a genetically
conserved group and is known to belong to PGG 1 (Sola et al., 2003; Baker et al., 2004;
Gagneux and Small, 2007) was represented by strains from PGG 2 and 3.
The clades identified by MIRU typing were not in agreement with those of
published data and raised questions abolut the ability of MIRUs to classify isolates into
strain families. These families were found to be similar to those identified in other
countries (Al-Hajoj et al., 2007), an indication of the global nature of the infection and also
importantly of the fact that the disease could have been imported into the UAE.
3.2.11 Identification of the UAE isolates by spoligotyping
One hundred and seventy six UAE M. tuberculosis complex isolates were
spoligotyped according to the method of Kamerbeek et al. (1997). Eighteen isolates were
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not processed due to the lack of DNA. The direct repeat (DR) regions were PCR-amplified
using DR primers and products hybridised to 43 immobilized spacer oligonucleotides-
covalently bound to a membrane (Appendix 6, 7, 8, 9 and 10).
Families were assigned with reference to known M. tuberculosis family strains
using the Spotclust website and following specific recognition rules (Filliol et al., 2002;
Brudey et al., 2006; Vitol et al., 2006) which are: Rule A, the absence of spacers 29-32,
presence of spacer 33 and absence of spacer 34; rule B, the absence of spacers 21-24 and
spacers 33-36; rule C, the absence of spacer 18 and spacers 33-36; rule D, the absence of
spacers 39-43; rule E, the absence of spacer 31 and spacers 33-36 and rule F, the absence of
spacers 33-36) (Appendix 6, 7, 8, 9 and 10). Spacer 33 is known to be related to ancestral
and modern mycobacterial strains (Filliol et al., 2002). As observed in other studies in
nearby countries e.g., Pakistan (Ali et al., 2007), and the work of Vitol et al. (2006), spacer
33 was present in some UAE strains and absent in others (Appendix 11).
Spoligotyping identified twelve families, namely Central Asian strain (CAS), LAM,
EAI, T, Haarlem, Africanum, Beijing, X and the hypothetical families 33, 34, 35 and 36.
Four strains were classified as M. bovis-BCG, two strains as H37Rv and two strains were
not classified (Appendix 11).
The CAS family (61) isolates was identified by the lack of spacers 4-7 and spacers
23-24 with reference to the CAS1 (subclade 1) strains while the lack of spacers 4-10 and
spacers 23-34 identified the CAS 2 strains (Appendix 11). Fifty eight CAS strains were
designated PGG 1 and 3 strains were designated PGG 2.
The LAM family (8) isolates was identified by the lack of spacer signatures with
reference to LAM 7-LAM 9 strains as follows: lack of spacers 26 and 27 and rule B for
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LAM 7 and lack of B for LAM 9. Seven strains belonging to LAM families were identified
as PGG 2 and 1 was assigned to PGG3.
The 25 isolates belonging to the EAI family were identified with reference to EAI2
– EAI5 strains according to the following rules: rule A and lack of spacer 40 for EAI1; lack
of spacers 20 and 21, and A for EAI 2; lack of spacers 2 and 3, A and lack of spacers 37-39
for EAI 3; lack of spacers 26 and 27 and A for EAI 4; and A for EAI5. The EAI strains
which were designated to PGG 1 were found frequently in Asia (Gagneux and Small,
2007).
The 27 isolates of the T family was identified with reference to T1–T4 strains as
follows: F for T1; lack of spacer 13 and F for T 3; and lack of spacer 19 and F for T4. PGG
grouping of these strains were as follows; five strains were PGG 1, 13 strains were
designated PGG 2 and nine strains were classified as PGG 3
Haarlem family compromised nine isolates and were identified with reference to
Haarlem3 strains; spacers 26-30 and E for Haarlem2; and E for Haarlem3. These nine
strains were classified as, eight strains PGG 2 and one strain as PGG 3 (Brudey et al.,
2006).
The eight isolates of the Beijing family with were identified by the lack of spacers
1-34 (Filliol et al., 2002; Brudey et al., 2006).
Three BCG isolates were identified with reference to M. bovis-BCG reference strain
which lacked spacer 3, spacer 9, spacer 16 and D. Four strains were defined as M. bovis-
BCG and all were PGG 1.
Two strains were identified as M. africanum by the lack of spacers 7-10, 33 and 39
in one strain, while the other lacked spacers 4, 7-10, 33 and 39 (Brudey et al., 2006).
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Family33 is a shared type lacking either one of spacers 33 or 34 or both; while most
of other spacers are present (Appendix 6). These mentioned characteristics have related
family33 to the MANU family (Singh et al., 2004). In this study, 17 UAE strains were
identified as Family33. PGG results showed that 15 of these strains were PGG 1 and 2
were designated as PGG 2. Family33 strains are frequently found in India (Singh et al.,
2004; Vitol et al., 2006). Family36 was identified by the lack of spacers 1-24 and 33-36.
Six strains were defined and designated as PGG 2 (Vitol et al., 2006). Family35 identified
by the lack of spacers 4-7, 10, 14-36 and 42-43 was identified in two isolates (Vitol et al.,
2006). Spoligopattern of Family34, represented as an odd pattern of M. africanum, was
found in one isolate. It is worth noting that, these families have not yet been well
established and names have been given for practical purposes (Vitol et al., 2006). One
strain was defined as X3 by the lack of spacers 4-12, 18 and 33-36 and designated PGG 3.
One strain lacked spacers 9-10 and F and was defined as Sf strain (previously
identified as LAM) and classified as PGG 2; two strains lacked spacers 20 and 21 and F
and were defined as belonging to the H37Rv strain and designated PGG 3 (Filliol et al.,
2002). The identification of BCG and H37Rv strains indicated the presence of
contamination during the process of DNA extraction or PCR amplification.
Two UAE strains (#119 and #185) were not classified by spoligotyping: this was
possibly due to the limited variability of the technique, which covers only one locus;
evolutionary changes; contamination of DNA samples; or a lack of reference match. Strain
#119 was however, identified by 16S rRNA as M. kanasasii, while strain #185 was not
identified by any of the methods used in this study probably due to DNA contamination or
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degradation. The possibility remains that the sample requires a more sensitive genotyping
method needs further investigation.
3.2.12 Comparison between MIRU-typed and spoligotyped families in association with
katG463/gyrA95 groupings
The spoligotyped families were subdivided by katG/gyrA polymorphism in codons
463 and 95 into groups and compared to the MIRU typed families to identify the
applicability and accuracy of both methods in identifying UAE families with the help of a
Venn diagram (Fig 3.7). Families were prioritised in a descending order based on the
number of isolates identified by both methods. Some families such as CAS were not
included in this comparison because MIRU typing did not identify strains in this family.
Although there were 33 MIRU-typed Haarlem isolates, only two isolates belonging
to PGG 2 were assigned to the Haarlem clade by spoligotyping (Fig. 3.8-A). The
remaining 31 MIRU typed Haarlem isolates were assigned to different PGGs (Fig. 3.8-A).
Spoligotyping alone had further identified seven Haarlem isolates (Fig. 3.8-A). For the 38
MIRU-typed EAI isolates, 34 were assigned to PGG 1 of 21 isolates were identified by
spoligotyping; three MIRU typed isolates were designated PGG 2 while one isolate was
designated to PGG 3 (Fig. 3.8-B).
For the 18 MIRU-typed T isolates, six isolates were assigned to PGG 1 and only
one isolate was identified by spoligotyping, nine MIRU typed isolates belonged to PGG 2,
of which five isolates were confirmed by spoligotyping, and remaining three isolates were
designated as PGG 3, of which two isolates were confirmed by spoligotyping (Fig. 3.8-C).
In addition, spoligotyping identified alone an extra of 18 T family isolates assigned to
different PGGs (Fig. 3.8-C). Of the 18 MIRU-typed LAM isolates, nine were designated
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to PGG 1, five isolates assigned to PGG 2, of which three isolates were confirmed by
spoligotyping as LAM (Fig. 3.8-D), and the remaining four MIRU typed LAM isolates
designated to PGG 3 only one isolate was confirmed by spoligotyping as LAM (Fig. 3.8-
D). In addition, spoligotyping alone identified four isolates as LAM (Fig. 3.8-D). For the
MIRU-typed 14 Beijing isolates, 11 isolates belonged to PGG 1 of which two isolates (#14
and #167) were confirmed by spoligotyping as Beijing; while the remaining three isolates
belonged to PGG 2 and PGG 3 (Fig. 3.8-E). A further six isolates were identified alone by
spoligotyping as Beijing isolates with PGG 1 (Fig. 3.8-E). Of the 19 MIRU-typed X
isolates, 11 isolates assigned to PGG 1; seven isolates belonged to PGG 2 of which only
one isolate was confirmed by spoligotyping as X family, and the remaining one MIRU
typed isolate belonged to PGG 3 (Fig. 3.8-F).
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Fig. 3.7 Comparison between MIRU typed and spoligotyped UAE families in association with
katG463/gyrA95 groupings
UAE isolates were grouped into families by MIRU typing and spoligotyping. The isolates
in each family were classified into principal genetic groups (PGGs) 1, 2 and 3 based on
katG463/gyrA95 polymorphism (Sreevatsan et al., 1997). Sets in both methods were
matched in a Venn diagram.
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3.2.13 Clustering analysis of UAE spoligotyped isolates
Spoligotyping yielded 30 clusters of identical strains, while MIRU typing yielded
only eight clusters (Appendix 12). The presence of clusters is an indication of the presence
of TB transmission links (Narayanan et al., 2004). To assess the discriminatory power of
MIRU typing to verify spoligo-clusters, MIRU data were simultaneously compared to
spoligo-genotypes. Selected spoligo-clusters represented all identified families, including
sublineages of small, medium and large sizes of clusters (Appendix 12).
Spoligotyping cluster #1 consisting of three isolates was identified as having a T3
genotype (Appendix 13). This cluster was split by MIRU typing into two different
genotypes, even though the difference between these two MIRU genotypes was minimal
and occurred in only one MIRU locus (Appendix 13). Spoligo-cluster #5 with three
isolates (#162, #163 and #188) was identified as belonging to the T3 family, and was spilt
into three MIRU genotypes. Four isolates which were identified in cluster #8 as having the
Family33 genotype (isolates #102, #155, #174 and #186) were subdivided by MIRU typing
into four different genotypes with more than eight MIRU loci differences. Two isolates
comprising cluster #10 with EAI5 genotype were distinguished into two different MIRU
genotypes. MIRU profiles of these isolates were different in three MIRU alleles, indicating
that they were epidemiologically unlinked. Four isolates were grouped into cluster #21
(isolates #18, #30, #34 and #110) and spoligo-defined as belonging to the Haarlem3
genotype. This cluster was subdivided by MIRU into four different MIRU genotypes. Ten
isolates comprising spoligo-cluster #13 with the CAS genotype were differentiated into
eight different MIRU genotypes. Of these, three isolates were identical by MIRU namely
isolates #5, #10 and #11 which establish epidemiological links between these isolates (van
Deutekom et al., 2005). The remainder had differences in more than five MIRU loci
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indicating that these isolates were unlinked epidemiologically. Cluster #17 consisting of 11
isolates were spoligo-defined as CAS and was split by MIRU analysis into ten different
genotypes. Two MIRU profiles were identical in this cluster indicating a possible
epidemiological link between the two isolates (isolates #16 and # 17). On the other hand,
two strains were different in only one MIRU locus (isolates #21 and #39) which might
indicate a possible epidemiological link between them (van Deutekom et al., 2005). The
remaining isolates differed in more than five MIRU loci, indicating that epidemiologically
there was no relationship between them. Lastly, spoligo-cluster #23 which comprised eight
isolates and was assigned to the Beijing genotype was split into eight different MIRU
genotypes. With the exception of three MIRUs (2, 4 and 24), the profiles were different in
most loci indicating that these strains were epidemiologically unlinked.
3.2.14 Combination of MIRU clusters versus spoligo-profiles
MIRU clusters were compared with their spoligotyping genotypes to determine
whether these clusters were real (Table 3.3). Although MIRU typing identified eight
clusters; only seven were included in this comparative study because of the shortage of
DNA extracts of two strains (#57 and #59) and no spoligo-patterns were determined for
these two.
MIRU cluster #1, comprising of four isolates, had similar spoligopatterns in three of
the isolates, while isolate #3 was not included because of DNA shortage. MIRU cluster #2
possessed patterns that were identical by spoligotyping. The two isolates of MIRU cluster
#3 had different spoligopatterns with only five spacers. These differences could be
attributed to evolutionary changes in association with variable rates of molecular clock
occurring within MIRU typing and spoligotyping (Prodinger, 2007). MIRU cluster #4 with
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three isolates had identical spoligotype fingerprints. MIRU cluster #5 comprising of two
strains, were identified as T3 by spoligotyping and lacked spacers 10-19 and 33-36 in both
strains. Two strains grouped in MIRU cluster #6, had very similar spoligo-fingerprints
with only two spacer differences and both belonged to the CAS family. Similarly, MIRU
cluster #7 consisting of two strains, possessed different spoligopatterns in only one spacer
and belonged to the CAS family, which could be attributed to the hypervariable nature of
these strains (Ali et al., 2007). These findings confirmed the higher discriminatory power
of MIRU typing over spoligotyping in identifying clusters and establishing epidemiological
links (Supply et al., 2001; Sola et al., 2003; van Deutekom et al., 2005). In this study,
MIRU typing was more discriminate than spoligotyping. In addition, spoligo-clusters were
mostly false clusters with no or very distant epidemiological links (Sola et al., 2003; van
Deutekom et al., 2005).
3.2.15 Allelic diversity of spoligo-defined families MIRU alleles
The allelic diversity of the twelve MIRU alleles for each family was determined
using the Hunter-Gaston discriminatory index (HGDI) (Hunter and Gaston, 1988; Sola et
al., 2003). Allelic diversity was assessed along with the frequency of repeats in each locus
to determine the frequency of these isolates and their differentiation ability. These factors
would show the differences in the discriminatory features of MIRU loci and could be
targeted further for distinguishing between strains in the UAE as has been demonstrated by
Mathema et al. (2006).
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Table 3.3 Identified UAE identical MIRU clusters versus spoligo-defined families
___________________________________________________________
Cluster # Isolate # MIRU profile Spoligo-family Missing spacers
_______________________________________________________________________
1 3
5
10
11
226425153533
26425153533
226425153533
226425153533
ND ND
CAS 4-13 and 23-34.
CAS 4-13 and 23-34.
CAS 4-13 and 23-34.
2 16
17
226525143533
226525143533
CAS 4-7, 23-34 and 37-38.
CAS 4-7, 23-34 and 37-38.
3 46
47
226425143533
226425143533
Family33 10, 23-32 and 33-34.
Family33 10,23-24,27,31 and 33-34.
4 37
41
42
226425173533
226425173533
226425173533
CAS 4-13 and 23-34.
CAS 4-13 and 23-34.
CAS 4-13 and 23-34.
5 169
170
224126113332
224126113332
T3 10-19 and 33-36.
T3 10-19 and 33-36.
6 140
141
223525174523
223525174523
CAS 4-7, 10, 17 and 23-34.
CAS 4-7, 10 and 23-37.
7 111
112
224525174523
224525174523
CAS 4-7, 10 and 23-34.
CAS 4-7 and 23-34.
_____________________________________________________________________
UAE isolates were identified by MIRU typing and spoligotyping. The MIRU clusters were
matched with those of similar fingerprints. ND, the test was not done because of DNA
shortage.
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MIRU repeats of spoligo-defined families in each locus were analysed and the
discriminatory power of each MIRU locus was calculated accordingly (Hunter and Gaston,
1988; Sola et al., 2003). Eight spoligo-defined families, namely, CAS, T, EAI, Haarlem,
Beijing, LAM, Family33 and Family36 were included. The remaining families were not
included because of the paucity of sample (two strains).
The discriminatory power of MIRU alleles in the CAS family (61 isolates) was
calculated (Table 3.4) and it was determined that MIRU 2, 4, 20 and 24 were least
discriminatory with HGDI. These MIRUs have been found to be moderately
discriminatory in other CAS related studies (Ali et al., 2007). This could be explained by
the differences in the sample size used in the two studies. MIRUs 23, 27, 31 and 40 were
moderately discriminatory of this family; with HGDI result of, 0.36, 0.50, 0.46 and 0.38
respectively. These MIRUs have also been found to have moderate discriminatory power
in other studies in Pakistan (Ali et al., 2007). MIRUs 10, 16, 26 and 39 were highly
discriminatory with MIRU 26 having a HGDI of 0.85 which is comparable to that found by
Ali et al. (2007). The reported lower discriminatory power of CAS strains in the UAE
could be explained by the sample size and the complexity of the background of patients in
the UAE.
The second largest family was T with 27 strains. HGDI discriminatory index
showed that, MIRU 2, 4 and 27 had low discriminatory values of 0.11, 0.04 and 0.27
respectively, while MIRUs 23 and 26 were moderately discriminatory between isolates
with HGDI of 0.41 and 0.32 respectively (Table 3.5). Six MIRUS were highly
discriminatory with MIRU 16 and 40 having the highest discriminatory value of 0.78.
MIRU 4 was the least discriminatory with 0.04 which is expected since MIRU 4 is
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genetically specific and stable (Mazars et al., 2001; Cowan et al., 2002). The low HGDI
value could also be explained by the low number of strains studied.
HGDI of twenty-five East-African Indian (EAI) strains family was also calculated.
The results indicated that while MIRUs 20, 24, 26, 27 and 39 were lowly discriminatory
MIRUs 2, 20 and 31 were moderately and MIRUs 4, 10, 16 and 40 were highly
discriminatory (Table 3.6). These results indicate that the degree of variability between
EAI strains was lower than those of other families with MIRU 24. For example, it was
stable and had only two copies (Supply et al., 2001; Cowan et al., 2002; Sola et al., 2003)
while, MIRU 4 had ≥3 copies in all EAI strains (Mathema et al., 2006).
The discriminatory power index of Haarlem strains showed that MIRUs 2, 4, 10, 20,
24, 27 and 40 had low discriminatory values, while MIRUs 16, 23, 31 and 39 were
moderately discriminate between strains (data not shown). Only one MIRU allele, namely
26, was highly discriminatory with HGDI of (0.70) and variation in this locus is similar to
those identified by Sun et al. (2004). These results could be explained by the low number
of strains (9) identified as belonging to the Haarlem family.
The Beijing family is a well defined family and genetically stable. HGDI of these
strains showed that, MIRU 26 had the highest HGDI with (0.54), which was classified as
moderately discriminatory, followed by MIRU 10 with (0.39) and two MIRUs 16 and 31
with (0.32). The remaining MIRUs were all classified as having low discriminatory value.
These results demonstrate that Beijing family strains are genetically stable but minor
differences in variability between strains were probably due to the small sample size (Sun
et al., 2004).
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LAM strain family is known to be variable (Ferdinand et al., 2004) and the HGDI
results confirmed these observations even though a very low number of strains (seven
strains) were examined. Five MIRUs, (MIRU 10, 23, 26, 39 and 40) were highly
discriminatory, while MIRUs 16, 27 and 31 were moderately discriminatory. The
remainder MIRUs had a low discriminatory value and hence their power to differentiate
between strains was limited. The last two families namely, Family33 and Family36 have
been shown to have moderate to high variability and could therefore be classified as unique
families (Dissanayake et al., 2001; Ali et al., 2007). Family33 comprised 17 strains.
HGDI results showed that six MIRUs were highly discriminatory and two MIRU loci were
moderately discriminatory. The remaining MIRU loci had low discriminatory values.
HGDI results of Family36 showed that, MIRU alleles 4, 24 and 39 had low discriminating
while seven MIRUs were moderately discriminatory. Two MIRUs, 31 and 40, were highly
discriminatory. These results were comparable to the values reported of these unique
strains that exhibited similarities in their diversity pattern with CAS family (Ali et al.,
2007). Furthermore, CAS strains were associated with higher discriminatory power which
may explain the high discriminatory power of the UAE isolates in previous results of this
study.
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Table 3.4 Allelic diversity of CAS spoligo-defined family strains
Number of strains was lower than 61 in some strains because no amplification products were
produced for different MIRUs.
Table 3.5 Allelic diversity of T spoligo-defined family strains
Number of strains was lower than 27 in some strains because no amplification products were
produced for different MIRUs
0 1 2 3 4 5 6 7 8 9
2 0 1 59 1 0.05 61
4 0 0 59 2 0.05 61
10 0 0 0 8 20 13 18 1 0.83 60
16 0 1 3 7 31 17 1 0.63 60
20 0 3 54 4 0.17 61
23 0 0 0 0 0 46 12 2 0.36 60
24 0 55 6 0.17 61
26 0 2 2 2 12 19 5 17 0 1 0.85 60
27 0 1 2 40 18 0.50 61
31 0 1 2 7 10 38 3 0.46 61
39 0 6 21 27 7 0.66 61
40 0 7 3 42 2 5 1 1 0.38 61
MIRU allele MIRU copy number Allelic diversity Strains
MIRU number MIRU number of repeat Allelic diversity No of strains
0 1 2 3 4 5 6 7
8 9
2 0 1 25 1 0.11 27
4 0 0 24 1 0.04 25
10 0 0 2 13 6 3 2 0.66 26
16 0 5 6 4 7 3 0.78 25
20 0 0 25 1 0.04 26
23 0 0 1 0 1 19 4 1 0.41 26
24 0 21 6 0.32 27
26 0 6 4 0 7 6 1 1 0.77 25
27 0 0 0 22 5 0.27 27
31 0 1 2 14 6 3 1 0.64 27
39 0 7 7 10 3 0.71 27
40 0 1 8 6 6 4 0.78 25
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Table 3.6 Allelic diversity of EAI spoligo-defined family strains
The number of strains with the defined repeat number in each MIRU and all MIRUs were
amplified
MIRU number MIRU number of repeat Allelic diversity No of strains
0 1 2 3 4 5 6 7 8 9
2 0 0 19 6 0.34 25
4 0 0 0 13 5 2 5 0.63 25
10 0 0 0 8 11 5 1 0.65 25
16 0 0 2 14 8 1 0.55 25
20 0 2 23 0.11 25
23 0 0 0 0 0 0 16 6 3 0.49 25
24 0 0 25 0 25
26 0 0 22 2 1 0.18 25
27 0 0 0 22 3 0.10 25
31 0 0 0 3 7 15 0.39 25
39 0 0 2 23 0.11 25
40 0 0 9 3 13 0.57 25
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3.2.16 Identification of Beijing isolates in UAE using IS6110dnaA-dnaN
MIRU typing identified 14 isolates out of the 194 UAE M. tuberculosis complex
isolates as Beijing, while spoligotyping identified only eight different isolates, namely, #14,
#68, #86, #87, #105, #139, #149 and #167 (Fig 3.8). Only two isolates (#14 and #167)
were identified by both MIRU typing and spoligotyping. In order to verify these results,
the IS6110dnaA-dnaN method was carried out. The basis of this method is that Beijing has
one IS6110 insertion in the dnaA-dnaN intergenic region. The IS6110dnaA-N region was
PCR-amplified using dnaA-dnaN primers (Milan et al., 2004). Samples suspected as
Beijing yield ~ 2 kbp products after PCR amplification, while those lacking the dnaA-dnaN
insertions produce only 537bp (Milan et al., 2004).
PCR analysis confirmed that three isolates (#2, #14 and #167) were Beijing strains
(Fig 3.9). These isolates had been assigned to PGG 1 as expected (Fig. 3.8). The multiple
bands in lanes 3, 4, 9 and 15 probably represent artefacts (Fig 3.9). The faint bands
observed in lanes 8, 9 and 12 were probably due to the low concentration of DNA. The
presence of only 500bp inserts in isolates #27, #34, #35, #69, #113, #118, #125 and #140
indicated that they were not Beijing. No products were obtained for isolates #141, #153,
#168 and #171, but the lack of DNA precluded further repeats, so that the confirmation of
Beijing could not be made.
MIRU analysis identified three isolates confirmed by IS6110dnaA-dnaN (#2, #14
and #167) while spoligotyping and dnaA-dnaN typing identified seven isolates (#14, #68,
#86, #87, #139, #149 and #167). But, combination of spoligotyping, MIRU typing and
dnaA-dnaN typing confirmed that isolates #14 and #167 belonged to the Beijing family.
The remaining isolates which were misidentified by MIRU typing as Beijing were
spoligo-defined, which revealed that isolate #27 was EAI, isolates #34 and #171 were
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Haarlem, isolates #35, #113, #118, #140, #141, belonged to the CAS family, while isolates
#153 and #168 belonged to Family36 and Family34 respectively.
The last two strains namely isolate #2 which was not spoligo-defined as Beijing as a
result of the 70bp deletion, and isolate #105. The latter was not identified by IS6110dnaA-
dnaN method probably as result of the difficulties in amplification of most MIRUs in this
isolates.
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Fig. 3.8 Identification of UAE Beijing isolates by three typing methods
Fig. 3.9 Amplification of IS6110dnaA-N from UAE Beijing isolates
The IS6110dnaA-N in 15 UAE isolates (lanes 3-17) identified by MIRU typing. M1 (1KB)
and M2 (100bp) are genetic markers. Lanes 3, 4 and 15 are isolates #2, #14 and #167.
Lanes 5, 6, 7, 8, 9, 12, 16 and 17 are isolates# 27, #34, #35, #69, #113, #118, #125 and
#140. With the exception of isolates in lanes 8, 9 and 12 which produced faint bands, the
remaining isolates had large bright bands at ~ 500bp level. Lanes, 10, 11, 13 and 14 are
isolates #141, #153, #168 and #171 which did not amplify. Multiple bands were seen in
lanes 3, 4, 9 and 15. Lane 18 represents H37Rv included as a negative control for IS6110
dnaA-dnaN insertion.
MIRU typing
SpoligotypingIS6110 dnaA-N
27, 34, 35, 113, 118, 125,
140, 141, 153, 168, 171
14, 167
Isolates #
2
68, 86, 87,
139, 149
105
M1 M2 3 4 5 6 7 8 9 10 11 12 131415 16 17 18 M2 M1
2 kbp
1.5 kbp
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3.2.17 Identification of M. kansasii strains among unclassified UAE isolates using 16S rRNA
MIRU typing and spoligotyping failed to classify 13 and two UAE isolates into
families respectively. These strains could represent unique strains circulating between
nationals in Al Ain or NTM organisms which were wrongly diagnosed and treated as M.
tuberculosis. In order to sort out such discrepancies and to identify these strains, the 16S
rRNA region of 13 unclassified strains was PCR-amplified using 16S rRNA primers
(Kirschner and Bottger, 1998). Isolates, which failed to amplify one or more MIRU loci
were included. Two strains were not included due to the lack of DNA samples. The
amplification products were sized, excised, purified and sent for sequencing. The faint
band products in lanes 3, 4 and 11 were probably due the fact that small quantities of DNA
were tested. The appearance of multiple bands was probably due to the presence of
artefacts.
Two isolates (#119 and #162) were identified by 16S rRNA analysis as M. kansasii
(Fig. 3.10) (Kirschner and Bottger, 1998). The remaining isolates were identified as M.
tuberculosis isolates that may have possibly undergone evolutionary changes that hindered
their spoligo-identification. M. kansasii spoligos for strain #119 were indicated by the
absence of spacers 3-10, spacers 15-16, spacers 24-26, spacers 28-37 and spacers 38-43.
M. kansasii strain #162 spoligos lacked spacer 13 and spacers 33-36.
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Fig. 3.10 Amplification of 16S rRNA from representative of unclassified UAE isolates
The DNA samples were collected from 13 isolates that could not be classified by
spoligotyping and MIRU typing. The 16S rRNA gene was PCR-amplified using the 16S
rRNA primers (Table 2.1). M, marker (1 kbp) in lanes (1 and 15); lanes (3-11) showing
bands of amplified 16S rRNA of representative isolates. No product was seen in lane 2 and
faint band in line 11. Multiple bands were observed in lanes 3, 4, 5, 6 7 and 8.
M 2 3 4 5 6 7 8 9 10 11 12 13 14 M
1.5 kbp
1 kbp
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3.3. DISCUSSION
Reported TB incidence rates in the UAE increased between the years of 1997 to
2003 from 23 cases to 85 cases/100,000 populations respectively among both natives and
non-nationals (Dissanayake et al., 2001). To address the question of the alleged presence
of indigenous strains or exogenous ones, there is a crucial need to utilize molecular
genotyping methods and to conduct molecular studies to identify circulating strains and
families, trace out-breaks and monitor the performance of TB control programmes in Al
Ain in the UAE.
3.3.1 Classification of the UK and UAE isolates by katG/gyrA typing
The classification of UK isolates by katG463/gyrA95 polymorphism, showed
dominance of PGG 1 and 2 organisms which are more virulent and transmissible than the
less virulent PGG 3 organisms (Sreevatsan et al., 1997). PGG 1 organisms contain both
animal pathogens (M. bovis and M. microti) and human pathogens (M. tuberculosis and M.
africanum). The presence of PGG 1, 2 and 3 indicated that both the ancient (endemic type)
bacilli and modern (epidemic) bacilli are present in the UAE. The virulence of these
organisms might have exerted their effect on the TB clinical epidemiology in the UAE with
the clinical picture among infected nationals being dominated by extra-pulmonary. The
claim of the effect of the virulence associated with the presence of these unique organisms
on the host is debatable or even refutable (Rhee et al., 1999). In the light of this virulence
debate, the lack of IS6110 RFLP analysis of the isolates and clinical data from patients, it is
difficult to correlate these results to the TB status in the UAE. Even though PGG 2 has
recently been associated with strains that are more easily transmissible (Dolzani et al.,
2004) and PGG 2 strains were attributed to only two of the clusters observed in the UAE
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isolates. The identification of these family groupings confirmed that the SNP technique is a
better genetic marker for reconstructing phylogeny than MIRU typing as mutations are
stable and did not seem to be affected by selective genetic pressure (Sreevatsan et al.,
1997).
3.3.2 Molecular typing of UK and UAE isolates
The sizes of the MIRU band products were relatively non-discriminative for the UK
TBM isolates indicating that they are to some degree related (Fig. 3.2). Dissimilarity of the
UK isolate MIRU profiles (Table 3.2) indicated that they were genetically distinct, even
though a high degree of relationship was observed in patients with TBMs. The majority of
the UAE isolates (175 isolates) also revealed dissimilar MIRU profiles indicating that they
were not related and were probably imported and represented unique strains commonly
associated with reactivation of latent TB (Vynnycky et al., 2007).
The dissimilarity among the UK and UAE clinical isolates was further confirmed
using MIRU discriminatory power and allelic diversity, which segregated the isolates into
low, moderate, and high variability that showed that the isolates belonged to heterogeneous
populations. The most discriminating MIRU loci were 10, 16, 23, 26, 31, 39 and 40 (Table
3.3). With the exception of MIRU 2 locus, the majority of these loci have been utilized to
genotype strains, study evolution and assess heterogeneity in a population (Supply et al.,
2000; Mazars et al., 2001; Sola et al., 2003). Previously, MIRUs 10, 23, 26, 31 and 40
were found to display more allelic diversity than others (Ferdinand et al., 2004).
Alternatively, MIRU evolutionarily changes might have occurred in the region of the
variable tandem repeats of these loci and made them highly discriminatory (Arnold, 2006)
in the diverse population groups in Al Ain. In addition, MIRU 4 has been reported to be
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more discriminatory than MIRU 26 in differentiating EAI strains (Gibson et al., 2005;
Mathema et al., 2006). These allelic diversity results show that, TB in the UAE is caused
mainly by reactivation of latent TB infected patients within the community (Tazi et al.,
2004).
3.3.3 Clustering analysis of isolates
The UK isolates did not show any identical MIRU profiles, which might have
hinted at the introduction of any foreign strains. By contrast, the presence of a low number
of UAE isolates (19 strains) with identical MIRU profiles (eight clusters), indicated, as
described by Lee et al. (2002), that there was probably a low ongoing transmission of
infection between these patients. MIRU typing produced a high number of unique profiles,
an indication that cases arising out of probable reactivation dominated M. tuberculosis
epidemiology in the UAE (Lee et al., 2002). Since epidemiological information has not
been provided yet, these clusters could be pseudo-clusters representing strains emerging
from reactivated cases and spreading the infection or recovered from patients who did not
experience close contact or due to a local epidemic strain causing infection (van Soolingen,
2001; Prodinger, 2007). It is worth noting that MIRU typing could produce identical
profiles with distant related strains (Mathema et al., 2006). Sometimes MIRU-VNTR
patterns in a few patients with reactivation or who are distantly living may evolutionary
converge leading to fake identical profiles giving impression of recent transmission
(Mathema et al., 2006). The extent of clustering rate, the incidence of recent M.
tuberculosis cases and the duration of the study within a community, may affect the
interpretation findings and conclusions. Hence, conventional epidemiological information
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is important to draw a more accurate link between index and affected cases (Vynnycky et
al., 2001; Mathema et al., 2006).
MIRU typing robustly relies on copy number of repeats calculated from PCR
amplification of MIRU alleles. There were some difficulties with specific MIRUs in
certain isolates due to the sensitivity of specific MIRU alleles, which hindered the
amplification of the exact size of the MIRU locus amplification product. These difficulties
were associated with multiple bands, inability to amplify regions and weak bands, which
limited the proper identification of isolates. These difficulties were attributed to DNA
degradation and PCR artefacts. Indeed, it highlights the need for proper optimising
conditions for MIRU amplification reactions. Both Beijing and EAI strains belong to PGG
1, known to contain ancient organisms and implicated in recent dissemination of TB in
some human populations (van Embden et al., 1993; Sreevatsan et al., 1997; Mokrousov et
al., 2002; Ferdinand et al., 2004). The presence of Beijing and EAI strains in the UAE
isolates correlates well with the presence of Asian expatriates who constitute the majority
of the population of the UAE (Annual Statistics Reports, UAE, 1981-1998; WHO, 2002;
Annual Statistics Reports, UAE, 2003).
The ability of MIRU to classify strains into their corresponding circulating families
was rejected in relation to samples included in this study as some MIRU typed Beijing
isolates were assigned to different principle genetic groupings that diverted from the
original classification of Biejing family strains to PGG 1 (Sola et al., 2003; Ferdinand et
al., 2004; Filliol et al., 2006). Discrepancies such as those discussed in relation to PGG of
Beijing, Haarlem and others were established and confirmed using spoligotyping and
further verified in Beijing using IS6110 dnaA-N amplification.
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Classification of some MIRU-typed family groups into further subgroups by
katG463/gyrA95 polymorphism argues against the applicability of this method for
assigning strains to their corresponding superfamilies. These reasons make it imperative
that another well established method to correctly assign strains to their corresponding
superfamilies and resolve such discrepancies is needed to correctly define strain families.
Yet, MIRU typing identified the smaller band of 70bp deletion in MIRU 40 for
UAE isolate 2 which was missed by spoligotyping indicating that MIRU analysis is highly
sensitive in detecting small deletions (Lee et al., 2002).
3.3.4 Spoligotyping
Spoligotyping is known to reproducibly reconstruct family trees. Assignment of
strains into families provides important clues to virulence, evolution, sort of diagnostic tests
that can be used and measures of control such as design of vaccines that might be needed
(Gagneux and Small, 2007). Spoligotyping was used as a secondary typing method, to
identify UAE isolates and to classify them into global clades. The reconstruction of
phylogenetic tree of any M. tuberculosis isolate is vital for the classification of isolates into
groups to facilitate the study of their evolution and relationships (Gagneux and Small,
2007). Because of its slow molecular clock and the well established database,
spoligotyping has been used by many research workers to reconstruct M. tuberculosis
phylogeny and identify circulating M. tuberculosis strains (Filliol et al., 2002; 2003;
Brudey et al., 2006; Filliol et al., 2006). Analyses of international databases including
SpolDB3 and the updated version, SpolDB4 on M. tuberculosis isolates collected from
more than 160 countries have formed the basis of different spoligotyping patterns which
have helped to assign family strains and sublineages (Filliol et al., 2002; Brudey et al.,
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2006). Mostly, the results of this method have agreed with the work of other researchers
who have used different techniques. These techniques include SNP-based phylogeny that
utilize single nucleotide polymorphisms as well as LSPs found along the genome of M.
tuberculosis to cluster groups (Gutacker et al., 2002; Filliol et al. 2006), define lineages
(Baker et al., 2004; Gagneux et al., 2006) or identify the known three principal genetic
groups (Sreevatsan et al., 1997).
Spoligotyping in the current study identified eight international families: CAS,
Haarlem, LAM, Beijing, EAI and Africanum, X and T in Al Ain. In addition, spoligo
identified five new hypothetical families, some of which belonged or were related to Manu
and Africanum strain families. This was similar to findings in other geographically
neighbouring countries such as India and Pakistan with similar strain families (Gascoyne-
Binzi et al., 2002; Singh et al., 2004; Hasan et al., 2006). Because MIRU typing does not
include MIRU data for Africanum and CAS (Ferdinand et al., 2004) these families could
not be identified. With the exception of Bovis and Manu families, our results of the clonal
structure of M. tuberculosis agreed with the findings of others who have recently described
such structures in Saudi Arabia, a neighbouring country that shares a border with the UAE
(Al-Hajoj et al., 2007).
The predominant presence of CAS family (35%) is comparable to a study in two
South Asian countries, namely, Pakistan and India which showed that the CAS family
constituted 22% of TB isolates indicating that the disease in the UAE could have been
imported from these countries (Gascoyne-Binzi et al., 2001; Singh et al., 2004; Gutierrez et
al., 2006). It is noteworthy too that the percentage of CAS family isolates in the UAE was
significantly more than what was found in Saudi Arabia (22.5%) (Al-Hajoj et al., 2007). A
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recent spoligotyping population study involving 314 isolates showed the predominance of
CAS family strains (39%) among other identified families such as LAM, EAI, Beijing and
T in Pakistan (Hasan et al., 2006). CAS genotypes are abundant in Central Asia, East
Africa such as Tanzania and Madagascar, and North India (Filliol et al., 2002; Brudey et
al., 2006). The presence of 8.5% EAI genotypes is important because it is used for tracing
origin of TB infections. As with the CAS, EAI genotypes are prevalent in East Africa,
South India and South East Asia. In addition, the Indian subcontinent is thought to be the
source of TB that spread to East Asia from where it spread globally (Brudey et al., 2006;
Filliol et al., 2006).
The prevalence of Beijing genotypes (5%) in this study was comparable to that in
Pakistan (6%), (Hasan et al., 2006), India (8%) (Singh et al., 2004), but it was slightly
higher than that in Saudi Arabia, which has a prevalence of 4.4% (Al-Hajoj et al., 2007).
This discrepancy could be due to the low number of samples used in the study. The
majority of patients infected with CAS, EAI, LAM and Beijing strains (Appendix 14) were
of Asian origin. Asian immirgrants constitute more than 60% of the UAE population and
since most of these patients originated from TB endemic areas, where these genotypes
predominate, it is not surprising to find these genotypes in Al Ain clinical isolates. This
observation lends support to the view that the disease in Al Ain might be exogenous in
nature (Annual Statistical Reports, UAE, 1998; WHO, 2002; Annual Statistical Reports,
UAE, 2003). However, the predominance of CAS may mask M. tuberculosis
epidemiology; this strain family may have been circulating in the UAE for a long time and
spoligo-defined clusters might not be representing active or true transmission (Seidler et al.,
2004). The presence of Haarlem and LAM families which are geographically localized in
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Europe, the Americas, Middle East and North Africa (Gagneux and Small, 2007) might be
an indication of the presence of low numbers of infected expatriates coming from these
areas to work in Al Ain.
These results indicated that spoligotyping and MIRU typing identified the UAE
strains into families, yet discrepant results were noted. MIRU tying overestimated the
number of isolates in each family and produced false positive results specially, with
reference to Beijing isolates which were further classified into PGG 2 and 3 if compared to
spoligotyping. It is worth noting that combining more than one genotypic method
increased the resolution of these results and minimised discrepancies (Mathema et al.,
2006).
Although four spoligotyped strains were identified as BCG due to their high
spoligopatterns similarity to the known BCG vaccine strains included as positive controls,
these findings were questionable (Filliol et al., 2002; Lari et al., 2006). MIRU profiles of
the control strains contained two copy repeats in MIRU 24, while all query isolates
contained one copy repeat in that locus, which contradicts most of the publications (Lari et
al., 2006). This strongly suggests that these isolates may not represent BCG strains (Filliol
et al., 2002; Lari et al., 2006) but represent laboratory cross-contaminants accidentally
released from controls and carried over during handling and processing of samples or
spilled-over from laboratory equipments (Mathema et al., 2006). The same applies to the
H37Rv strains defined by spoligotyping. There is however, the possibility that the presence
of BCG clustered strains could be as a result of a disseminating disease which was probably
reactivated in the three infected patients who had a history of vaccination. These results
will be verified in the next chapter.
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3.3.5 Association of MIRU-typed/spoligotyped UAE families with katG463/gyrA95 typing
The majority of the families of the UAE isolates, including CAS, EAI, Africanum
and Beijing were assigned to the ancestral PGG 1. This could be explained by the presence
of the numerous cases that presented with pulmonary and extra-pulmonary signs
(Dissanayake et al., 2001). Similar predominance of ancestral clones of PGG 1 was
responsible for 45% of all TB cases in Saudi Arabia (Al-Hajoj et al., 2007). This is not
unexpected since both countries host immigrants coming from the same regions where the
disease is endemic.
The apparent increased number of MIRU typed isolates which were identified into
several of the families might, however, is an overestimation. This was evidenced by the
classification of three MIRU typed Beijing isolates (#34, #153 and #171) by
katG463/gyrA95 polymorphism into PGG 2 (isolates #34 and #153), and PGG 3 (isolate
#171) instead of their assignment to PGG 1 (Sola et al., 2003, Ferdinand et al., 2004). This
demonstrates that MIRU typing is insensitive and inaccurate for identifying families and
thus leads to the production of false positive results. In addition, MIRU typing was shown
to be inefficient in reconstructing a proper phylogenetic tree for an international collection
of M. tuberculosis isolates that could match the SNP-defined family tree when the data of
the latter were plotted on the MIRU phylogenetic tree (Filliol et al., 2002; 2003; 2006). By
comparison, most of the spoligotyping-built phylogenetic tree branches in the same study
were found to fit with those of the SNP cluster groups. However, the subdivision of
MIRU-typed and spoligo-typed families into further subgroups undermined both genetic
markers and made them unsuitable for reconstructing phylogeny for M. tuberculosis
compared to the SNP and LSP-based methods (Mathema et al., 2006). It is well known
that MIRU typing and spoligotyping are subject to rapid evolutionary alterations as
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opposed to the stable and irreversible mutations that have occurred in the SNP and LSP-
based techniques (Schork et al., 2000; Arnold, 2006).
3.3.6 Clustering analysis
The clustering rate of UAE isolates by spoligotyping of 46% was expected in a
country which continues to receive influx of immigrants and expatriates the majority of
whom originate from regions where TB flourishes (Filliol et al., 2006). Yet, the clustering
rate was less than the one (86%) reported in Saudi Arabia, which has similar TB
epidemiological conditions and using the same calculation formula (n-1) (Al-Hajoj et al.,
2007). This difference could be related to the seasonal occurrence of pilgrimage in Saudi
Arabia where there is congregation of great numbers of people from different countries the
majority are endemic with TB (Al-Hajoj et al., 2007).
3.3.7 Combination of both MIRU typing and spoligotyping for assessment of clusters
MIRU typing per se identified identical strains and when combined with
spoligotyping, reduced the overestimated number of spoligo-defined clusters from 30 to
only eight clusters, and the sizes of clustered strains was reduced from 2-11 to 2-4. These
results are of significance since they could help to target epidemiological efforts to public
health requirements and properly identify index cases so that the links can be traced for
intervention of transmission with minimal time and cost.
Comparison of the discriminatory powers of the methods showed that MIRU typing
was more discriminatory than spoligotyping. In addition, MIRU typing sub-classified
spoligo-defined clusters in to close, related and causal epidemiological links using MIRU
allele differences (van Deutekom et al., 2005). On the other hand, spoligopatterns of seven
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MIRU defined clusters were almost identical with minimal changes. This may contribute to
evolutionary and methodological changes (Murray and Alland, 2002; Arnold, 2006).
Although, cluster analysis was done using both methods which indeed decreased the degree
of bias, to accutately identify clustered cases and illuminate cross-contamination and other
operational mistakes such as labelling results will need to be combined with demographic
and clinical data (McNabb et al., 2004; Mathema et al., 2006). Conventional epidemiology
will further add more value specifically to this relationship and improve contact tracing as
described in the next chapter.
3.3.8 Validation of Beijing by the presence of IS6110dnaA-N
Three Beijing isolates (#2, #14 and #167) were identified with IS6110 dnaA-dnaN.
The IS6110 dnaA-dnaN strategy can be used as an alternative genetic marker to replace
such genetic methods as polymorphism in multiple IS6110 (Bifani et al., 2002; Milan et al.,
2002) and spoligotyping (Sola et al., 2001) to identify members of the Beijing family.
IS6110 dnaA-dnaN is a gold standard for identifying Beijing strains, particularly in areas
where the organisms are endemic (Kurepina et al., 2005). In addition, the presence of the
insertion in the intergenic region can further distinguish between the family strain lineages
such as the W strain family with two insertions and the N-family that lacks the insertion
(Milan et al., 2004).
3.3.9 Identification of M. kansasii using 16S rRNA
The use of 16S rRNA sequencing identified two isolates (#119 and #162) as M.
kansasii. It is noteworthy that, spoligotyping identified isolate #162 as belonging to the T
strain family allocate a strain to isolate #119. This is the first documented report of the
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presence of M. kansasii in the UAE. The presence of M. kansasii organisms is of
significance since these pathogens cause pulmonary disease in both healthy and
immunocompetent humans, which requires a long period of treatment (British Thoracic
Society, 2000; Marras and Daley, 2002; Koh et al., 2005). Source, clinical picture and
quantity of these isolates in each patient should be identified to help prompt diagnosis,
treatment and epidemiology (Shitrit et al., 2006). It is worth noting that infection with M.
kansasii is not transmitted by direct contact and while aerosol route may be involved, the
primary route of transmission is by ingestion of contaminated materials (Falkinham et al.,
2002). In mines, these strains are frequently isolated from NTM disease affecting
mineworkers predisposed to tuberculous infection by silicosis, a disease caused by
exposure to silica dust (Corbett et al., 1999).
It is worth noting that these two M. kansasii strains were unfortunately missed and
the infected patients were treated for TB instead. On the other hand, all strains included in
this study were culture-confirmed twice as Mycobacterium without speciation in Al Ain
hospital and UAE university laboratories and treated accordingly, which raises a huge
concern about safety measures, prompt diagnosis and codes of practice. It is worth noting
that identification of Mycobacterium to the species level and confirmation requires
shipment of the samples to Germany in a procedure that takes about six weeks.
3.3.10 Conclusions
Genotypic epidemiological analysis provided a descriptive insight into the M.
tuberculosis clonal structure in Al Ain. The high diverse population of M. tuberculosis
with low transmission in this study documents the evidence that reactivation of latent M.
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tuberculosis infection is probably responsible for the increased notification rates of the
disease in the UAE.
The effectiveness of the twelve MIRU typing methods in differentiating between
isolates varies according to different settings, samples and population. This highlights the
importance of evaluating the discriminatory power of MIRU loci to be utilized in
outbreaks. In the UAE, the most discriminatory locus was MIRU 26 and interestingly this
MIRU maintained its high discriminatory power relatively well in all spoligo-defined
families.
Correlation of MIRU typing with the ancestral and modern TB definition was not
well established. This could be explained by two reasons. Firstly, there were only a low
number of ancestral strains in this study population and secondly, TbD1 was not tested.
The TbD1 was not examined because we ran short of DNA and time. The majority of UAE
isolates were PGG 1 using principal genetic grouping, which is a more reliable lineage
identifying method in comparison to MIRU typing and spoligotyping, and these isolates
have known to acquire great virulent characteristics (Sreevatsan et al., 1997).
The utility of a genotypic method in any setting depends on the aim of the
population based analysis and the targeted genetic markers (Mathema et al., 2006). For
example, in the UAE the principal aim was to assess the existence of two M. tuberculosis
populations and to identify families for these circulating strains so as to trace the isolates to
their origins. Hence, the use of MIRU typing because of its efficacy in differentiation and
tracing contacts and spoligotyping for defining UAE strain families. Furthermore, MIRU
typing has the added advantage of epidemiologically differentiating clustered strains
identified by other genotypic methods (van Deutekom et al., 2005).
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Discrepancies in some of the results presented in this chapter, especially when all
three genotypic methods were combined, might be explained by the independent deletions
observed in these loci as has been noted by others (Gutacker et al., 2002; Mathema et al.,
2006).
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CHAPTER 4 ASSOCIATION OF UAE STRAIN GENOTYPING WITH CLINICAL,
DEMOGRAPHIC AND SOCIAL DATA, AND RIFAMPIN RESISTANCE
4.1 INTRODUCTION
Genotypic epidemiological studies help fill some of the existing gaps in the
prevention and control programmes against TB because rapid and higher resolution are
achievable especially when conventional and genotypic methods are combined (Small et
al., 1994; Rhee et al., 2000; Yates et al., 2002). Conventional epidemiology aims to
identify possible contacts of patients at home, work, and other places, while genotyping
methods identify strains causing the disease and confirm the presence of ongoing
transmission between these contacts (Godreuil et al., 2007). The most utilized application
of genotypic methods has been in cluster analysis, where conventional epidemiology adds
substantial value to genotypically generated data and identifies unknown epidemiological
links between patients (McNabb et al., 2004; Godreuil et al., 2007). It also aids in
identifying existing outbreaks and accurately defines the source of potentially exposed
candidates (Diel et al., 2004). Adding epidemiological and genotypic data together has had
a huge impact on the identification of cross-contamination, where the clinical picture does
not correlate with the recovered genotype confirming the existence of multiple infections in
specific settings. This has been, attributed previously to M. tuberculosis super-infection
(Braden et al., 2001; Shamputa et al., 2004). It also helps in understanding the course of
active and reactivated TB infection. Reactivation of latent M. tuberculosis infection is
documented to have a major influence on TB epidemiology, especially in countries with
low TB incidence (Geng et al., 2002; Godreuil et al., 2007).
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The flow of immigrants from countries with high TB prevalence to areas with low
TB prevalence poses a great threat to public health, as these individuals act as reservoirs for
latent TB and typically spread infections in the community within the first five years of
their arrival (El-Hamad et al., 2001). The UAE is a prosperous country with a low
prevalence of TB (WHO, 2007). It has a heterogeneous population, the majority of which
are immigrants seeking work in the country (UAE interact, 2007). The existence of such a
mixed population creates considerable public health hazards as persons entering the country
can import many infectious diseases, including TB and HIV. To combat this problem, the
UAE government has implemented a general health screening policy that targets adult
expatriates aged between 18 and 60 years old, which is mandatory before work permits are
issued. Secondly, entry visas are issued on personal basis so that expatriates are not
permitted to reunify with their families unless they earn more than AED 5000 a month (£1=
7.85 AED). All successful visa applicants have to be free from TB, hepatitis B and C, and
HIV. As part of the routine screening, all workers with salaries less than AED 3000 are
chest X-rayed and if this is found to be abnormal, Mantoux test or a tuberculin skin test
(TST) is carried out. If tests are positive for TB, the visa applicants are immediately
deported to their home countries.
In fact, most of expatriates with low income live in overcroweded shared rooms or
flats in Al Ain. Low income is linked to TB because the low income group of people
usually live in poor and crowding conditions that act as potential risk factors for recent
transmission (Alland et al., 1994).
This TB control policy, which is supported by other parameters such as proper
infrastructure, availability of safe water supply, the accessibility of health service
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organisations, good living standards and efficient immunisation programmes, have
contributed in classifying the country as a low prevalent TB country. However, this policy
has some drawbacks. Firstly, it is entirely dependent on chest X-ray screening to spot
individuals with active TB and who are immediately deported but ignores latent cases.
Encouraged by fear of deportation, the latent cases with negative X-ray may pass unnoticed
among the community and spread infection. Individuals with latent infection also tend to
illegally purchase non-curative medicines and remain as potential infectious foci for others.
Moreover, the government policy does not include measures about health education and
awareness to remove stigma and encourage people to seek medical attention. These
drawbacks have been discussed in the undergoing study and a new strategy has been
suggested to improve the existing TB control policy.
In this chapter investigation of the effect of demographic data, such as age, gender,
nationality, country of birth and other host-related factors on TB epidemiology and
assessment of their role among national and non-national TB patients in Al Ain, UAE, is
presented. In addition the study has assessed the prevalence and the dominant M.
tuberculosis strain circulating in the UAE, and any association with the clinical symptoms
presented by patients, gathered from their medical notes together with the accompanied
pathological lesions and chest X-ray abnormalities. The prevalence of TB among both
categories (nationals and immigrants) was equally evaluated using chest X-rays and TST.
The recovered genotyped family strains were correlated with the clinical signs and
pathological lesions to establish any possible epidemiological links. In addition, clustered
genotypes were used to detect transmission patterns, trace epidemiological links and to
identify the source of infection.
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Furthermore, this study examined the prevalence of rifampin resistance as a marker
for MDR-TB on this study population. A recent report of an increase in the rate of MDR-
TB from 2% to 8% by Bener et al. (1996) and the lack of government policy to control the
dispensation and control of TB drugs has further confirmed the necessity of the study.
Previously 17 various mutations in rpoB, including a point nucleotide substitution in
residue 516, deletions and insertions, were incriminated in conferring resistance to rifampin
(Jin and Gross, 1988). The occurrence of allelic mutations differs with geographic
locations and among ethnic groups. For example, in the USA the most frequent rpoB
mutations occur at codons 531 (43%), 526 (31%) and 516 (5%) (Kapur et al., 1994).
Ahmad et al. (2002) detected rpoB mutations mainly among expatriates originating from
the South Asian region and who have been working in Kuwait and Dubai. RpoB mutation
at codon 526 was observed in abundance amongst South Asian expatriates, while mutation
at codon 531 was found in workers who originated from the Middle East (Ahmad et al.,
2002). Similarly, this study was intended to explore the presence of rpoB mutations and
assess their role in mediating rifampin–resistance among nationals and immigrants and
determine the possible source of resistance in Al Ain.
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4.2 METHODS AND RESULTS
Retrospective data collection from medical records is associated with tremendous
difficulties. In this study, data was collected and correlated from different sources. These
included medical records, notification, and laboratory forms for 194 TB participants from
34 countries. These 194 patients represent culture confirmed cases out of the 327 cases
diagnosed with TB in the period between 2003 and 2005 in Al Ain. These data were
verified with the UAE Immigration Department records with regard to the nationality of
patients as an important factor in associating with the demographic data. Participants’
resident addresses were obtained from the municipality in Al Ain.
Generally, contact tracing of TB presents a major challenge in the management of
the disease. Contact tracing was also a problem in this study as formal addresses for many
of the patients in the UAE and in Al Ain in particular, were unavailable. In fact, the
majority of TB patients were workers or labourers whose addresses were those of their
work places and usually had no specific residential address. In this context, it was found
that 52 participants provided the same day time addresses while each participant had a
different night time address. Difficult too was the documentation of the addresses for
nationals as the name of each patient had to be correlated with the district or locality of
residence, the building where the participant lived, his family and employer and/or
employees.
Although the low number of samples did not help in the statistical analysis, it
provided an opportunity for more investigative research with regard to the missing
information. Overall, the data collected on age, nationality, type of disease, sample smear,
sample culture, place of birth, date and place of diagnosis as well as tuberculin test were
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most useful and complete. The success of the collection of the remaining pieces of
information varied from 80% to 92%.
4.2.1 Study population, clinical, demographic and host-related factors data
This work was conducted in Al Ain which has a population of approximately
500,000 individuals (UAE interact, 2007). Participants were adults and children who were
UAE nationals and non-nationals attending Tawam hospital, Al Ain hospital, and the
Preventive Medical Department (PMD) in Al Ain. Clinical, demographic and social factors
data were obtained by examination of medical records, laboratory requests and notification
forms. Information was double-checked with respect to the available medical notes by
combining information from the three sources.
Patients came from three different sources. Most national patients (33) representing
65% of the national group attended Tawam hospital for treatment, the remainder (18); 16
attended Al Ain hospital only two (31%) attended PMD (4%) (Appendix 15). The majority
of non-nationals (90) attended PMD (63%), the remainder (53); 44 attended Al Ain hospital
(31%), while nine patients attended Tawam hospital. The main reason for visiting these
health centres by participants was illnesses among nationals (94%) and non-nationals
(66%); this was followed by renewal of immigration documents (25%) and new immigrants
seeking new work permits (8%) (Appendix 16). The high percentage of immigrants
attending health centres with illnesses was due to their delay in presentation and thus
progression of the disease from a latent stage to an active form of the disease. The possible
reasons for the delay was the fear of being arrested or deported by health officials if they
tested positive, and attempted self treatment due to the availability of cheap drugs over the
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counter because of the lack of a government policy controlling the dispensing of drugs in
the UAE.
4.2.1.1 Demographic profile and host-related factors
The calculated mean age for infected patients with TB was 34.4 years, and was
ranged from 4 years to 68 years. Of the total 194 TB cases, 171 were adults and 23 were
children. The majority of adult cases occurred within the 40 – 49 year age group; followed
by 30 - 39 year group, those aged from 20 – 29, and finally individuals aged 50 – 59 (Table
4.1). The absence of TB cases in non-nationals after the age of 60 years old was probably
due to the fact that they had developed residual immunity or to the small number of
samples included in this study.
The number of paediatric TB cases (<13 years old) were relatively higher among
UAE nationals (25%) than non-nationals (7%) (Table 4.1), possibly because most
immigrants granted visas are not allowed to bring their children unless their salaries exceed
AED 5000. There were no TB cases observed in children aged three or less in either
nationals or non-nationals in this study (Appendix 17).
Of the total 194 TB samples, 123 were from males and 71 from females. The ratio
of male to female notification rate of 2:1 was similar to that reported worldwide. Higher
TB notification rates were also observed in men than women in three age groups (Table
4.1).
The majority of TB patients (143) were non-nationals, who originated from 33
different countries (Table 4.2). The higher number of immigrants, compared with
nationals, participating in this study was probably due to more sampling from this category
as they constitute the majority of Al Ain residents (UAE Interact, 2007). It is also
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noteworthy that these immigrants represent 98% of the work force in the UAE (UAE
Interact, 2007). Patients originating from the Indian subcontinent and East Asia
outnumbered those originating from the other countries represented on the UAE. The most
affected groups were of Indian (43) and Pakistani (19) origin.
Identifying patients’ home addresses was a very difficult task. National addresses
which are stated in in the medical notes and notification forms were incomplete.
Addressees were traced using information retrieved with the aid of Al Ain municipality.
Each district site plan and owner identities were retrieved as stated in Section 2.17. Non-
nationals were grouped into two major groups; those who were employed by nationals
(such as maids, servants and drivers), who live in the same houses as their employers and
those who live separate from their employers. The addresses of non-nationals in the second
group were more difficult to trace as these are not required for any official documents.
Infected patients were distributed in eight districts (Fig. 4.1; Table 4.3). National
patients resided mainly in Hili (22) representing 43%, with a few distributed in other
districts. The district encompassing the Industrial area of Sanaiya was not included. The
presence of patients infected with TB in Hili is surprising since the district has the
wealthiest inhabitants in the UAE, typically earning more than AED 25,000 a month
(Appendix 18). The presence of such infection could be related to the ability of these
people to recruit many workers, such as maids and drivers, who could be the source of
infection via close contact.
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Table 4.1 Age and sex distribution
Age Malenationals
Female
nationals
Male
immigrants
Female
immigrants Total
<13 8 5 7 3 23
13 - 19 2 2 3 4 11
20 - 29 5 2 15 13 35
30 - 39 5 6 18 13 42
40 - 49 7 2 24 14 47
50 - 59 4 1 24 5 34
>60 1 1 0 0 2
Total 32 19 91 52 194
Distribution of age and sex amongst the 194 TB patients who were included in this study;
51 individuals were UAE nationals compared with 143 non-nationals, a considerably higher
proportion of males made up the study group (123 compared with 71), and this correlates
with previously reported worldwide male: female infections.
Table 4.2 Country of origin of TB patients
Country name No. of Patients Country name No. of Patients Country name No. ofPatients
Afghanistan 1 Kuwait 4 Sri Lanka 3
Bahrain 2 Lebanon 2 Sudan 4
Bangladesh 5 Madagascar 1 Syria 3
Brazil 1 Morocco 2 Thailand 1
Croatia 1 Nepal 2 Tibet 1
Egypt 6 Oman 6 Turkey 1
Ethiopia 1 Pakistan 19 UAE nationals 51
Greece 1 Palestine 8 Ukraine 1
India 43 Philippines 4 Vietnam 1
Indonesia 5 Qatar 1 Yemen 2
Iran 4 Russia 1
Jordan 5 Somalia 1 No. of countries 34
Distribution of country of origin for the 194 patients included in this study, in total 34
countries was represented. 51 individuals were of UAE origin, the next largest group was
made up of individuals originating from India (43), followed by those of Pakistani origin
(19).
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Non-nationals resided mainly in the Industrial Area (52), with a few distributed in
other districts (Fig. 4.1; Table 4.3). The presence of TB cases in the Industrial Area
(Sanaiya) was expected since it is an overcrowded, business district where the majority of
immigrants work. The lack of 52 patients’ addresses of this highly mobile infected group
poses a huge threat to the community, especially when we consider that these patients are in
close contact with two or more groups; those at work and those in their residences.
Previous TB infection, in the family, as assessed by enquiry from family members,
individuals or relatives living together, was 45% in non-nationals, and 37% in nationals
(Appendix 19) with 42% and 31.4% of household members reporting previous TB
symptoms respectively. The lower percentage of TB (37%) and household reporting
(31.4%) among national patients could also be due to fear of the stigma associated with the
disease and lack of awareness of the disease and its health implications.
Information regarding potential risk factors for acquiring TB was also collected
from medical notes. Many non-nationals reported a history of travel in the previous year to
their countries of origin, which increases the risk of acquiring infection. Other potential
risk factors such as existence of chronic conditions reported by infected participants
showed that the main associated illnesses (chronic diseases other than TB that affect the
immune system) were diabetes mellitus, allergy, hypertension, ischemic heart disease,
rheumatic fever, peptic ulcer and chronic sinusitis. These diseases are prevalent in Asia.
These might have predisposed to or exacerbated TB and also masked the symptoms and
resulted in delay in presentation and diagnosis (Sharma et al., 2007).
Table 4.3 Patients residing different districts of Al Ain
Place in Al
Ain Nationals (51) Non-nationals(143)
Total
Al Jimi 14 6 20
Al Maqam
2 8 10
Al-Markhaniya
5 18 23
Al-Masoudi
5 15 20
Hili
22 7 29
Industrial Area
0.0 52 52
Mezyad
0.0 17 17
Zakhir
3 20 23
The breakdown of TB patients numbers residing in eight districts of Al
Ain with respect to nationals and non-nationals for comparison.
Fig. 4.1 Al Ain districts map
This map was kindly supplied by Al Ain Municipality Department. Eight residential districts of TB patients; Hili, Al Maqam, Al Jimi,
Al Markhaniya, Al Masoudi, Zakhir, Industrial Area (Sanaiya) and Mezyad. The number of infected patients residing in each district is
given.
The data on TB cases (Table 4.4) on a monthly basis showed that more cases were
reported in September, October, November and December in 2003 and 2004 (Table 4.4).
This was probably due to the fact that the academic year commenced in September, when
active movement of immigrants in and out the country, movement of people, tourists and
students occurred, increasing the chances of perpetuating infection as a result of improved
climate conditions in the UAE (Table 4.4). In 2005, TB cases were not reported during
these four months due to implementation of a new government policy, which restricted the
influx of expatriates and their families, and also probably because of refurbishment work
that was being done in the laboratories at Al Ain hospital.
4.2.1.2 Clinical and pathological profiles
The most prominent symptoms of diagnosed non-national TB patients were coughs
(73%) and fever (62%), which are important symptoms of pulmonary TB (Fig. 4.2).
Pulmonary disease occurred more frequently among non-nationals (71%) than natives
(61%) (Appendix 20), while extra-pulmonary was more prevalent in nationals (13 cases
representing (25.5%) of the total TB cases in this group), than immigrants (21 cases)
representing 14.7% (Appendix 20). Although extra-pulmonary disease has not been
previously associated with cough, this was presented by 23 patients in this study (Fig. 4.2).
This could be due to other causative factors, such as irritation to the upper respiratory tract
as a result of the tropical nature of the country; smoking and allergy were reported by
patients. Co-infections with other bacteria and viruses, such as flu viruses, could also be
responsible for this symptom.
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Table 4.4 Year and month-wise distribution of confirmed TB cases in Al Ain
Number of cases reported in the year
Month 2003 2004 2005 Total
January 6 8 2 16
February 3 8 3 14
March 7 3 2 12
April 4 4 6 14
May 8 2 5 15
June 4 3 9 16
July 4 3 4 11
August 6 4 2 12
September 10 8 NR 18
October 12 10 NR 22
November 9 13 NR 22
December 11 11 NR 22
Total 84 77 33 194
Breakdown of samples collected in this study, typically more cases were reported in the
later half of the year, as a result probably of the fact that this coincided with
commencement of the academic year, when movement of immigrants, tourists and students
occurs. In 2005, TB cases were not reported during September - December due to the
implementation of a new government policy, which restricted the influx of expatriates and
their families, and refurbishment works being done in the laboratory at Al Ain hospital.
NR, not reported.
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Fig. 4.2 Symptoms and form of tuberculosis
The breakdown of the symptoms shown by patients with pulmonary TB compared with
those presented with extra-pulmonary TB.
Association of clinical picture of TB and defining the causative strain family
improves the understanding of the course of the disease and the assessment of the severity
of specific genotypes or strains of M. tuberculosis. Furthermore, it identifies specific
clones associated with odd epidemics and potential outbreaks (Mathema et al., 2006).
Cases with productive cough were more abundant (14) than non-productive (7) in
nationals who had had the disease for a duration of 4-6 weeks, while for the same period
productive and non-productive cases were 36 and 20 in non-nationals respectively implying
a more severe form of disease in the latter group (Appendix 21). The dominant colours of
coughed sputum were yellow (38) possibly indicating mixed infection and allergy, green
(15) an indication of bacterial infection, and white probably indicating allergy (12)
(Appendix 22).
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Each suspected patient was subjected to at least two consecutive chest X-rays as
routine screening. Examination of radiographs revealed abnormalities in 32 (84%) of
nationals and 102 (83.6%) of non-national (Appendix 19). The most common radiographic
abnormality was fibrosis (60), followed by cavitations (52) and calcification (9), signalling
reactivated disease (Fig. 4.3). For patients with pulmonary disease TST examination gave
more positive results in non-nationals 71 than national 27 patients (Appendix 23). Biopsied
tissues taken from patients with extra-pulmonary disease produced less positive results
among non-nationals 14 (33%) than nationals 10 (50%), probably because of sampling
difference as more non-nationals were included in the study or most of nationals were
reluctant to undergo such procedure (Appendix 24).
Fig. 4.3 Chest abnormal radiographs among nationals and non-nationals in Al Ain
Chest X-rays showed that fibrosis and cavitation were more prevalent than calcification and
pleural effusion. However non-nationals had a higher proportion of calcification and other
conditions identified by radiography than nationals.
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4.2.2 Genotyped family strains in association with clinical and pathological profiles
The association of phenotypic and genotypic characteristics provide insight to
molecular epidemiology, evolution and virulence of M. tuberculosis (Arnold, 2006; 2007).
It also enables comparisons between clinical and radiographic properties of specific strains
and helps to differentiate between clustered and unique cases (Geng et al., 2005). Previous
studies have suggested that certain family strains significantly caused pulmonary disease
rather than extra-pulmonary, suggesting an interplay between genotypic and phenotypic
properties of M. tuberculosis (Dale et al., 2005; Malik and Godfrey-Faussett, 2005). The
high diversity of the population in Al Ain provided a good opportunity to study such
association. Moreover, the study investigated any possible association between clinical and
pathological features and the causative agents. This could be of great value in the diagnosis
of the disease or the determination of any tropism that could influence virulence.
In this study, the correlation between MIRU-typed and spoligotyped family strains
(chapter 3) and clinical symptoms and signs and the pathological characteristics observed in
patients in Al Ain was determined. Among the defined MIRU and spoligotyped families
(chapter 3) in Al Ain, CAS was dominant and associated with clustered isolates. Of the 19
patients included in the MIRU typed clusters, five were working in the Industrial Area in Al
Ain.
There is a heightened emphasis on tackling CAS and Beijing family strains in
relation to clinical and pathological characteristics because they are recognised as notorious
organisms (Bifani et al., 2002) which are frequently associated with clustering (Ali et al.,
2007). Spoligotyping identified 13 families and 30 clusters in Al Ain. Although these 30
spoligo-defined clusters were not true clusters, adding the clinical data further emphasized
the concordance between molecular and clinical information. For example, the eight CAS
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clusters and all the Beijing strains were found in one cluster hinting virulence rather than
transmission. CAS family (47 -40.5% vs. 14- 26.9%), the T strain famly (20- 17.2% vs. 7-
13.5%), the Haarlem (8 (6.8%) vs. 1 (1.9%), and Beijing (7 (6%) vs. 1 (1.9%) were all
associated more with pulmonary than extra-pulmonary disease (Fig. 4.4). These findings
showed that CAS family strains were involved in both forms but the strains had preferential
tropism toward pulmonary disease in affected patients (Fig. 4.4). The EAI showed more
percentage of extra-pulmonary, 11 (21.1%), than pulmonary disease 14 (12.1%), and more
percentage of extra-pulmonary was also seen with Family33 (Fig. 4.5). CAS family was
also frequently associated with pronounced coughs, 48 (41.4%), followed by 18 (14%) for
T family, EAI and Family33 each with 11 (9.5%), Haarlem with 8 (7%), 7 (6%) for
Beijing, five (4.3%) for LAM, three (2.5%) for Family36, and one (0.01%) for each of S
family, Family35, X family, Africanum and Family34 (Appendix 25). Of the 45
pulmonary patients included in the CAS cluster, tuberculin sensitivity test (TST) diagnosed
28 cases: while TST diagnosed only four of the eight pulmonary cases infected with
Beijing.
The most common chest radiographic abnormality in patients in Al Ain were
cavitations observed in 30 (50.8%) cases infected with CAS; 11 cases (18.6%) by T family;
6 cases (10.2%) with Beijing and five (8.5%) cases infected with EAI (Fig. 4.6). Patients
infected with CAS were also affected more commonly in the upper lobe of the lung (16),
followed by the lower lobe (6) and then the middle lobe (3). Lesions in patients infected
with the Beijing strain were observed most commonly in the in the upper lobe of the lung
(5) followed by the middle lobes (1). Two cases of with fibrosis were also observed in
Beijing infected patients (not shown).
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Fig. 4.4 M. tuberculosis family strains tropism for pulmonary TB among patients in Al Ain
While the CAS family was found to be most prevalent in causing pulmonary TB (47/116, T
family was found to be the next most prevalent in pulmonary infections, and the EAI was
third.
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Fig. 4.5 M. tuberculosis family strains tropism for extra-pulmonary TB among patients in Al
Ain
While the CAS family was found to be most prevalent than other families in causing extra-
pulmonary TB (14/52) in patients, EAI family was found to be the next most prevalent, and
T family was third in order.
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Fig. 4.6 Spoligotyped family strains recovered from patients with cavitations
The distribution of family strains taken from patients with cavitations. CAS was found
more prevalent in patients presented with cavitations almost three times than the next
represented family group, the T family.
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4.2.3 Spoligotyped family strains in association with nationalities and demographic data
Identification of the nationality of a TB patient aids in defining the geographical
location of mycobacterial strains and provides a useful tool for contact tracing. CAS
genotypes (61, 36.3%) were dominant strains recovered from TB patients of various
nationalities born aboroad in different countries (Table, 4.5); 14 genotypes (8.3%) were
harboured by Emirati patients; seven genotypes (4.2%) were borne by each of the Indian
and Pakistani patients, six genotypes (3.6%) by the Palestinian patients, five genotypes
(3%) by Egyptians and the rest were recovered from other nationalities (Table, 4.5). T
genotypes, (27, 16.1%), were the next largest family recovered from patients of different
nationalities, of which eight (4.8%) genotypes were isolated from the Indian patients while
the rest were from other nationalities (Table, 4.5). EAI genotypes (25, 14.9%) were
harboured by many nationalities, 13 (7.7%) genotypes were recovered from Indian patients
and the remaining 12 genotypes were from different nationalities. Family33 strains (17,
10.1%) were borne by patients from several nationalities of which eight (4.8%) genotypes
were borne by the Emirati. Haarlem strains (9, 5.4%) were wholly recovered from different
Asian patients including three Emirati. LAM (8, 4.8%) genotypes were primarily
recovered from Amirati patients, a Brazilian, a Greek and the rest were from Asians.
Beijing genotypes (4.8%) were mainly harboured by the Indian and Emirati patients;
Family36 (3.6%) genotypes were recovered from an Iranian, Omani, a Pakistani and 3
Emirati; Family35 (1.2%) strains were recovered from an Indian and an Emirati; while M.
africanum (1.2%) was isolated from a Jordanian and an Emirati; Family34 (0.6%) strains
were harboured by an Emirati; X family (0.6%) strains were from a Sudanese, while Sf
family (0.6%) strains were from a Pakistani (Table, 4.5). It appears that expatriate workers
infected with TB and living in Al Ain, UAE, harbour the most predominant pathogenic
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strains such as CAS and family strains genotypes, and originated mainly in India and
Pakistan. This demographic data and family strains identification coupled with other
information stated in the next section such as patients’ clinical characteristics and
pathological profiles are essential in tracing TB epidemiology in Al Ain.
Table 4.5 Distribution of spoligotyped M. tuberculosis complex family strains harboured by patients born abroad and living in Al Ain
Country of birth M. africanum Beijing CAS EAI Haarlem LAM T X F36 F33 F34 F35 Sf
Bahrain 0 0 0 0 1 0 0 0 1
Bangladesh 0 0 1 1 1 0 2 0
Brazil 0 0 0 0 0 1 0 0
Croatia 0 0 1 0 0 0 0 0
Egypt 0 0 5 1 0 0 0 0
Ethiopia 0 0 0 0 0 0 0 1
Greece 0 0 0 0 0 1 0 0
India 2 7 13 1 1 8 3 1
Indonesia 1 3 0 0 0 0 0
Iran 0 0 0 20 0 0 1
Jordan 1110 0 3 0 0 1 0
Kuwait 0 1 2 0 0 1 0 1
Lebanon 0 0 1 0 0 10 0
Madagascar 0 0 0 0 0 0 1 0
Morocco 0 0 0 0 0 1 0
Nepal 0 0 3 0 0 0 0 0
Oman 0 0 4 10 0 0 0 0 1
Pakistan 0 1 7 0 0 1 1 0 1 2 1
Palestine 0 0 6 1 1 0 1 0 1
Philippines 0 0 1 1 0 0 1 0
Qatar 0 0 1 0 0 0 0 0
Russia 0 0 0 0 0 1 0
Somalia 0 0 0 0 10 1 0
Sri Lanka 0 0 1 1 0 0 0 0
Sudan 0 0 1 0 0 0 0 1
Syria 0 0 0 0 0 10 3 0
Thailand 0 1 0 0 0 0 0 0
Tibet 0 0 1 0 0 0 0 0
Emirate 1 2 14 3 3 2 3 0 3 8 1 1
Ukraine 1 111
Vietnam 0 1 0 0 0 0
Yemen 0 0 0 0 10 110 0
Total 2 8 61 25 9 8 27 1 6 17 1 2 1
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Distribution of M. tuberculosis complex family strains recovered from patients of
different nationalities born abroad: 61 CAS family genotypes were recovered from
patients of 17 nationalities originated in different countries; the next most prevalent
family was the T family harboured by 27 patients from 14 nationalities originated
outside the UAE.
4.2.4 Spoligotyped family strains in association with clinical, pathological profiles and
demographic data among UAE nationals in Al Ain
Molecular identification of TB epidemiology in nationals is of major importance
since this will specifically address the issue of the presence of unique genotypes
previously proposed by Dissanayake et al. (2001) in the UAE and to identify circulating
strains among nationals. Utilization of this information would help in adjusting TB
prevention and control programs in the UAE (Mathema et al., 2006).
The number of UAE national TB patients included in this study was 51, and this
consisted of 32 males and 19 females. Identification of these and the associated strain
families would provide basis to investigate the strains circulating in the community
(Ugustynowicz-Kopeć et al., 2007). Among the nationals the most affected groups
were children aged below 13 years old, followed by those aged 20-40 years old (Table
4.6). Native UAE patients of different ages and sexes in Al Ain exhibited various
symptoms of pulmonary or extra-pulmonary TB and pathogenic profiles. In Hili and Al
Jimi more pulmonary cases (27) were observed than extra-pulmonary (13). Of the 32
male cases, 23 had pulmonary disease; whilst 12 males had extra-pulmonary or both; 16
pulmonary cases were observed among females (out of the total of 19); whilst 7 had
extra-pulmonary or both (Table 4.6). Fifteen TB pulmonary cases had a previous TB
history in the family while previous history in the extra-pulmonary cases was a factor in
eight cases. While 11 native children had pulmonary disease, four children had extra-
pulmonary TB. Of these children with extrapulmonary disease, two lived in the Hili
district, and one each of Al Jimi and Al Masoudi (Table 4.6). The CAS family strains
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caused more pulmonary disease (23.5%) than extra-pulmonary (7.8%). It also caused
fibrosis (9.8%), cavitations (5.9%) and pleural effusions (5.9%) in a number of patients
indicating more severe disease perhaps due to the greater virulence of the strains.
Strains of Family33 were ranked next to CAS in association with pulmonary (13.7%)
and extra-pulmonary diseases (5.9%). They were also associated with pleural effusions
(7.8%), fibrosis (5.9%) and cavitations (3.9%).
Beijing strains are of great public health concern because they are more virulent,
have a high rate of transmission and have been associated with the occurrence of drug
resistance in several countries worldwide (Anh et al., 2000). In this study, Beijing
strains were recovered from two adult national patients aged 34 and 68 years old (Table
4.6), one of whom carried a single drug resistant strain. Both cases were also associated
with pulmonary and cough symptoms, cavitations and upper lung infection suggestive
of recent transmission and confirmation of the genotypic findings. Two unidentified
isolates were recovered from adult nationals with pulmonary symptoms. They could be
unique isolates to Al Ain and need further investigation.
4.2.5 Summary and discussion
In this section, CAS family strains were the most dominant virulent strains.
Infections due to this family, were more associated with pulmonary than extra-
pulmonary symptoms and lesions. The most common symptoms were fever, coughs
and these were associated with lesions of cavitations, pleural effusions and fibrosis
among nationals and non-nationals residing in Al Ain. The majority of these patients
originated in the Indian sub-continent known for its high TB prevalence and as the
primary source of migrant labour to the UAE (Khoja, 2002; Hasan et al., 2006). Other
strains imported into Al Ain and causing public health concerns were EAI, T, Family33
and Beijing. Strains of Family33 were abundant among UAE natives, implying that
194
they might have emerged locally and probably represent the postulated unique strains
identified by Dissanayake et al. (2001). UAE native patients were also equally infected
with strains originally found in the main source of migrant labour suggesting the
possibility of cross-infection from immigrants to locals.
Table 4.6 Demographic and clinical data, and chest X-ray abnormality in association with spoligotyped family strains for UAE nationals
Patient Age Male(M)
Female
(F) Residence Pulmonary
Extra-
pulmonary TB History Fibrosis Cavitations Calcification
Pleural
effusion
Family
strain
3 65 F Zakhir Yes No Yes No Yes No No ND
23 16 F Al Jimi Yes No Yes No Yes No No CAS
24 3.5 M Hili Yes No No No No No Yes LAM
32 52 M Al Maqam Yes No Yes Yes Yes No No CAS
36 8 M Al Jimi Yes No No No No No Yes F33
46 28 F Al Jimi Yes No No No No No Yes F33
48 25 F Al Jimi Yes No No No No No No CAS
53 31 M Hili No Yes NK Yes Yes No No EAI
55 54 M Hili Yes No NK Yes Yes No Yes T
60 11 F Hili Yes No Yes No No No Yes CAS
61 6.5 M Hili Yes No Yes No No No Yes CAS
65 38 F Hili No Yes Yes No No No No T
67 12 M Al Masoudi Yes No Yes No Yes No Yes ND
74 49 M Hili No Yes No No No No No F35
76 33 F Al Jimi Yes No NK No No No No CAS
80 38 F Hili Yes No Yes Yes No No No F33
81 38 M Hili Yes No Yes Yes No Yes No Haarlem
82 41 M Hili Yes Yes Yes Yes Yes No No F33
86 68 M Al Jimi Yes No No No Yes No Yes Beijing
89 50 M Hili Yes No No Yes Yes No No F33
90 30 F Al Maqam Yes No NK No No No No CAS
93 38 F Hili Yes Yes NK Yes Yes No Yes CAS
100 32 M Al Markhaniya Yes No No No No No Yes EAI
104 6 M Zakhir Yes No NK No No No No F36
106 9 F Al Jimi Yes No No No No No No CAS
109 5 F Al Jimi Yes No Yes No No No No Africanum
114 50 F Al Masoudi Yes Yes Yes Yes No No No CAS
115 4.6 M Al Jimi Yes Yes Yes No No No No CAS
120 28 M Zakhir Yes No Yes No No No Yes F33
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129 38.7 M Hili Yes No No Yes No No No EAI
136 25 M Al Masoudi Yes No No No No No Yes F36
133 18 M Al Masoudi Yes Yes No Yes No No Yes F36
132 42 M Al Masoudi No Yes No No No No No ND
134 7 F Al Jimi Yes No No No No No Yes F33
135 50 M Al Jimi No Yes No No No No No ND
138 18 M Al Jimi No Yes No No No No No ND
139 34 M Zakhir Yes No Yes Yes Yes No No Beijing
140 29 M Al Jimi Yes No Yes Yes No Yes Yes CAS
150 20 M Hili Yes No No No No No Yes T
154 17 M Hili Yes No No No Yes No No LAM
160 35 F Hili Yes No Yes No No No No LAM
164 49 F Hili Yes Yes NK Yes No No No ND
165 45 F Al Jimi No Yes No No No N No LAM
168 9.6 M Al Masoudi No Yes Yes No No No No F34
171 44 M Hili Yes No No No Yes No Yes Haarlem
174 29 M Al Markhaniya No Yes No No No No No F33
176 42 M Hili Yes No No Yes No Yes Yes CAS
177 5 M Hili No Yes Yes No No No No CAS
182 45 F Al Markhaniya No Yes Yes No No No No F33
187 38 M Hili No Yes No No No No No Haarlem
194 8 F Hili No Yes Yes No No No No ND
Breakdown of demographic, clinical data, and chest X-ray abnormality for UAE nationals, and the spoligo-defined family strain. ND,
Not determined.
4.2.6 Identification of TB transmission links in Al Ain
Conventional and genotypic associations can define the characteristics of patients in
family clusters by age, sex, and other parameters, which can contribute to a better
understanding of TB epidemiology (Vynnycky et al., 2001; Jensen et al., 2005). Clustering
of isolates can help to identify TB transmission patterns (van Deutekom et al., 2005). In
this context, attempts were made to trace infected individuals uisng identified MIRU (real
clusters) and spoligotyping clusters in conjunction with conventional epidemiology to
identify possible links of transmission and determine the source of disease in Al Ain.
MIRU identified eight clusters and each clustered isolate was subjected to full
investigation and contact tracing. Of the eight MIRU-typed clusters or patterns, only two
patients (harbouring isolates #3 and #5) were identified as part of a cluster, with a formal
address, where a link was established. The patients were infected with CAS family strains
and lived in the Zakhir district of Al Ain (Table 4.7). One patient in this transmission chain
(harbouring isolate #3) was a UAE national female and earning more than AED 10,000 a
month, while the second patient harbouring isolate #5 was a maid with a confirm workplace
contact.
MIRU cluster 1 compromised of four patients all of whom were females. The index
case was the maid (patient #5). She was diagnosed during her visa renewal process on the
14/01/2003. She had a mild cough of six weeks duration and general malaise. She had
reported that she had been in close contact with her father in the same place for a period of
two months, and who had been diagnosed as having TB about eight months before her own
diagnosis. Her chest X-ray results were positive for cavitations and calcification. TST was
also positive and she was diagnosed with pulmonary TB. All the members of the
household were screened for TB at the PMD. Even though she had been complaining of
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cough, fever, night sweat and occasional haemoptysis, she did not seek medical advice until
after almost two weeks in January when it is normally very cold in Al Ain. Her chest X-ray
was positive and showed cavitations in the left upper lobe according to her medical records
and was diagnosed with pulmonary TB on 22/01/2003. The third case was a Philippino
maid working in one of the districts and was diagnosed at Al Ain hospitals on the
28/01/2003. She presented with cough and fever for three weeks, and had complained of
similar symptoms in the past. Her chest X-ray revealed cavitations but her TST was
negative. Interestingly, she had revealed in her history that she had been in contact with an
Indonesian friend who had similar TB symptoms. The Indonesian friend had been treated
with some tablets when she attended a hospital but she did not know whether she had TB.
The last patient in this cluster was also a female living in Hili district. She had complained
of recurrent attacks of cough and persistent fever for which she had been treated previously
in Oman. She was referred from the PMD to Al Ain hospitals for further investigation
where she was diagnosed as having pulmonary TB on 29/03/2003. Although, contact
tracing was established in two of these patients, decentralization of TB management
hindered establishing an epidemiological link with the third case in this cluster and the data
of the fourth case showed no epidemiological association. These patients were all infected
with M. tuberculosis strains belonging to the CAS family which is frequent in South Asia
and typically associated with the pulmonary form of TB (Hasan et al., 2006; Ali et al.,
2007).
The second MIRU cluster consisted of two patients, two expatriates with two
different nationalities; both were living in the Industrial Area. The first case was diagnosed
with pulmonary TB on the 27/04/2003 at the PMD, but the reason for his visit to the PMD
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could not be established from the records available. His chest radiograph revealed the
presence of pleural effusion with milliary nodules. Records revealed that the patient shared
a room with people from different nationalities with coughs but this was about a year
previous to his visit to the PMD. The second patient was a Palestinian shop keeper who
was diagnosed with pulmonary TB during his visa renewal process. Interestingly, the
medical records indicated that this patient stated that he shared a room with a Pakistani who
had a cough. These two patients were diagnosed a day apart from each other, but it was
difficult to establish a firm link between them. The presentation after such a short period
indicated that these patients were infected from a different source, which was probably
undiagnosed at the time. Contamination of clinical samples could not be excluded.
Because the possibility of cross-contamination often exists in a range extending from 2% to
4% even in laboratories that work under sound conditions (Glynn et al., 2004).
The third MIRU cluster comprised three female patients. The first female was a
Palestinian, and was diagnosed at the PMD on 15/08/2003. She had a history of travelling
abroad before she was diagnosed with pulmonary TB. She complained of coughs and fever
on and off, which lasted for three weeks. Her chest X-ray results showed cavitations and
fibrosis. No TST results were included in her records. This patient did not have any close
contacts or family members in the UAE. The second patient was an Indonesian maid living
in Zakhir. She was diagnosed with TB at the PMD during her residence visa renewal
process and was diagnosed as having both pulmonary and extra-pulmonary TB.
Information about household screening of patients living in close contact with this patient
was not known according to her medical records, although the number of people in the
household was stated as six. The third patient was an Egyptian subject living in Hili, who
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was diagnosed at the PMD during a visa renewal on the 02/09/2003 with a clinical picture
similar to that of the Indonesian patient, i.e. pulmonary and extra-pulmonary TB. No
information about close contacts or people living in the same household was available.
MIRU profiles from one contact with M. tuberculosis infection showed a similar profile,
with only one repeat difference; this individual was a young national (eight years of age)
living in the Al Jimi district, and who was diagnosed with TB on 13/8/2007. This patient
was referred from school to the PMD as he had been suspected of having TB by the class
teacher. No other epidemiological data were available. Molecular results showed that,
strains in cluster #3 had the same MIRU profiles and spoligopatterns, and was classified as
belonging to the CAS family. The MIRU of the isolate from the eight year old child was
different from the three isolates and was spoligotyped as Family33. Clinically, two of these
cases shared a similar presentation of TB. Further epidemiological links could have been
established between these cases if more focused interviews of these patients had been done
at the time of diagnosis, especially if combined with the clinical and molecular results.
The fourth MIRU cluster was made up of two patients. One of these patients was a
national female living at Al Jimi and who was diagnosed with pulmonary TB at Tawam
Hospital on 19/09/2003 when a chest X-ray taken after a road traffic accident revealed old
cavitations. The second patient was an Indian female working in a house at Mezyad and
who had been diagnosed on 22/09/2003 during her visa renewal process. Reviewing the
Indian maid’s medical notes and notification forms indicated that all member of her
household at that time were screened for TB and her sponsor had been diagnosed with TB
in the previous year, i.e. in 2002, but no further information was available. This indicates
that neither of the two patients were the index case and both probably had acquired the
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disease from the index case (the owner of the house). It was difficult to establish any
epidemiological links between these patients because information on the index case was not
available because he was diagnosed in 2002. Medical records and contact tracing of the
two female patients were not helpful for establishing any association between them.
The fifth MIRU cluster was also made up of two patients. The first patient was an
Indian male working and living in the Industrial Area. He was diagnosed at the PMD on
the 23/10/2003 with pulmonary TB during his visa renewal process. No data about contact
tracing and family were available. The second patient was also an Indian male working and
living in the Industrial Area. He complained of cough and fever and was diagnosed with
pulmonary TB at the PMD on the 23/10/2007; he presented himself after finding out that a
co-worker, with whom he had been working with for more than eight months, was infected
with TB. Comparing these two patients, although both were diagnosed on the same day
and one patient provided clues about previous exposure, the other was reluctant to provide
such information. Identical MIRU profiles of infecting strains indicated that these patients
were infected by the same strain.
The sixth MIRU cluster again consisted of two patients; a Palestinian male and a
Lebanese female. The former was diagnosed with TB during his visa renewal process
screening at the PMD on 20/10/2004. The latter provided a history of having travelled to
Egypt three months before his examination and that he had stayed there for three weeks.
No information about contact tracing or family screening and history was available. The
Lebanese patient lived in Zakhir and was diagnosed at the PMD during the new work visa
application. She was diagnosed with TB on 25/6/2004. Usually, new work visa applicants
are considered only for new arrivals, yet this patient was living in Zakhir according to her
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medical notes and notification forms which may raise epidemiological concerns. Molecular
results of these two patients revealed that these two patients had identical MIRU profiles
and had only one spacer difference in their spoligo-patterns, strongly indicating that these
patients were infected by a CAS strain of M. tuberculosis. It is likely that the Palestinian
patient was working at the Industrial Area and probably contracted the infection from
another individual with TB and subsequently spread it to others. This could also be
supported by their time of diagnosis and their reluctant behaviour to provide any contacts
information.
The seventh cluster comprised once again of two patients, a UAE-national
businessman living at Al Jimi and an Indian driver working in Zakhir. The former was
diagnosed at Tawam hospital on 18/11/2004, complaining of persistent fever of four weeks
duration. His chest X-ray showed fibrosis and calcification. Screening of his family was
negative. The latter patient was diagnosed at Al Ain hospital on 20/12/2004. The driver
presented with cough and positive family history of TB in India where he had visited three
months before diagnosis. The clinical pictures of the two patients were different as one
presented with cough and cavitations while the other had fibrosis and pleural effusion on
the chest X-ray. No epidemiological links were detected between these patients although
they shared the same MIRU profile and one spacer difference in their spoligopatterns.
Spoligotyping defined these strains as belonging to the CAS family which is prevalent in
India and other south Asian countries.
The last MIRU cluster consisted of a Somali and a Moroccan both of whom were
males. The former was a driver living at Al Maqam and was diagnosed with TB during the
renewal of his resident visa at the PMD on 05/3/2005. Analysis of his data showed that ten
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months prior to being diagnosed, he had visited Somalia where his sister had been
diagnosed and treated for TB. The second patient was also diagnosed at the PMD, but no
reasons were stated for his screening. He indicated that he had contracted the disease from
an Algerian room mate who had left the country six months prior to his diagnosis. Both
patients were diagnosed at the same time and molecular results indicated that the two
isolates shared the same MIRU and spoligo-pattern that identified them as belonging to the
T strain family. This could possibly indicate that there was an epidemiological link or that
there could have cross-contamination during the processing of sputum samples or culture in
the UAE.
These results document the importance of including molecular techniques to the
clinical presentation in the management of TB in Al Ain. Missing information on the
records of these patients hindered the establishment of epidemiological links in these
clusters. The closeness of dates of the diagnosis of these patients indicates that immigrants
are frequently health screened in the UAE. In spite of these positive findings, significant
number of index cases were unidentifiable, and hence, the need for an integrated system for
TB management which combines molecular analysis with clinical details of patients.
Spoligotyping defined 30 clusters, compared with eight from MIRU typing.
Clinical data of patients representing these clusters were also analysed. Some of these
clusters will be analysed in details, while others will be summarized. Interestingly, most of
the MIRU identified clusters were included in those identified by spoligotyping. Although
these clusters were not real clusters (chapter 3), some clusters were analysed to further
highlight the unrelated nature between clinical and molecular findings of these spoligo-
defined clusters.
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The first spoligotype cluster comprised three patients harbouring isolates #161,
#169 and #170. Two of these patients were MIRU-defined and diagnosed on the same date
while the third patient, an Indian female living at Al Masoudi was screened and diagnosed
at the PMD. No reason was given for her screening. There was some time difference
between her diagnosis with pulmonary TB on the 30/12/2004 and that of the others and.
No further information about this patient was given in her medical notes. Furthermore, the
first patient included in the spoligo-cluster had a different MIRU profile (Appendix 7).
These observations support the view that a high probability exists for cross-contamination
of the samples from the other two patients before they were sent to the UK.
The next spoligotype cluster comprised two patients harbouring isolates #8 and #12;
the first patient was a Lebanese female diagnosed at the PMD during her visa renewal
process on 10/02/2003. She had a typical pulmonary TB picture of cough, fever and night
sweats. No history of contact tracing was stated in her notes. The other patient was an
Indian male screened at the PMD and diagnosed with pulmonary TB on 26/03/2003. This
patient stated that he had previously visited his brother in the UK who was a known TB
patient. These two patients had totally different MIRU profiles and the fact that the male
patient was screened at arrival precludes any possibility of an epidemiological link between
these two patients. Such similar patterns between unrelated strains has been noted
elsewhere and explained by the rapid and multiple DR deletions that occur in some strains
(van Deutekom et al., 2005; Mathema et al., 2006).
Another spoligotype cluster comprised two patients, a Russian female working at a
beauty saloon and an unemployed Syrian male, harbouring isolates #88 and #128. The
former resided in Al Masoudi and was diagnosed with pulmonary TB at Al Ain hospital on
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04/01/2004. She was forced by her job to go to hospital after complaining of cough and
fever. Her chest X-ray results showed consolidation of the left lung. No history of contact
was documented, which raises concerns because of the number of contacts she made
through her work. The Syrian patient was diagnosed at Al Ain hospital with pulmonary TB
on 30/09/2004 and also had consolidation on his chest X-ray. Family and contact tracing
data was not reported for this patient. No epidemiological link could be established
between these patients. Molecularly these patients had the same spoligopattern but
different MIRU profiles. Further more, the presence of consolidation on both patients’
radiographs indicated that these patients had been exposed to TB previously and that the
present infection could have resulted from reactivation of a latent infection.
There was a medium-sized spoligotype cluster formed of five patients harbouring
isolates #7, #50, #55, #83 and #98. The first patient was a Palestinian female diagnosed
with both pulmonary and non-pulmonary forms of the disease at the PMD on 03/02/2004.
The address of the patient was stated as the Industrial Area, but no official residential
address was recorded, and although she was reported as married in her records no contact
tracing was documented in her medical or notification forms. The second patient was a
Jordanian female student living in Mezyad. This girl was referred from her school to the
PMD where she was diagnosed with pulmonary TB on 30/12/2003. Information about
family and contact screening was not available. The third patient was an Indian male driver
diagnosed at the PMD on 04/02/2003 during his visa renewal process. He was diagnosed
with pulmonary TB and his chest X-ray showed consolidation and cavitations. Contact
tracing of this patient revealed that he lived at Al Jimi with his family and parents, and his
father was also TB patient who had been treated six months ago. The next patient was a
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UAE national, diagnosed at Tawam hospital on 18/10/2003 with pulmonary TB. He lived
in a household with 23 people, yet no contact screening results were available. The last
patient was an Indian female diagnosed at the PMD on 29/09/2003 during screening for
visa renewal process. These clusters had no obvious epidemiological links. MIRU typing
results showed that in the third and the fourth patient the MIRU profiles were different in
only one allele, which could imply some degree of epidemiological links between these two
patients (van Deutekom et al., 2005). Furthermore, the difference in the time of diagnosis
and their jobs might have established a possible link, if the patients had been interviewed
again (Sintchenko and Gilbert, 2007).
To conclude, an epidemiological link was established in one MIRU typed cluster
while except the clusters that had previously identified MIRU clusters, for example isolate
#16 and #17, none of the spoligotyping defined clusters were epidemiologically related.
This further supports the high discriminatory power of MIRU and its suitability for
molecular epidemiology studies in the UAE.
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Table 4.7 UAE patient clusters and house address codes
Cluster # MIRU profile Spoligotyping House address code
1 226425153533 No DNA Z5
226425153533 CAS Z5
226425153533 CAS Mr1
226425153533 CAS H2
2 226525143533 CAS In44
226525143533 CAS In47
3 226425173533 CAS Ma18
226425173533 CAS Mr20
226425173533 CAS H29
4 226425173433 Family33 In40
226425173433 Family33 In24
5 224425123433 No DNA M6
224425123433 No DNA Mr6
6 224525174423 CAS H11
224525174423 CAS J16
7 223525174523 CAS In22
223525174523 CAS H6
8 224126113332 T M6
224126113332 T Mr6
Clusters 1-8 with the associated MIRU profile; the family group as defined by
spoligotyping; the house address code indicated by the initials of districts of Al Ain and
numbered accordingly represents the place from which pathologicl sample(s) were taken.
208
4.2.7 Evidence of cross-contamination in the UAE clinical samples
In this study, two different M. bovis BCG vaccine strains and M. tuberculosis strain
H37Rv were used as reference strains for spoligotyping. One of the vaccine strains was
obtained from the Mycobacterium Reference Unit (MRU), the other one and also the
H37Rv DNA was supplied by Professor Tanya Parish. Spoligotyping identified four
patients with BCG and two patients with H37Rv infection (chapter 3).
Spoligotyping identified four strains as BCG and two as H37RV in clinical sample.
MIRU profiles of these four BCG defined infected patients did not match the defined 12
digit profile in most of the MIRU alleles (Lari et al., 2006), while the other two H37Rv
strains were slightly different from the reference strain included as a positive control in this
study (Supply et al., 2001). Clinical data suggested the presence of sample contamination
of these clinical samples. With the exception of a national female, all patients were non-
national males who were more than 40 years old. This was indicative of probable sample
contamination, since BCG is commonly associated with disease in childhood (Hesseling et
al., 2007).
The appearance of pulmonary and extra-pulmonary symptoms and signs noted in
the medical notes of these patients, cavitations and pleural effusions were probably caused
by other pathogenic strains due to contaminants. Yet no indication of disseminated disease
was found in their medical notes as this phenomenon is often observed in certain population
groups (Hesseling et al., 2007). This could also be held true for the non-national patients
harbouring strain H37Rv, both of whom were aged above 40 years old, and complained of
cough and other pulmonary symptoms.
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4.2.8 Medications used by patients with previous history of TB symptoms and sources of
medications
Many more non-nationals with previous TB clinical symptoms (40) attended
pharmacies to obtain their medicines compared with a few who went to private clinics (9)
and government hospitals (5) (Appendix 26). By contrast, the majority of national patients
attended private hospitals (10), then government hospitals (2), and pharmacies (1). The
main medicines previously taken to treat TB symptoms were: cough syrups (54%),
antipyretics (45%), antibiotics (40%), and herbal medicines (12%) (Fig. 4.7). In this
instance the action of non-nationals was probably related to fear of revealing identities and
the probable consequence of deportation, while the action of nationals was probably related
to stigmatisation.
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Fig. 4.7 Type of over shelf medications used by patients with previous history of TB
symptoms.
Various non-curative medicines were used by non-national and national patients without
prescription to treat TB.
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4.2.9 A field drug study among pharmacies
As part of the above investigation, which covered clinical, demographic profile and
social data and the presence of genotyping strains, nationals and non-nationals in Al Ain
claimed that they could buy medications of different classes without prescription from local
pharmacies. Dispensation and misuse of prescription drugs by Al Ain pharmacies could
lead to the development of drug resistance and increased cost of treatment. Therefore, a
small field study was carried out to determine the extent of this problem. Two persons, an
investigator and an ordinary non-national person pretending to be sick visited four
pharmacies in Al Ain. They described clinical symptoms indicative of TB to the consulted
pharmacists and separately requested curative medicines for their complaints including
anti-tuberculosis drugs and cortisone tablets.
The field study showed that pharmacists released several medicines on request
including cough syrups, bronchodilator, anti-histamine, and co-amoxiclav (Augmentin);
confirming that these drugs are prescribed without government supervision. Requests for
anti-tuberculosis drugs were declined, since they were only available through government
hospitals. In addition in one pharmacy the non-national’s request for cortisone tablets was
accepted, probably because the pharmacist knew him and felt he would not report the
illegal dispensation of the drug. For the same reason the request for cortisone by the
national was rejected because he was not known by the pharmacist who feared that the
transaction might be reported. These illegal and irresponsible actions demonstrate the
influence of personal relations in the dispensation of medicines in Al Ain. Such behaviour
also indicates the ineffectiveness of governmental law to regulate such a vital branch of
health service in order to deliver proper services to the community.
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4.2.10 Genotypic detection of rpoB
Fragments of rpoB covering the 511-533 codons were PCR-amplified using rpoB
forward and reverse primers (Table 2.1) as described by Kapur et al. (1994) to test RIF -
resistance in Al Ain. Sequencing of 350bp rpoB fragment from both UK and UAE isolates
showed the absence of mutations in the majority of isolates. Only two UAE isolates had
mutations when using Pfu polymerase (data not shown); Pfu polymerase was used
preferably over Taq polyemerase because the use of Taq has resulted in multiple
amplification failures in this study and that Pfu polymerase has a high fidelity (Cline et al.,
1996). Isolate #139 had a missense mutation from GAC (aspartic acid) to TAC at codon
position 516 and a mutation at codon 523. This patient was an UAE national male infected
with the Beijing strain. This spoligotyped strain #139 was found within a cluster that
belonged to group 1 and comprised patients who originated from different countries
including some of those considered as major sources of immigrant labour.
Mutation in rpoB was associated with resistance to rifampin as obtained by
antibiotic susceptibility testing for this isolate; while there was no mutation in the gene
sequence of RIF-susceptible M. tuberculosis strains.
Isolate #78 had a novel mutation located outside the designated region from CGA
(arginine) to CAA (glutamine) at codon 507. The same novel mutation was detected by the
use of the generated sequences of the MasterMix. The detection of this novel mutation at
codon 507 in isolate #78 was probably of no significance with regard to RIF-resistance
since it was located outside the designated region and not previously reported in association
with this resistance. Isolate #78 was identified as a T 1 family by spoligotyping designated
to group 2 and as part of a cluster. The infected patient was a Syrian student living in Al
Masoudi, Al Ain and who contracted the infection from a roommate in his home country.
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4.2.11 Results and discussion of statistical analysis
In this study, statistical analysis showed that significant P-values were inversely
proportional to higher Chi square values and lower proportion values (Table 4.8; 4.9; 4.10).
Pleural effusions were significantly (P>0.03) associated with immigrants (Table 4.8). But,
the selected variables of fever and cough, form of disease whether pulmonary or extra-
pulmonary, coughs (productive and non-productive) and radiographical abnormalities
(fibrosis, cavitations and calcifications) were not significant neither among immigrants nor
among nationals (Table 4.8), although these associations could become significant with a
bigger sample size (minimum of 400 participants required in population based studies) and
this was considered a potential weakness of this study. Similarly, no significant correlation
could be derived between family strains (CAS, EAI, T, F33 and H) and TB symptoms
(pulmonary, extra-pulmonary and coughs), and cavitations (Table 4.9) probably due to the
small size of collected sample. With reference to TB family strains, EAI strains were
significantly associated (P=0) with the place of patient’s origin in UAE and India while
and the T strains were significantly (P>0.04) linked to patients originated in Pakistan, UAE
and India (Table 4.10). While Family33 was nearly significantly (P>0.09) associated with
place of birth for patients in India, Pakistan and USE. The low sample size was not
unexpected; however it could be justified because of the fact that UAE is a young country
with a population of approximately 4.95 million and having a low prevalence of TB (Houle
et al., 2005; UAE Interact, 2007).
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Table 4.8 Association of immigrant/national patients with TB symptoms and pathogenic
profiles in Al Ain
Symptoms or
abnormalities
Immigrants Nationals Total
patients
Chi square P-value
Fever 89 (n=143)
0.62† (0.54-0.70)††
38 (n=51)
0.75† (0.63-0.86)
194
2.504 0.113546
Coughs 105 (n=143)
0.73 (0.66-0.81)
40 (n=51)
0.78 (0.67-0.90)
194
0.498789 0.480033
Pulmonary TB 101 (n=143)
0.71 (0.63-0.78)
31 (n=51)
0.61 (0.47-0.74)
194
1.675633 0.195506
Extra-pulmonary 21 (n=143)
0.15 (0.09-0.20)
13 (n=51)
0.25 (0.14-0.37)
194
3.036331 0.08142
Productive coughs 36 (n=105)
0.34 (0.25-0.43)
14 (n=40)
0.35 (0.20-0.50)
145
0.00655 0.935538
Non-productive coughs 20 (n=105)
0.19 (0.12-0.27)
7 (n=40)
0.18 (0.06-0.29)
145
0.045783 0.830572
Chest radiographic
abnormality
Fibrosis 59 (n=102)
0.58 (0.48-0.67)
15 (n=32)
0.47 (0.30-0.64)
134
1.185053 0.27633
Cavitations 52 (n=102)
0.51 (0.41-0.61)
13 (n=32)
0.41 (0.24-0.58)
134
1.405745 0.306489
Calcifications 9 (n=102)
0.09 (0.03-0.14)
3 (n=32)
0.09 (0-0.19)
134
0.009086 0.924061
Pleural effusions 8 (n=102)
0.08 (0.03-0.13)
7 (n=32)
0.22 (0.08-0.36)
134
4.824555 0.028059***
†, numbers with two decimal points outside the brackets represent proportion of patients
whether immigrants or nationals relative to various symptoms and pathological profiles; n,
represents number of patients.
††, brackets containing numbers with two decimal points which are separated by a hyphen is
the confidence interval (C.I.) = Proportion ± standard error (S.E.) X 1.96.
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Table 4.9 Association of M. tuberculosis family strains with TB symptoms and pathogenic
profiles
Pulmonary
(n= 116)
Extra-
pulmonary
(n= 52)
Coughs
(n= 116)
Cavitations
(n= 59)
Chi
square
P-
value
CAS 47
0.41† (0.32-0.49) ††
14
0.27 (0.15-0.39)
48
0.41 (0.32-0.50)
30
0.51 (0.38-0.64) 6.635 0.084
T 20
0.17 (0.10-0.24)
7
0.13 (0.04-0.23)
18
0.16 (0.09-0.22)
11
0.19 (0.09-0.29) 0.671 0.880
EAI 14
0.12 (0.06-0.18)
11
0.21 (0.10-0.32)
11
0.09 (0.04-.0.15)
5
0.08 (0.01-0.16) 5.535 0.137
F33 10
0.09 (0.04-0.14)
7
0.13 (0.04-0.23)
11
0.09 (0.04-0.15)
3
0.05 (0-0.11) 2.412 0.491
H 8
0.07 (0.02-0.12)
1
0.02 (0-0.06)
8
0.07 (0.02-0.12)
2
0.03 (0-0.08) 2.637 0.451
Beijing 7
0.06 (0.02-0.10)
1
0.02 (0-06)
7
0.06 (0.02-0.10)
6
0.10 (0.02-0.18) 3.280 0.350
†, numbers with two decimal points outside the brackets represent proportion of genotypes
in association with various symptoms and pathological profiles.
††, brackets containing numbers with two decimal points which are separated by a hyphen
is the confidence interval (C.I.) = Proportion ± standard error (S.E.) X 1.96; H, Haarlem
family; T, T family; CAS, Central Asian; n, represents number of patients.
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Table 4.10 Association of representative M. tuberculosis dominant genotypes in UAE with TB
patient’s country of origin
Genotype
family
Recovered
genotypes
Patient’s origin
____________________________________
UAE India Pakistan Total
patients
Chi
square
P-value
CAS* 61 14
0.23† (0.12-0.34)††
7
0.11 (0.03-0.19)
7
0.11 (0.03-0.19)
168
3.500 0.174
T 27 3
0.11 (0-0.23)
8
0.30 (0.12-0.47)
1
0.04 (0-0.11)
168
6.500 0.039***
EAI 25 3
0.12 (0-0.25)
13
0.52 (0.32-0.72)
None 168
17.375 0.000***
Family 33 17 8
0.47 (0.23-0.71)
3
0.18 (0-0.36)
2
0.12 (0-0.27)
168
4.769 0.092
* Genotypes with three known origins (UAE, India and Pakistan).
† Proportion of genotypes in each origin.
†† Brackets containing numbers with two decimal points which are separated by a hyphen
represent the confidence interval (C.I.) = Proportion ± standard error (S.E.) X 1.96.
*** Represents small expected significant values.
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4.3 DISCUSSION
The increased number of TB cases among non-nationals (143) versus nationals (51)
in Al Ain, UAE was not surprising since it reflects the TB picture in their originating
countries where the disease is endemic, but the lack of exact figures hindered proper
application of this information. In the UAE, 85-95% of TB cases were previously reported
among immigrants, particularly those originating from in the Indian subcontinent (WHO,
2002). The occurrence of most TB cases in the age groups 30 – 39 and 40 – 49 was
probably related to the increased number of expatriates and workers in these age groups. In
a separate study, the prevalence rate of latent TB among immigrants was found to be as
high as 40% (El-Hamad et al., 2001). The presence of such latent cases represents a
potential source of infection and transmission which could be prevented by early
identification and treatment. However, these latter preventive measures were lacking in the
government policy for TB control.
The smaller number of childhood cases as compared to adults was probably due to
the implementation of government policy aimed at deporting TB positive reactors and
prohibiting reunification of immigrants families with monthly incomes of less than AED
5,000. In relation to the age groups we did not observe any specific age group of females
showing an increased natural resistance to TB compared with men, an observation that in
disagreement with a recently reported observation that sexual hormones may be important
in modulating increased resistance to TB in females (Balabanova et al., 2006). The excess
of TB in association with the male gender (double than that observed in women) has been
previously reported internationally and could be related to susceptibility genes predisposing
to the disease or as a result of female under-notification of cases (Holmes et al., 1998;
Bellamy et al., 2000). The majority of women in the UAE are not educated medically and
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more attached to traditional social customs that might have forced them to be victims of
stigma, which could made them reluctant to seek medical treatment. This scenario is in line
with other studies (Holmes et al., 1998; Hudelson et al., 1996; WHO, 2002). Such
stigmatization is a great problem as it hinders. TB control measures and requires
educational health programmes which are not available in the government control policy
being presently being implemented. Hence, the needs for another TB control strategy to
replace the existing one. This strategy should include mandatory chest X-ray and IFN γ 
assay because they ares cheap and since it detects latent TB, it should reduce transmission
of the disease (Mazurek et al., 2001).
Frequent occurrence of pulmonary disease in non-nationals correlated with infection
with strains from highly endemic regions of origin where infection is associated with more
exposure. Following migration, the immune system of patients who might have incubated
latent infection would gradually be perturbed leading to the development of active TB.
This may be exacerbated by the nature of hard work an immigrant would undertake in order
to enjoy a decent life. The presence of latent TB was supported by the presence of many
non-nationals who were TST positive. In contrast, the relatively high prevalence of extra-
pulmonary TB in national patients might be explained by the delay in presenting for long
periods, which leads to more severe or disseminated form of the disease. This delay could
be attributed to the existing stigma associated with TB. It is also probable that the
increased extra-pulmonary disease could be due to increased susceptibility of nationals to
the newly imported M. tuberculosis strains or unknown genetic susceptibility. In addition,
the easy access to drugs without prescription used for the treatment of symptoms but will
not cure TB could mask the presentation of symptoms and lead to delay in the presentation,
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which in turn will lead to development of more severe form of the disease as is sometimes
seen in the TB infected population in the East End of London (Personal communication
with Dr. S. Das). The dominance of cough and fever in both national and non-nationals
was in agreement with a recent population study involving civilians and prisoners in the
Oblast region of Russia where pulmonary TB is common (Balabanova et al., 2006).
The predominance of CAS strains in association with the pulmonary disease
compares well with their prevalence and behaviour in south Asian countries, for example,
India, Pakistan and Bangladesh (Hasan et al., 2006). This observation also verifies the
existence of an exogenous TB source in the UAE.
Clustered isolates were reported in association with virulence (Gagneux and Small,
2007) and clustering in combination with conventional epidemiology can help in tracing
transmission links (van Deutekom et al., 2005). Identification of identical strains from two
females forming a cluster and living in one place in Zakhir district, Al Ain, helped to
conclude that this infection was probably contracted by contact transmission. This
conclusion was further supported by the fact that the second case was identified by screen
testing in that household. However, the study was unable to identify and epidemiologically
trace the other clustered isolates and determine transmission links as there were no formal
home addresses for many patients. Yet, there are several factors that hint to the ongoing
transmission of the disease. This was expected in the undertaken study as it was conducted
in a community with a highly diverse population in an overcrowded town such as Al Ain.
These factors might have created a suitable environment for the possible development of
these ongoing transmission links. The distribution of clusters in 13 recognised families in
Al Ain showed global dissemination of these family strains via human movement and
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globalisation. This holds true in this study as the isolates forming clusters were mainly
harboured by infected Asian patients who moved from their respective endemic homelands
to UAE and thus helped to spread the TB infection. The majority of these patients were
working in the Industrial Area in Al Ain, where transmission is facilitated by close contact.
The higher number of non-nationals (40) who used pharmacies as sources of
medications could be explained as these pharmacies could be easier, quicker and cheaper
way to obtain drugs compared with what they may consider the laborious processes
involved in obtaining these drugs at a TB clinic. Pharmacists were more flexible with non-
nationals as verified by the field drug study in which steroid tablets were given to the non-
national but declined to the national investigator. The refusal of anti-tuberculosis drugs for
both conductors was genuine as these drugs are unavailable in pharmacies and can only be
obtained through government hospitals. The easy reach for different kinds of drugs
including steroids raises a huge public health hazard, as these drugs may mask the
symptoms and signs of TB without treating the disease (Fig. 4.8). In addition the use of
such drugs could lead to high costs for both the government and the patient, and an
increased risk of side effects. Accordingly, there is a need to control such misuse of drugs
by developing measures such as were used in a multi-intervention antibiotic trial recently in
The Netherlands with respect to respiratory diseases (Welschen et al., 2004). These
measures include restricting the use of antibiotics to culture confirmed cases only and
monitoring antibiotic dispensation from private pharmacies.
The infected patient harbouring isolate #139 with RIF – resistance was an adult
unmarried national male aged 43 years old, with a previous history of taking antibiotics.
He lived with his family which had a previous history of TB in Zakhir, Al Ain. The family
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employed an infected Indonesian maid tempting speculation of close contact. Isolate #139
was identified by spoligotyping as belonging to the Beijing family strain and as part of a
cluster. The Beijing family strains are associated with multiple TB drug resistance to and
high transmissibility (Anh et al., 2000), but the strains were not noticed to spread in Al Ain.
It was impossible to establish links of transmission because there were no formal addresses
for patients from whom isolates had been produced.
The absence of rpoB mutations in the sequenced portion of the gene verifies the
importance of sequencing in prompt detection of RIF-resistance. The findings of low
percentage of TB drug resistance in this study is in contrast with the increased number of
rpoB mutations (conferring RIF resistance) demonstrated in the majority of M. tuberculosis
isolates from Dubai, Kuwait and the Middle East by other researchers particularly in a
country with such a heterogeneous population (Ahmad et al., 2000; 2002; Ahmed and
Husain, 2004; Ahmad and Mohandas, 2005). In addition, the majority of patients included
in this study were workers who migrated from the Indian-subcontinent particularly India
with high endemicity of MDR-TB and from where several mutations coding for RIF-
resistance frequently occurring at codon 531 have been reported (Suresh et al., 2006).
However, the lack of detection could probably be due to the limited number of collected
samples or the acquired resistance trait not being transmitted among patients in Al Ain.
In summary, this chapter presents results of clinical and demographic data, and
social factors relative to national and non-national patients infected with M. tuberculosis
strains residing in Al Ain. The results confirmed the presence of TB and its exogenous
nature, supported the findings of MIRU typing and spoligotyping and the lack of
government implementation of policy to control the disease. It also highlighted the high
222
prevalence of latent TB infection in immigrants. In addition, the study demonstrated a low
grade of RIF – resistance of TB, which was probably imported from abroad.
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CHAPTER 5 GENERAL DISCUSSION
This TB molecular epidemiological study is the first to be conducted in Al Ain,
UAE and was carried out between the years 2003 to 2005. It was prompted by the increase
in TB incidence rate among nationals and immigrants to the UAE originating from TB-
endemic countries in the period from 1997 to 2003 (Dissanayake et al., 2001; WHO, 2002;
Annual statistic Reports, 2003; UAE Interact, 2007). There was also an increase in the
mean TB prevalence among children during the same period (Bener et al., 1996; Annual
Statistical Reports, 1998; Annual Statistical Reports, 2003). The origin of M. tuberculosis
strains in the UAE and their implications to the subsequent unique epidemiology of TB in
the UAE however remains questionable (Dissanayake et al., 2001). Added to this is the
increased number of reported cases of drug resistant strains among UAE nationals from 2%
to 8% (Bener et al., 1996). Only one study by Dissanayake et al. (2001) implied the
presence of unique TB strains which could be resistant to available therapies. This
proposition was questionable because even though there was an overall increase in the
incidence in both nationals and non-nationals (immigrants), the increase among nationals
was greater. The current composition of the UAE population includes immigrants from TB
endemic countries, who constitute more than 60% of the population and is suggestive of
probable cross-transmission of infection between the two groups of inhabitants. It is
improbable that there would be different strains of TB infecting nationals and non-
nationals, especially when the two groups lived in such close proximity. Furthermore,
studies from these TB endemic countries suggested a high prevalence of latent TB in these
populations (Pai et al., 2004). Individuals with latent infections slip through the screening
methods specified by the UAE government policy for TB control and remain as sources of
infection when reactivated to cause active disease. With the exception of a single
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molecular study conducted by Dissanayake et al. (2001), no genotypic studies has ever
been undertaken to identify the circulating strains or construct their phylogeny in Al Ain.
5.1 Study subjects and targets
The utility of genotypic method for a specific setting depends on the purpose of the
study in the targeted population and the choice of genetic tools used (Mathema et al.,
2006). In this study one of the aims was to establish whether there are unique M.
tuberculosis strains circulating among nationals in Al Ain. MIRU typing was used to trace
these strains between nationals, while spoligotyping was used to identify the prevalent
strain families. The laboratories in the Faculty of Medicine and Health Sciences of the
UAE University were previously used in a molecular typing study of TB strains and their
expertise was utilized for DNA extraction in this study. In addition, there was a well
established link between the university laboratory and those in the regional hospitals which
facilitated the transfer of samples to the university laboratory where all isolates were sub-
cultured, DNA extracted and shipped to the UK.
Molecular typing studies were performed on 194 UAE M. tuberculosis complex
positive cultures recovered from 327 sputum and biopsy culture specimens collected from
TB patients, this represented a yield of 59.3%. The reduction in the recovery could be
related to laboratory cross-contamination, lack of skills and experience in using advanced
techniques. Forty UK isolates, including eight TBM, were concurrently MIRU typed for
comparison. The UK isolates were included in this study for several reasons: Firstly, the
efficiently-extracted DNA samples were used as templates to amplify MIRUs in the UK
isolates and serve as controls for amplification of the corresponding MIRUs in the UAE
samples. Secondly, the results of UK MIRU analysis were used as a standard reference to
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determine the accuracy of the procedures used for the UAE isolates. More importantly,
previous studies indicated that strains recovered from patients in the UK showed high level
of diversity among ethnic groups infected with TB but with low levels of transmission
(Dale et al., 2005). It was therefore assumed that the UK data will be useful for
comparison in the light of the fact that a similar ethnic diversity exists in the UAE and the
MIRU diversity was expected to be high.
5.2 Implications and significance of MIRU typing
MIRU typing was found as an unsuitable genetic tool for identifying strain families
in Al Ain. For example, several Beijing isolates were mis-identified. Beijing strains are of
public health concern and have been responsible for the dissemination of TB and drug
resistant strains worldwide (Bifani et al., 2002). The availability of a confirmatory PCR
based method, IS6110 dnaA-N insertion, to classify strains correctly defined Beijing strains
(Milan et al., 2004).
The study of MIRU allelic diversity among M. tuberculosis strains in Al Ain
showed that six MIRUs: 10, 16, 26, 31, 39 and 40 had high allelic diversity; MIRUs 23, 24
and 27 were of moderate allelic diversity, while the remainder MIRUs had poor diversity.
The presence of high MIRU allelic diversity in TB strains in Al Ain reflects the presence of
a diverse population of strains that probably arose from reactivation of lesions in latently
infected individuals originating from and living in a diverse population. In contrast, MIRU
allelic diversity ranged from low to moderate in the UK isolates, specifically TBMs,
indicating a closer genetic relationship between strains.
Recently, similar MIRU variability results were demonstrated to discriminate
between CAS strains in Pakistan reflecting the presence of imported strains due to active
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movement of individuals from different ethnic groups in the country (Ali et al., 2007).
Using MIRU typing this study was successful in identifying clusters of identical strains in
Al Ain as reported in other studies (Sola et al., 2001; 2003; van Deutekom et al., 2005).
MIRU 26 showed the highest discriminatory power and since this was confirmed in all
spoligo-defined families, the result could be of epidemiological value in Al Ain. The
MIRU clustering rate among UAE isolates of 5.6% was made up of small sized clusters.
This pattern has been interpreted by others to indicate a low grade transmission since
clustering is mostly assumed as a marker for this linkage or association (Burgos and Pym,
2002; Godreuil et al., 2007). The presence of 175 unique isolates among residents in Al
Ain may represent probable reactivation of TB cases as the majority of these patients were
immigrants with increased prevalence of latent infection (Patel et al., 2007). Such
conclusion linking unique M. tuberculosis strains with reactivated TB cases was further
supported by the presence of a high allelic diversity of M. tuberculosis strain populations in
Al Ain (Nguyen et al., 2004; Martin et al., 2007).
In the absence of demographic data pertinent to UK isolate panels, comments and
conclusions on transmission dynamics and nature of sample population were difficult to
achieve. Previous TB epidemiological reports from the UK based on cluster analysis have
implicated new immigrants and foreign-born residents from countries with high prevalence
rates of TB in the modification of TB epidemiology (McEvoy and Maguire, 1995; Ohkado
et al., 2005).
5.3 Importance of katG/gyrA SNP typing
The dominance of ancestral clones of PGG 1 represented by EAI and CAS families
following katG/gyrA typing in Al Ain suggested an exogenous source of the disease as
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these families have specific phylogeographic locations (Filliol et al., 2002; Brudey et al.,
2006). katG/gyrA SNP typing is a more an accepted method for constructing a real
phylogeny for TB strains (Sreevatsan et al., 1997) compared with other genotyping
methods such as MIRU typing and spoligotyping, which have produced discrepancies when
they have been used to construct phylogenies. In this context, SNP typing further
subdivided super-families into PGGs 1, 2 and 3 indicating that MIRUs and spoligotyping
are not ideal methods for building proper family phylogenetic trees. This conclusion was
reached after the division of CAS isolates into PGGs 1 and 2 instead of PGG 1 by
katG/gyrA SNP typing (Hasan et al., 2006). However, some specific associations have
been established in a number of studies. For example, most members of EAI had two
copies of MIRU 24, belonged to PGG 1 and had specific spoligo-pattern (Ferdinand et al.,
2004; Arnold, 2006; Mathema et al., 2006; Prodinger, 2007). These differences were
probably related to rapid molecular clock changes that usually occur in the spacers in DR
and VNTR loci (Sreevatsan et al., 1997; Baker et al., 2004; Prodinger, 2007). The majority
of UAE strains were designated PGG 1 indicating that there were more virulent strains
circulating in the UAE.
5.4 Implications and significance of spoligotyping
Spoligotyping was applied to identify family strains circulatig in Al Ain (Filliol et
al., 2002; 2003; 2006). Thirteen clades were characterized, of which eight families
(Haarlem, LAM, EAI, Beijing, Africanum, CAS, T, X) were identified, confirming the
presence of these circulating clades in Al Ain, while the remainder, including Family33,
Family34, Family35, Family36 and the S families were recently added to the SpolDB3
database (Filliol et al., 2002; Vitol et al., 2006). A recent report demonstrated the existence
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of similar circulating clades of Haarlem, LAM, EAI, Beijing, Bovis, Manu, CAS, T and X
in Saudi Arabia (Al-Hajoj et al., 2007). The presence of Family33, Family34, Family35
and Family36 was interesting since these families could represent the unique strains which
were reported in Al Ain by Dissanayake et al. (2001). Family33 is closely related to the
Manu family while Family34 is similar to M. africanum (Vitol et al., 2006). In Al Ain,
these family strains caused pulmonary and extra-pulmonary diseases among nationals and
non-nationals, and were associated with fibrosis, cavitations and pleural effusions all of
which indicate virulence. Although spoligotyping is appropriate for identifying strains
causing epidemics (Prodinger, 2007), it has some significant limitations because its
molecular clock is slower than MIRU typing. Negative factors, include the fact that some
spacers can interact, or may be lost occur independently culminating in convergence of
spoligotypes when different families merge. This makes family identification essentially
impossible (Warren et al., 2002; Vitol et al., 2006). Moreover, spoligotyping involves only
one locus with DR repeats and entangled spacers, some of which can be masked by IS6110
insertions making such spacers undetectable (Mokrousov et al., 2002). Due to this latter
limitation spoligotyping could not be used to identify UAE isolate #2 which possessed a
small deletion (chapter 3). Spoligotyping and MIRU typing results showed a clustering
rate of 46% and 5.6% respectively, suggesting ongoing transmission. However, clustering
of identical fingerprinting can occur between individuals or patients living in isolated rural
areas lacking previous close contact or in different geographical states or in various remote
geographical locations within a country. This shows that a probable prevalent strain can be
involved as a causative agent and spread the infection in these localities and in the process
modify the epidemiology of the disease (Braden et al., 1997; Picard, 2000; Yang et al.,
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1998). Alternatively, the presence of 65 spoligo-defined unique isolates may indicate a
reactivation process existing among immigrants who probably acquired TB at their home
countries before arriving in the UAE (Lillebaek et al., 2002; Dahle et al., 2007).
5.5 Supplemental genotyping methods
Spoligotyping could not identify some M. tuberculosis complex isolates suspected as NTM
and some Beijing isolates. Hence, 16S rRNA and dnaA-dnaN methods were selected to
augment the results. 16S rRNA typing identified two M. kansasii isolates in patients with
respiratory symptoms for the first time in the UAE. These isolates could have been missed
if this technique had not been applied or worse still the patients could have been mistakenly
treated for TB with the possible development of side effects and the wastage of hospital
resources. Their prompt identification in this study prevented misdiagnosis and
unnecessary treatment for TB for later samples.
The use of IS6110 dnaA-dnaN typing was found to be valuable in identifying
Beijing isolates particularly in areas with abundant strains. These findings necessitated the
use of multiple genotypic methods for proper identification of strains.
5.6 Combination of MIRU typing and spoligotyping in identification of clusters and
significance of clustering
Clustering of isolates has been used to denote virulence of strains and also assumed
to reflect recent transmission (Burgos and Pym, 2002). MIRU typing reduced the
spoligotyped clusters from 30 to eight clusters implying that they were false clusters with
respect to transmission. It also reduced the size of the clusters from 2-11 patients to 2-4
patients indicating that MIRU allelic alteration is sensitive in identifying clustered isolates
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and thus minimises time and cost of any epidemiologic investigation. Consequently,
MIRU clusters were used in this study to determine the transmission patterns of TB and to
trace the sources of the organism. As mentioned earlier MIRU clustering is indicative of
probable ongoing transmission of TB. This observation was supported by two patients with
TB, a UAE female national who contracted infection from an Indonesian maid working in
the same household in Zakhir, Al Ain, while the transmission links and contact tracing were
hindered by the lack of proper residential addresses for the rest of the patients. But,
clustering of isolates could still happen even in a remote past and without close contact
(Burgos and Pym, 2002). This was further supported by the presence of high MIRU
variability profiles among patients in Al Ain, while spoligodefined in clusters, suggesting
the existence of distant genetic relationship among isolates. This high variability was also a
marker of the heterogeneous population inhabiting Al Ain.
5.7 Association of genotyped strains with clinical signs and pathology
The strain genotyping results are only meaningful when combined with
epidemiological data to determine the episodes of disease and to trace the source, and
establish transmission chains or to identify drug resistant strains (Barnes et al., 2003). In
this study all genotyped strains were associated with the different symptoms and signs
associated with TB to establish association between strains and specific presentation as
previously reported in a recent study by Laifer et al. (2007). Defective host immune
response in a TB patient predisposes to extra-pulmonary disease as a result of increased
spreading of M. tuberculosis infection from the pulmonary site to a different body site
(Mandell et al., 2000). Yet, other researchers have cited the role of bacterial determinants
in initiation of extra-pulmonary disease (Garcia de Viedma et al., 2002; 2005). Co-
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infecting in vitro macrophage cell cultures and murine experiments with strains of M.
tuberculosis causing extra- pulmonary and pulmonary diseases showed that the former
strains were more virulent than the latter ones in infecting tissues and this was associated
with an increased bacterial load (Garcia de Viedma et al., 2005).
The selection of CAS and Beijing strains in this population was related to their
reported virulence, clustering and ability to threaten public health (Bifani et al., 2002;
Hasan et al., 2006). In addition, these strains were identified for the first time in the UAE.
In this study, CAS strains were frequently associated with coughs and fever. CAS and
Beijing strains also caused many pulmonary and extra-pulmonary cases in Al Ain possibly
indicating a greater virulence of these strains. Moreover, CAS strains were responsible for
the majority of upper lung field lesions found in this study, suggesting active TB disease,
while in other cases they infected the lower lung field with accompanied pleural effusions
and fibrosis probably reflecting reactivated disease (Geng et al., 2005). Hasan et al. (2006)
reported significant association of extra-pulmonary disease with distinctive spoligotypes.
The same authors proposed that increased infectivity of tissues might be correlated with
high genetic variability of extra-pulmonary strains in comparison to pulmonary strains.
These findings supported the assumption that reactivation and a low grade of ongoing
transmission have attributed to the prevalence of TB in Al Ain. Consequently, further
demographic data are needed to support transmission dynamics and to determine the source
of TB. The recovery of genotyped ancestral strains, such as EAI and CAS, from TB
patients originating mainly from the Indian subcontinent and Far East Asia (areas where
these bacilli predominate) implied that the disease was of exogenous source.
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The previous proposition of unique strains circulating among nationals that were
thought to cause a severe disease was not found in this study (Dissanayake et al., 2001).
However, the presence of unidentified variants of families such as Family33 and Family 35
found in association with extra-pulmonary TB, a severe form of TB in this study and as
documented elsewhere could represent these unique strains (Vitol et al., 2006).
A further merit for genotyping results in supporting the clinical data in this study
was shown by the classification of approximately 91% of strains tested circulating in Al
Ain by katG/gyrA typing into PGGs 1 and 2 denoting higher virulence and transmissibility
which could partially explain the frequency of extra-pulmonary TB disease among
nationals (Sreevatsan et al., 1997).
5.8 Association of genotyped strains with demographic characteristics
Demographic data including age, nationality, place of birth and place of residence
are essential in the epidemiology of TB for identifying the source of and transmission of
disease. The majority of infected patients residing in Al Ain were Asian immigrants
originating from the Indian subcontinent, Far East Asia and the Middle East, indicating
imported TB. This was substantiated by the identification of ancestral families that are
predominant in the Indian subcontinent and East Asia, the original home for for these
particular strains from which infection spreads globally (Filliol et al., 2002; 2003; Brudey
et al., 2006; Hasan et al., 2006). The CAS strains are also still frequently reported to cause
active pulmonary disease at their places of origin in Asia (Hasan et al., 2006).
The average age of infected patients in this study was 34 years, and the majority
were above 20 years- which favours the proposition of reactivation of latent infection since
TB infections tend to become reactivated after 20 years (Vitol et al., 2006). While both
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males and females were susceptible to TB infection, male cases were twice as high as
females which necessitated more attention and care regarding this gender without ignoring
the promotion of health awareness among illiterate women and men in Al Ain (Holmes et
al., 1998). The tropism of CAS strains for children below 13 years old in association with
pulmonary and extra-pulmonary diseases was noticeable and requires further research
work. A similar phenomenon in association with CAS has been reported in young children
in New York (Vitol et al., 2006). The presence of TB in national children may also reflect
a low grade of ongoing transmission of exogenous strains circulating among members of
households in Al Ain. Thus epidemiological and control measures should also target this
age group to reduce transmission and ultimately control the disease.
5.9 Association of genotyped strains with drug resistance
It is vital to determine the genotypic resistance of strains in different regions in
order to trace dissemination and design strategies for control. With the exception of one
resistant isolate identified as Beijing, all M. tuberculosis strains in Al Ain were found to be
susceptible to rifampin as confirmed by the absence of rpoB mutations in the RRDR
following in vitro antibiotic susceptibility testing. These findings were contrary to those in
India, the major source of immigrant labour to the UAE and where high RIF-resistance
prevails and from where MDR-TB is spreading across the country in association with
Beijing, CAS1 and EAI strains (Suresh et al., 2006). The presence of one RIF-resistant
Beijing strain shows that the spread of these strains in Al Ain is limited and does not seem
to pose an imminent public health threat. In addition, the paucity of collected samples
might have contributed to the observed low level of resistance. Hence, the crucial need for
adequate information about mutations in the RRDR l and facilitates for conducting a rapid
234
and accurate diagnostic test for RIF, a surrgate marker for MDR-TB and a direct TB control
strategy (Ewen et al., 2000).
Although the great development of a significant level of RIF-resistance was not
detected in Al Ain, the ongoing misuse of drugs can lead to the development of drug
resistance in the future, aggravate TB transmission and increase the cost of treatment. To
prevent easy access to medicines, the government should implement a policy similar to that
practiced in The Netherlands that restricts the dispensing of drugs (Welschen et al., 2004).
Although anti-TB drugs were not dispensed because these medicines are dispensed only in
government hospitals and not available in private hospitals and pharmacies, since nationals
have the ability to obtain medications which they want, it is absolutely necessary to
promulgate a drug policy that would have jurisdiction even over pharmacies within the
hospitals.
5.10 Value of screening tests
The use of screening tests and the prompt identification of M. tuberculosis are vital
for the control of TB (Laifer et al., 2007). This becomes even more important for
immigrants in the light of the observation that TB infection in the UAE was dominated by
exogenous strains. Culture of sputum samples using conventional laboratory procedures
confirmed the existence of M. tuberculosis in Al Ain. Sputum culture and sputum acid fast
staining of smears and chest X-ray radiograph also detected active cases. The use of chest
X-ray is mandatory as a screening test since it is included in the government TB control
policy for immigrants but TST is only performed if the chest radiography shows the
presence of lesions characteristic of TB. Of all the TB lesions, this study identified fibrosis
as the most common abnormality encountered in chest radiographs among non-national and
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national patients which supports the viewpoint that TB infections in Al Ain were due to
reactivation of old or latent infections rather than ongoing transmission. This is supported
by the findings of Geng et al. (2005) who reported that fibrosis, infection of lower lung
field and presence of lung infiltrates were signs of a reactivated disease.
5.11 Public health threat of immigrants and role of workplace in TB transmission
The presence of immigrants among natives could pose substantial threat to public
health especially in a country with low prevalence of TB. Transmission of disease from
foreigners to natives in the Al Ain community is inevitable since the majority of these non-
nationals have latent infections as confirmed by TST. Similar transmission links from
infected immigrants to native population have been reported in countries where immigrants
reside among the natives, and between the latter and foreign-born individuals (Borgdorff et
al., 1998; Inigo et al., 2007). Several clusters had mixed national and non-national patients
especially those working in the Industrial Area showing probable cross-infection, making
the workplace a risk factor for TB in Al Ain. The workplace, characterized by sustained
crowding, movement and interaction of people that facilitate proximity of contacts or the
transmission of infection from infectious cases to healthy individuals through e.g., coughs,
sneezes and other means (Dannenberg, 1989). For example, silicosis, an occupational
disease acts as a risk factor for TB infection and NTM disease amongst gold mines workers
in South Africa (Corbett et al., 1999). Further spread of TB infection was assisted by
several factors including congregation of these mineworkers at work in nearby living hotels
and in close contact with other potential groups in the community (Corbett et al., 1999,
Sonnenberg et al., 2005). In low and medium-income countries, inefficient healthcare
facilities such as hospitals, and laboratories have been implicated in nosocomial
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transmission of TB from infected patients to healthcare workers namely nurses, doctors,
radiologists and laboratory workers who have increased risk of TB (Joshi et al., 2006).
Conversely these immigrant healthcare workers recruited from countries like Philippines
workers in some developed countries may harbour latent TB infection and create potential
sources of TB infection to close contacts upon reactivation (Anderson et al., 2007). But,
application of certain control measures involving pre-employment testing using GIRAS and
administration of preventive treatment may minimize the impact of TB from this category
of immigrants (Anderson et al., 2007).
5.12 Drawbacks of the government policy for TB control
The existing government policy for control of TB has several drawbacks. It is
wholly reliant on chest X-ray results which identifies only active cases and ignores latent
infection. Hence, a person with normal chest radiography will pass unnoticed and becomes
a potential risk for public health if the disease is reactivated. The situation has worsened
because most infected immigrants are reluctant to seek medical treatment and are not likely
to report for screening procedures for fear of being deported. They would rather go to the
nearest pharmacies to purchase a non-curative medicine, which could further exacerbate the
problem. Although government policy was reported to reduce TB prevalence from 85
cases/100,000 population in 2003 (Annual Statistical Reports, 2003) to 24 cases/100,000
population in 2005 (WHO, 2007), there is still a need to introduce more efficient control
measures as influx of immigrants and expatriates seeking work from high TB endemic
areas to the UAE continues to increase by an annual rate flow of 20% with number of
immigrant quoted as 2.5 million (Khoja, 2002).
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5.13 TB control policies in other countries
It has been reported that 70% of new immigrants do not show any symptoms of TB
on arrival at their destinations (Laifer et al., 2007). To examine this Moonan et al. (2006)
conducted a geographic information system (GIS) analysis using standard genotyping
methods and TST to identify areas in the USA with TB cases showing a high risk of
spreading TB. Accordingly and with the help of community-based organizations and
political involvement, they managed to identify one actively infected TB case for every 83
screened applicants or one individual with latent infection for every five cases. This
information was effectively used to reduce transmission in the county.
An example of a successful and an efficient TB control programme is demonstrated
by Israel and Norway, both rich countries with low TB incidence and confronted with a
continuous inflow of immigrants, similar to the situation in the UAE (Chemtob et al., 2003;
Dahle et al., 2007). Israel has launched a massive TB control programme which has
reduced the incidence of the disease in both natives and immigrants (Chemtob et al., 2003).
The Israeli government considered TB as a dangerous disease, established a National
Tuberculosis Unit (NTU) and legislated for a TB control programme. Different health
structures including Ministry of Health (MoH), NTU, Health Maintenance Organizations
(HMOs), two regional laboratories and TB centres cooperate with each other at the central
level. So that the local Primary Health Centres (PHCs), physicians and nurses all work
under one umbrella organisation to tackle the menace of tuberculosis. At the local level,
MoH supports the programme by providing free treatment under observation following
short course (DOTS) programs at TB centres. The latter centres are rewarded with
incentives by the HMOs for structured work. The MoH also takes the responsibility for
continuous training of physicians and nurses to manage TB cases and to adopt control
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programmes. Overall, the implemented TB strategy involves provision of public health
care facilities according to WHO recommendations (WHO, 1994) and vigilant contact
tracing to limit spread. Similar successful control efforts have been implemented in
Norway to counteract imported TB but in addition, the programme incorporates screening
tests of immigrants on arrival and the vaccination of individuals in the vulnerable age
groups (Dahle et al., 2007). Moreover, the programme integrates and cooperates with TB
control units in counties and has a check TB point that tackles notification cases and traces
contacts. These two TB control models can be of great value in designing a similar strategy
in UAE.
5.14 Suggestions for improvement of TB control strategy in UAE
Being a relatively small country with a population of approximately 4.95 million
and faced with huge influx of immigrants (UAE interact, 2007), the UAE can benefit from
the above outlined efficient TB control programmes in Israel and Norway but with some
modifications (Chemtob et al., 2003; Dahle et al., 2007). Yet, there is no ideal
implemented TB control strategy in a country that can be copied to fit another country as
settings in different countries vary. In the new TB control strategy, a TB Registry Unit or
TB Centre, and a Central Diagnostic Laboratory is proposed to supplement the existing
UAE National TB Programme as found in Norway and Israel (Chemtob et al., 2003; Dahle
et al., 2007). The TB Registry Unit or TB Centre should have its separate budget, be
located at each of the two international airports of Abu Dhabi and Dubai and supervised by
MoH but patronized and supported by GAHS and the PMD. Diagnosed TB cases in PMD,
hospitals, PHCs and representative PMD units in each of the seven emirates should be sent
to this Unit for notification, registering and further confirmation. Each emirate is supposed
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to implement a separate TB Control Unit designed to identify index cases, trace contacts
and treat cases among immigrants, foreign residents and natives in a manner similar to the
policy in Norway which managed to limit transmission (Dahle et al., 2007). The Central
Diagnostic Laboratory, which should be well-equipped and staffed with well trained and
competent technicians, should be able to verify the identity of M. tuberculosis complexes
and isolate positive cultures submitted from PMD and hospital laboratories conventionally
and molecularly for epidemiological purposes. They should also be able to perform
antibiotic susceptibility testing to improve treatment (Dahle et al., 2007). Reports from
these laboratories should be sent to the TB Unit or Centre.
To apply this new TB control policy in the UAE, TST must be a mandatory
procedure to detect lesions among new immigrant cases with reactivation. In addition, new
immigrants to the UAE from countries with high TB prevalence should be screen-tested by
the application of compulsory chest radiography and GIRAS (QuantiFERON-TB Gold or T
SPOT-TB) on arrival at each of the two airports to identify active and latent cases to
prevent their escape into the community and help to reduce TB incidence. The GIRAS was
chosen to replace or supplement TST because the latter has several drawbacks noticeably,
its cross-reactivity with BCG vaccine and NTM, high subjectivity and diificulty of
interpreting results (Pai et al., 2004). In addition GIRAS is highly sensitive and specific,
and time-saving as results can be obtained overnight compared with several weeks required
by standard methods including TST (Mazurek et al., 2001; Davies and Drobniewski, 2006;
Madariaga et al., 2007). Moreover, GIRAS has recently been approved by USA and many
European countries as a useful test for diagnosis of M. tuberculosis infection (Pay et al.,
2004; Kanunfre et al., 2008). Furthermore the test has been shown to be valuable in
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detecting latently infected cases and pulmonary TB in resource-poor countries endemic
with high TB such as the Gambia (Adetifa et al., 2007). However, GIRAS has been found
relatively more costly than TST in USA with a value of approximately $37.39 per patient
compared to ~ $9.79 per patient for TST (Madariaga et al., 2007). Although the current
estimated cost of TST in UAE is reported to be about $100 per patient, there is no problem
in implementing the extra GIRAS and new policy since the UAE is a wealthy country. In
fact, the GIRAS assay has already been approved by the MoH in the UAE and its use could
probably start in 2009.
If a person has a normal chest radiography and negative GIRAS, the person is
allowed to stay and work. Immigrants and foreign residents who have chest radiographic
abnormalities and GIRAS positives are not deported but instead receive free treatment and
other health services as in Israel and Norway (Chemtob et al., 2003; Dahle et al., 2007).
The proposed banning of deportation and delivery of free treatment will encourage patients
to attend screening tests. Patients will be cured and subsequent transmission prevented.
Positive GIRAS reactors of both foreign groups are sent to the PMD to be treated under
supervision in accordance with WHO guidelines (WHO, 2007), while positive reactors
from natives are sent to the district health authorities including hospitals and PHCs for
treatment and follow-up. If contacts with index case are tested with GIRAS and found
positive, they will be given prophylactic treatment as in the Israeli programme. Payment of
treatment for immigrants and foreign residents is borne by employers who recruited them
and that for for nationals is borne by the health insurance companies in Abu Dhabi and
MoH in the other emirates. Information obtained from follow-up treatment sessions are
reported to the TB Registry Unit or TB Centre. In cases with indeterminate GIRAS results,
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diagnosis is carried out by combination of clinical signs and microbiological investigations
and if they turn positive action is taken as stated above (Madariaga et al., 2007).
The TB Registry Unit or TB Centre is also responsible for handling TB screening
tests, vigilant monitoring of TB cases, efficient reporting system, keeping of statistical data,
recoding of databases and plan management of TB cases. The MoH supports and rewards
activities of the TB Centre, and trains medical staff to develop expertise and skill to deal
with cases and to implement TB control efforts as in Israel (Chemo et al., 2003). Equally
the government should provide sufficient anti-TB drugs, control dispensation of antibiotics
in pharmacies to stop indiscriminate use and carry out vaccination programmed to cover
susceptible age groups such as teenagers as in the Norwegian programme (Dahle et al.,
2007). The government is also responsible for promoting health awareness about the
dangers of the disease among all residents particularly in the Hili and Al Jimi areas.
Moreover, the government should support community-based organizations following the
approach of Moonan et al. (2006), and encourage public-private health partnership to
combat the disease (Uplekar et al., 2001). Diligent and maintained TB surveillance
programme should be conducted in the Industrial Area in Al Ain and among families and
their contacts e.g. maids, and other emirates to detect active and latent cases for isolation
and treatment. All these control efforts should be bostered by political willingness to
provide finance and efficient managerial body to establish and meet targets as well as
execution of laws that would penalize patients who refrain from treatment and screening
tests. However, effective combination and coordination between the present National TB
Programme, proposed TB monitoring Centre, TB control teams in various emirates, and
workers in operational laboratory network is indispensible for achievement.
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5.15 Limitations of the study
This study has fulfilled all outlined objectives, yet there are a couple of limitations.
It was found difficult to define transmission dynamics of patients included in identical
clusters as formal addresses could not be traced due to the fact that this study was confined
to medical notes and other official forms and no interviews were conducted. The
municipality should establish formal permanent addresses for all residents in UAE which
could help finding index cases, tracing contacts and study transmission pathways in the
future. The government should raise knowledge about the devastating effects of TB among
various communities in order to eliminate stigma associated with the disease so that
infected people will acknowledge the need for sampling and allow personal interviewing
for the sake of TB research and control. It is proposed that another laboratory, equipped
with advanced technical facilities and supplied with qualified and experienced staff, should
be constructed in Al Ain for support. The new establishment will assist in expediting the
procedure of culturing and DNA extraction that could minimize the delay period, avoid
DNA degradation, contamination and most importantly the missing of some potential
genotypes. The inclusion of a small number of UAE samples in the study due to the short
period of time for collection greately affected statistical analysis. In spite of the paucity of
number of samples, not all of these identified patients were included in the study because
their samples could not be cultured for DNA extraction.
5.16 Future prospective
A research grant proposal derived from this study has been submitted to Sheikh
Hamden’s Award for medical research in Dubai in collaboration with Professor S.
Dissanayake. The research work will establish a defined link between the seven emirates,
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where all identified cases will be evaluated, tested and managed at the UAE University
Microbiology laboratory. This would provide an informed insight of TB epidemiology in
the UAE with a well established clinical data to control and eliminate the disease.
To test the efficacy of drugs or development of resistance to drugs in the area, a
large scale project should be implemented using conventional and molecular methods with
more than one anti-TB drug in order to achieve the right treatment and avoid development
of drug resistance.
5.17 Conclusions
This study has identified TB in Al Ain as being caused by imported strains of global
family clades of M. tuberculosis. These family strains were identified for the first time in
Al Ain using standard genotyping methods of MIRU analysis and spoligotyping. In Al
Ain, the notion of existing unique strains and presence of peculiar clinical signs in the
national population was rejected and an exogenous source of infections was well
established. Reactivation of latent TB was a major contributor to TB epidemiology in the
UAE. In addition, genotypic data in combination with demographic data facilitated the
establishment and the confirmation of epidemiological links between two patients,
existence of drug resistance, tracing of exogenous source of the disease and the role of
immigrants in perpetuating TB infection in the UAE. Current TB screening policy targets
only adult immigrants with active disease. The existing government policy for TB control
was evaluated and a new control strategy which urges political willingness and community-
based support suggested. The findings of this study could help and support the UAE
government screening policy for TB control by identifying active and latent TB cases
among immigrants originating in highly endemic areas particularly, countries of the Indian
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Subcontinent as major sites for exporting labour to UAE. Infected individuals should be
promptly identified and treated to combat transmission and eliminate the disease, although
TB is a difficult disease which requires international joint efforts to control. Finally, the
study highlighted the need for strict policy to control drug dispensing without prescription
from pharmacies in the UAE.
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Appendix 2 Patient’s data confidentiality form
The TB participants were informed that the collected data is confidential and would
only be used in this TB research project and would not be disclosed to a third party.
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Appendix 3 Notification form
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Appendix 4 Proforma for UAE patients
Clinical Epidemiology of Tuberculosis in Al Ain
1 Isolate No.
2 Name
3 ID No.
4 Nationality
5 Place of birth
6 Place of residence
7 Age (years)
8 Sex
9 Marital Status
10 Monthly income (AED)
11 Job status
12 History of traveling in last 1 years
12A When
12B Country
12C Duration (weeks)
13 Laboratory No. where diagnosed
14 Place of Laboratory diagnosis
15 Reason for attending the clinic/hospital
15A Illness
15B Employee/Immigration screening (New entry/Renewal)
15C High risk screening
16 Place where diagnosed
17 When diagnosed
18 BCG Vaccine taken
18A Vaccination scar present
18B
Confirmed Immunization program record available(for UAE
national)
18C If BCG given, when
19 Symptoms
19A Fever
19B Cough
19C Night sweat
19D Weight Loss
19E Anorexia
290
19F Joint Pain
19G Swelling
19H Hemoptysis
19I Others
20 Previous history of similar symptoms
21 If yes, how long the symptoms were present (weeks)
21A If so, any medication taken
21B What medication
21B1 Antibiotic
21B2 Cough syrup
21B3 Antipyretic
21B4 Herbal
21B5 Other
21C Source of medication
22 History of other illness
23 History of smoking
23A If yes, how long? (Years)
23B How many cigarettes
24 Form of tuberculosis disease:
25 Investigations - Pulmonary
25A X-Ray Chest
25B Mantoux
25C Gastric lavage (Applicable to children only)
25D Sputum AFB
25E Sputum Culture
26 Investigations- Extra-Pulmonary
26A Biopsy
26B FNA
26C Mantoux
27 Other Investigations - Routine Blood tests
27A ESR
27B Haemoglobin (Gm%)
27C Serum Ferritin (Applicable for children only)
28 If X-ray chest was abnormal, mention finding or abnormality
28A Fibrosis
28B Cavitation
28C No. of cavitation
28D Cavitation on which lung?
28E Which area of the lung
28F Calcification
28G Pleural effusion
291
29 Tuberculin sensitivity test
29A If done where?
29B Induration
30 Confirmatory diagnosis
30A AFB +Ve
30B Sputum culture +Ve
31 Infectivity status
31A Whether family/household contacted?
31B Any screening done in family/household?
31C Any treatment to the family/household member?
32 No. of people in household/family
33 History of TB in family or household member
33A If yes, family or household member has TB symptoms
33B Any screening procedure for TB done at home
33C If answer to above is yes, any member TB +Ve
34 If answer to question 33 or 33A or 33C is yes, then
34A Nationality
34B Relation to the patient
34C Duration of contact (months)
34D Any treatment to the family/household member
34E What medication
34F Any follow-up since treatment
34G Any prophylaxis given to family/household members
34H Any supplementary given to home members
35 Comments
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Appendix 5 UK and UAE MIRU repeats, katG463/gyrA95 and strain families
MIRU 2 4 10 16 20 23 24 26 27 31 39 40 katG/gyrA
UK.1 2 4 4 ∆ 2 7 2 2 4 5 4 4 1
UK.2 2 3 5 4 2 8 2 2 4 5 1 4 1
UK.3 2 5 4 3 2 7 2 2 4 5 4 4 1
UK.5 2 2 4 4 2 6 1 5 4 3 3 5 2
UK.6 2 2 10 3 3 2 6 1 2 4 3 3 1
UK.7 2 2 3 2 2 6 1 5 4 5 3 3 3
UK.8 2 2 4 5 2 6 1 5 4 5 4 4 1
UK.11 2 2 3 5 1 6 1 5 4 3 3 4 2
UK.12 2 2 4 5 1 6 1 5 4 3 2 1 2
UK.13 2 4 4 4 2 7 2 2 4 5 3 1 1
UK.14 2 2 3 ∆ 2 5 1 5 4 5 4 3 1
UK.15 2 3 7 4 2 3 2 3 4 5 2 2 1
UK.16 2 2 6 4 2 5 2 2 4 5 2 3 1
UK.17 2 2 5 4 2 5 1 7 4 5 3 2 3
UK.18 2 2 3 3 2 5 1 5 4 3 2 1 2
UK.19 2 2 3 3 2 5 1 5 4 5 2 3 2
UK.21 2 2 2 4 2 5 1 5 3 3 2 5 2
UK.22 2 4 4 4 2 7 2 2 3 5 3 4 1
UK.23 1 5 5 4 2 5 1 6 3 3 2 3 1
UK.24 2 2 4 ∆ 2 6 1 7 3 5 3 4 1
UK.25 2 2 5 5 2 6 1 2 3 5 2 3 2
UK.27 2 3 4 4 2 6 2 2 3 5 1 4 1
UK.28 2 6 4 4 2 6 2 2 1 5 3 1 1
UK.29 2 5 3 4 1 5 1 5 3 3 2 4 2
UK.30 2 2 6 5 2 5 1 5 3 6 3 4 1
UK.31 2 2 5 4 2 5 1 5 3 3 2 5 2
UK.32 2 2 6 4 2 5 1 5 4 3 2 4 1
UK.33 2 4 5 4 2 6 1 6 3 3 3 4 1
UK.34 2 3 5 4 2 6 2 2 3 3 3 3 1
UK.35 2 4 4 2 2 6 1 4 3 3 2 5 3
UK.36 2 2 4 3 2 6 1 5 3 3 2 5 2
UK.37 2 2 5 5 2 6 1 5 3 3 2 5 2
TBM.1 2 2 6 4 2 5 1 8 3 5 3 3 1
TBM.2 2 5 3 3 2 5 1 7 3 5 4 3 1
TBM.3 2 4 4 3 2 3 1 5 3 3 2 3 2
TBM.4 2 4 2 3 2 4 2 5 3 3 2 2 1
TBM.5 2 2 4 3 2 5 1 5 4 3 2 2 2
TBM.6 2 3 3 3 2 7 1 2 3 4 2 5 1
TBM.7 3 3 2 3 2 5 1 5 3 2 2 2 2
TBM.8 2 3 3 3 2 5 1 5 3 4 2 3 2
UAE.1 2 5 4 4 2 5 1 5 3 5 3 5 1
UAE.2 2 2 3 3 2 6 1 7 3 5 2 5 1
UAE.3 2 2 6 4 2 5 1 5 3 5 3 3 1
UAE.4 2 2 6 3 2 5 1 4 3 5 2 3 1
UAE.5 2 2 6 4 2 5 1 5 3 5 3 3 1
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UAE.6 2 2 1 1 1
UAE.7 3 2 3 3 2 5 1 4 3 4 2 3 2
UAE.8 2 2 5 5 2 5 1 5 3 4 3 2 1
UAE.9 2 2 6 3 2 5 1 4 3 5 3 3 1
UAE.10 2 2 6 4 2 5 1 5 3 5 3 3 1
UAE.11 2 2 6 4 2 5 1 5 3 5 3 3 1
UAE.12 2 2 5 5 3 2 1 5 3 5 3 3 2
UAE.13 2 2 4 3 2 5 1 4 3 2 2 4 2
UAE.14 2 2 3 3 2 5 1 5 3 5 3 3 1
UAE.15 2 2 3 1 2 5 1 4 3 3 2 1 2
UAE.16 2 2 6 5 2 5 1 4 3 5 3 3 1
UAE.17 2 2 6 5 2 5 1 4 3 5 3 3 1
UAE.18 2 2 4 4 2 6 2 2 3 5 3 3 2
UAE.19 2 3 4 4 2 6 2 2 3 4 1 4 1
UAE.20 2 2 6 4 2 5 1 5 3 3 3 3 1
UAE.21 2 2 5 5 3 5 1 5 3 5 3 3 1
UAE.22 2 2 4 3 2 5 1 4 3 4 2 3 2
UAE.23 2 2 5 3 2 5 1 5 4 3 2 3 1
UAE.24 3 2 4 4 2 7 2 4 4 4 5 4 2
UAE.25 2 2 6 4 2 5 2 4 4 4 2 3 1
UAE.26 2 4 4 2 2 6 2 2 3 3 2 3 1
UAE.27 2 4 3 2 2 6 2 2 3 4 2 4 1
UAE.28 2 2 7 6 2 5 1 5 3 6 2 3 1
UAE.29 2 3 6 2 1 5 1 1 3 5 2 3 1
UAE.30 2 2 5 4 2 5 1 7 3 4 2 3 2
UAE.31 2 2 6 4 1 5 1 7 2 4 1 3 1
UAE.32 2 2 6 4 2 7 1 6 2 4 2 5 1
UAE.33 2 2 3 2 2 6 1 5 3 4 2 3 1
UAE.34 2 2 6 3 2 5 1 1 3 2 1 3 2
UAE.35 2 2 4 3 2 6 1 7 4 4 2 3 1
UAE.36 2 2 6 4 1 5 1 7 3 5 3 3 1
UAE.37 2 2 6 4 2 5 1 7 3 5 3 3 2
UAE.38 2 2 6 2 2 5 1 4 3 5 4 2 2
UAE.39 2 2 6 4 3 5 1 5 3 5 3 3 1
UAE.40 2 2 6 4 2 5 1 7 3 5 3 3 2
UAE.41 2 2 6 4 2 5 1 7 3 5 3 3 2
UAE.42 2 2 6 4 2 5 1 7 3 5 3 3 1
UAE.43 2 2 4 5 2 5 1 5 3 3 3 1 1
UAE.44 2 5 6 3 2 7 2 2 3 4 3 4 1
UAE.45 2 2 6 3 2 5 1 5 3 2 2 3 2
UAE.46 2 2 6 4 2 5 1 7 3 4 3 3 1
UAE.47 2 2 6 4 2 5 1 7 3 4 3 3 1
UAE.48 2 2 6 4 2 5 1 7 3 4 2 3 1
UAE.49 2 2 6 3 2 5 1 7 3 4 3 3 1
UAE.50 2 2 3 4 2 5 1 5 3 3 2 2 2
UAE.51 2 2 3 3 2 6 2 4 3 3 3 3 1
UAE.52 2 2 4 4 2 5 1 5 3 4 3 3 1
UAE.53 2 3 3 4 2 6 2 4 3 4 3 4 1
UAE.54 2 3 3 3 2 6 2 4 3 4 2 4 1
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UAE.55 2 2 3 3 2 5 1 5 3 4 2 3 2
UAE.56 2 4 4 4 2 6 2 1 3 5 2 3 1
UAE.57 2 2 4 4 2 5 1 2 3 4 3 3 1
UAE.58 2 2 4 4 2 5 1 3 3 5 3 3 1
UAE.59 2 2 4 4 2 5 1 2 3 4 3 3 1
UAE.60 2 2 5 2 2 6 2 2 3 5 3 2 1
UAE.61 2 2 4 4 2 5 1 4 3 5 3 1 1
UAE.62 2 2 4 4 2 5 1 3 3 5 3 1 1
UAE.63 2 3 4 4 2 6 2 2 3 5 3 4 1
UAE.64 2 5 4 2 2 6 2 2 3 3 3 3 1
UAE.65 2 2 4 2 2 5 1 2 3 2 3 3 1
UAE.66 2 3 3 2 2 6 1 4 3 2 2 1 3
UAE.67 2 2 3 3 1 5 1 3 3 3 2 4 2
UAE.68 2 2 2 3 2 5 1 6 3 5 3 3 1
UAE.69 2 2 6 3 2 5 1 1 3 3 2 3 2
UAE.70 2 3 3 2 2 5 1 4 3 2 2 3 3
UAE.71 2 2 3 3 1 5 1 4 3 3 2 4 2
UAE.72 2 2 3 4 2 5 1 4 3 3 3 5 1
UAE.73 2 2 3 4 2 5 1 5 3 5 3 5 1
UAE.74 2 2 3 4 2 5 1 3 3 2 2 5 1
UAE.75 1 2 4 5 2 5 1 5 3 5 3 4 2
UAE.76 2 2 3 4 2 6 1 4 3 2 2 7 1
UAE.77 1 2 3 3 2 5 1 2 3 3 2 4 3
UAE.78 2 2 3 4 2 5 1 2 3 3 2 5 2
UAE.79 2 4 3 4 2 6 2 1 3 5 3 3 2
UAE.80 2 2 3 5 2 5 1 1 3 5 3 2 1
UAE.81 2 2 7 2 2 5 1 6 3 3 2 3 2
UAE.82 2 2 3 3 2 5 1 5 3 5 3 2 1
UAE.83 2 2 5 4 2 5 2 1 3 4 3 2 2
UAE.84 2 3 5 3 2 8 2 2 3 5 3 3 1
UAE.85 2 2 5 3 2 6 1 2 3 3 2 1 2
UAE.86 2 2 3 3 2 5 1 6 3 5 3 3 1
UAE.87 2 2 2 3 1 5 1 6 3 5 3 3 1
UAE.88 2 2 3 1 2 5 1 4 3 3 1 4 3
UAE.89 2 2 4 3 2 9 2 1 3 6 2 3 1
UAE.90 2 2 6 4 2 5 1 5 3 5 2 1 1
UAE.91 2 2 5 4 2 5 1 5 3 5 2 2 1
UAE.92 2 2 1 3 2 5 1 4 3 3 2 1 2
UAE.93 2 2 5 4 2 5 1 5 3 5 3 2 1
UAE.94 3 3 4 3 2 6 2 2 3 5 3 2 1
UAE.95 3 3 5 4 2 7 2 2 3 5 3 4 1
UAE.96 3 3 4 3 2 8 2 2 3 5 3 2 1
UAE.97 2 2 2 2 2 5 1 4 3 3 1 4 3
UAE.98 2 2 5 1 2 5 2 1 3 3 1 2 2
UAE.99 2 2 2 3 2 5 1 2 3 3 1 4 3
UAE.100 3 3 3 3 1 6 2 2 3 5 3 4 1
UAE.101 3 5 3 3 2 6 2 2 3 5 3 2 1
UAE.102 2 2 5 5 2 5 1 4 3 5 2 3 1
UAE.103 2 2 6 4 2 5 1 5 3 5 2 3 1
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UAE.104 2 2 4 3 2 6 1 4 3 3 1 7 2
UAE.105 2 2 3 2 1 5 1 5 3 3 2 3 1
UAE.106 2 2 5 5 3 5 1 5 4 5 3 3 1
UAE.107 2 2 4 5 3 5 1 5 4 4 3 3 1
UAE.108 2 2 5 5 3 5 1 5 4 3 4 3 1
UAE.109 2 2 3 3 1 4 1 2 4 5 3 2 1
UAE.110 2 2 6 3 2 5 1 1 4 3 3 3 2
UAE.111 2 2 4 5 2 5 1 7 4 4 2 3 1
UAE.112 2 2 4 5 2 5 1 7 4 4 2 3 1
UAE.113 2 2 4 5 2 6 1 7 4 5 3 3 1
UAE.114 2 2 4 5 2 5 2 7 4 5 1 3 1
UAE.115 2 2 4 5 2 5 1 7 4 5 3 3 1
UAE.116 2 2 3 4 2 7 1 9 4 6 2 2 1
UAE.117 2 2 4 4 2 5 1 7 4 2 3 6 2
UAE.118 2 2 3 5 2 5 1 5 4 3 3 2 1
UAE.119 2 2 4 3 2 5 1 5 4 3 1 3 1
UAE.120 4 2 4 4 2 4 1 6 4 3 1 2 1
UAE.121 2 4 3 2 2 4 1 1 4 3 1 1 1
UAE.122 2 2 2 3 2 5 1 5 3 3 2 2 1
UAE.123 2 2 5 3 2 5 1 5 4 3 2 2 1
UAE.124 2 2 2 3 2 5 1 5 3 3 2 1 1
UAE.125 2 2 3 4 2 5 1 7 4 3 2 2 1
UAE.126 2 3 4 5 2 6 2 3 3 5 3 2 1
UAE.127 2 2 4 3 2 5 1 5 4 3 1 3 1
UAE.128 2 2 3 4 2 5 1 5 4 1 2 4 3
UAE.129 2 3 4 4 2 6 2 3 4 3 3 2 1
UAE.130 2 2 4 3 1 5 2 4 4 4 1 3 1
UAE.131 2 2 4 4 2 5 1 4 4 3 1 2 1
UAE.132 2 2 3 3 2 5 1 3 4 3 1 2 1
UAE.133 2 2 3 4 2 5 1 4 4 2 1 2 2
UAE.134 2 2 3 4 2 1 1 2 4 4 5 1 1
UAE.135 2 2 4 3 2 6 1 3 4 5 1 3 1
UAE.136 2 2 4 5 1 5 1 4 4 3 1 2 2
UAE.137 1 4 5 2 2 5 1 4 4 5 2 3 1
UAE.138 2 2 2 3 2 5 1 4 4 5 2 2 1
UAE.139 2 2 3 4 2 5 1 5 5 6 3 2 1
UAE.140 2 2 3 5 2 5 1 7 4 5 2 3 1
UAE.141 2 2 3 5 2 5 1 7 4 5 2 3 1
UAE.142 2 2 4 3 1 5 1 3 4 4 1 3 1
UAE.143 2 4 4 4 2 5 1 4 4 3 1 4 1
UAE.144 2 2 4 4 2 6 2 3 4 5 2 5 1
UAE.145 2 2 4 2 2 5 1 5 4 3 1 4 2
UAE.146 2 2 3 2 2 7 2 8 4 5 2 4 1
UAE.147 2 4 3 4 2 6 2 2 4 5 3 4 1
UAE.148 1 2 3 4 1 6 1 4 4 4 1 3 2
UAE.149 2 2 3 3 2 5 1 6 3 5 3 2 1
UAE.150 2 2 3 5 2 7 2 4 4 6 1 5 1
UAE.151 2 4 4 4 2 7 2 2 3 4 3 4 1
UAE.152 2 2 3 2 2 6 1 6 4 2 1 3 3
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UAE.153 2 2 3 4 1 6 1 7 4 3 1 3 2
UAE.154 2 4 2 3 2 6 1 3 4 3 1 4 2
UAE.155 2 2 3 4 2 6 1 4 4 3 1 4 1
UAE.156 2 4 4 4 2 7 2 2 4 5 3 2 1
UAE.157 2 2 5 4 1 7 2 2 3 5 3 4 1
UAE.158 2 4 4 5 2 6 1 5 4 5 1 6 1
UAE.159 2 2 4 5 2 5 1 7 4 5 1 5 1
UAE.160 2 2 2 3 2 6 1 5 3 3 3 2 2
UAE.161 2 2 4 1 2 5 1 1 3 3 3 2 2
UAE.162 2 1 3 3 3 3
UAE.163 2 2 3 3 2 5 1 5 3 3 3 5 3
UAE.164 2 2 2 3 2 4 1 5 3 4 3 2 1
UAE.165 2 2 3 4 1 7 1 5 4 3 3 7 2
UAE.166 2 2 5 4 2 6 1 6 1 5 4 3 1
UAE.167 2 2 2 3 2 5 1 7 3 5 3 3 1
UAE.168 2 2 4 3 2 6 1 7 3 5 4 3 1
UAE.169 2 2 4 1 2 6 1 1 3 3 3 2 2
UAE.170 2 2 4 1 2 6 1 1 3 3 3 2 2
UAE.171 2 2 6 3 2 5 1 1 3 3 3 2 3
UAE.172 2 2 4 4 2 5 1 6 3 5 4 3 1
UAE.173 2 6 3 3 2 7 2 2 3 4 3 4 1
UAE.174 1 6 1 2 1 1 1 2 1 1
UAE.175 2 5 2 3 2 5 1 5 3 3 2 2 1
UAE.176 2 2 5 1 2 6 1 1 3 1 4 1 1
UAE.177 2 2 5 5 2 6 1 6 3 3 4 1 1
UAE.178 2 6 4 3 2 6 2 2 3 3 3 4 1
UAE.179 2 6 5 3 2 6 2 2 3 5 3 2 1
UAE.180 2 5 6 4 2 5 1 6 3 5 4 3 1
UAE.181 2 2 2 1 3 5 4 1
UAE.182 2 2 4 6 1 1 5 4 1
UAE.183 2 6 5 3 2 6 2 2 3 4 3 4 1
UAE.184 2 5 2 1 2 6 4 1
UAE.185 2 2 1 4 1
UAE.186 2 6 1 2 1 1 3 1 1
UAE.187 2 5 5 3 1 6 1 4 3 3 2 3 2
UAE.188 2 2 4 2 6 2 3 3 4 3
UAE.189 2 6 4 3 2 8 2 2 3 5 3 2 1
UAE.190 2 6 3 3 2 6 2 2 3 5 3 4 1
UAE.191 2 6 3 3 2 5 1 5 3 3 4 4 2
UAE.192 3 5 4 3 2 6 2 2 3 5 3 2 1
UAE.193 2 5 5 2 2 4 1 1 3 4 4 2 3
UAE.194 2 2 5 2 2 5 1 1 3 4 4 2 2
Yellow highlits indicate identical MIRU profiles of these isolates.
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Appendix 6 Direct repeats of spoligotyped strains recovered from national and non-national patients in Al Ain, UAE, autograph set 1
The direct region (DR) of repeats in the genomes of 39 potential UAE clinical M. tuberculosis complex isolates recovered from TB
patients were PCR-amplified and processed by spoligotyping as described by (Kamerbeek et al., 1997). Briefly, the PCR products
were hybridized to a set of 43 immobilized oligonucleotides-covalently bound to a membrane. The hybridized membrane was detected
using ECL detection fluid following exposure to X-ray film. The lack or presence of spacer signatures were visually observed to
identify isolates. Genomic DNAs extracted from M. tuberculosis H37Rv and M. bovis BCG strains were included as references for the
procedure. Row wells (1-36) extending from top of autograph downwards were filled by PCR products of tested UAE isolates. The
far top two row wells were filled with genomic DNAs of strains H37Rv and M. bovis BCG. The third row wells from top of autograph
were filled with Mastermixto act as a negative control. M. tub. H37Rv, M. tuberculosis H37Rv; Neg. control, a negative control.
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Appendix 7 Direct repeats of spoligotyped strains recovered from national and non-national patients in Al Ain, UAE, autograph set 2
The direct region (DR) of repeats in the genomes of 39 potential UAE clinical M. tuberculosis complex isolates recovered from TB
patients were PCR-amplified and processed by spoligotyping as described by (Kamerbeek et al., 1997). Briefly, the PCR products
were hybridized to a set of 43 immobilized oligonucleotides-covalently bound to a membrane. The hybridized membrane was detected
using ECL detection fluid following exposure to X-ray film. The lack or presence of spacer signatures were visually observed to
identify isolates. Genomic DNAs extracted from M. tuberculosis H37Rv and M. bovis BCG strains were included as references for the
procedure. Row wells (40-77) extending from top of autograph downwards were filled by PCR products of tested UAE isolates. The
far top two row wells were filled with genomic DNAs of strains H37Rv and M. bovis BCG but spacers were faint. The third row wells
from top of autograph were filled with the Mastermix to act as a negative control. M. tub. H37Rv, M. tuberculosis H37Rv; Neg.
control, a negative control.
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Appendix 8 Direct repeats of spoligotyped strains recovered from national and non-national patients in Al Ain, UAE, set 3
The direct region (DR) of repeats in the genomes of 39 potential UAE clinical M. tuberculosis complex isolates recovered from TB
patients were PCR-amplified and processed by spoligotyping as described by (Kamerbeek et al., 1997). Briefly, the PCR products
were hybridized to a set of 43 immobilized oligonucleotides-covalently bound to a membrane. The hybridized membrane was detected
using ECL detection fluid following exposure to X-ray film. The lack or presence of spacer signatures were visually observed to
identify isolates. Genomic DNAs extracted from M. tuberculosis H37Rv and M. bovis BCG strains were included as references for the
procedure. Row wells (78-116) extending from top of autograph downwards were filled by PCR products of tested UAE isolates. The
far top two row wells were filled with genomic DNAs of strains H37Rv sand M. bovis BCG. .The third row wells from top of
autograph were filled with the Mastermix to act as a negative control. M. tub. H37Rv, M. tuberculosis H37Rv; Neg. control, a
negative control.
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Appendix 9 Direct repeats of spoligotyped strains recovered from national and non-national patients in Al Ain, UAE, autograph set 4
The direct region (DR) of repeats in the genomes of 39 potential UAE clinical M. tuberculosis complex isolates recovered from TB
patients were PCR-amplified and processed by spoligotyping as described by (Kamerbeek et al., 1997). Briefly, the PCR products
were hybridized to a set of 43 immobilized oligonucleotides-covalently bound to a membrane. The hybridized membrane was detected
using ECL detection fluid following exposure to X-ray film. The lack or presence of spacer signatures were visually observed to
identify isolates. Genomic DNAs extracted from M. tuberculosis H37Rv and M. bovis BCG strains were included as references for the
procedure. Row wells (116-154) extending from top of autograph downwards were filled by PCR products of tested UAE isolates.
The far top two row wells were filled with genomic DNAs of strains H37Rv sand M. bovis BCG. The third row wells from top of
autograph were filled with the Mastermix to act as a negative control. M. tub. H37Rv, M. tuberculosis H37Rv; Neg. control, a
negative control.
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Appendix 10 Direct repeats of spoligotyped strains recovered from national and non-national patients in Al Ain, UAE, autograph set 5.
The direct region (DR) of repeats in the genomes of 39 potential UAE clinical M. tuberculosis complex isolates recovered from TB
patients were PCR-amplified and processed by spoligotyping as described by (Kamerbeek et al., 1997). Briefly, the PCR products
were hybridized to a set of 43 immobilized oligonucleotides-covalently bound to a membrane. The hybridized membrane was detected
using ECL detection fluid following exposure to X-ray film. The lack or presence of spacer signatures were visually observed to
identify isolates. Genomic DNAs extracted from M. tuberculosis H37Rv and M. bovis BCG strains were included as references for the
procedure. Row wells (154-194) extending from top of autograph downwards were filled by PCR products of tested UAE isolates.
The far top two row wells were filled with genomic DNAs of strains H37Rv sand M. bovis BCG. The third row wells from top of
autograph were filled with the Mastermix to act as negative control. M. tub. H37Rv, M. tuberculosis H37Rv; Neg. control, negative
control.
Appendix 11 Spoligotyped families, spoligo-patterns and principle genetic groupings (PGGs)
________________________________________________________________________
Isolate # Missing spacers Spoligo-defined family PGG
73 14-24 and 33-36 T 4 1
170 10-19 and 33-36 T 3 2
169 10-19 and 33-36 T 3 2
161 10-19 and 33-36 T 3 2
150 4-7, 10, 23-24 and 34-37 T 1 1
8 4-7, 23-24 and 34-37 T 1 1
12 4-7, 23-24 and 34-37 T 1 1
145 4-5, 7-8, 10, 17 and 33-36 T 1 2
38 4, 10, 17, 23-24, 29, 33-36 and 39 T 1 2
152 4, 10 and 33-36 T 1 3
25 3-4 and 33-36 T 1 1
65 3, 10 and 33-36 T 1 1
88 3 and 33-36 T 1 3
128 3 and 33-36 T 1 3
98 33-36 and 40 T 1 2
83 33-36 and 40 T 1 2
7 33-36 and 40 T 1 2
55 33-36 and 40 T 1 2
50 33-36 and 40 T 1 2
188 13 and 33-36 T 1 3
163 13 and 33-36 T 1 3
162 13 and 33-36 T 1 3
99 33-36 T 1 3
97 33-36 T 1 3
193 33-36 T 1 2
78 21 and 33-36 T 1 3
77 21 and 33-36 T 1 3
64 1-4, 7-8, 10-12, 16-19, 23-24, 27, 29 and 34 Family33 1
46 10, 23-31 and 33-34 Family33 1
120 4, 7, 10, 27-29, 31 and 33-34 Family33 1
134 8, 10, 17 and 36 Family33 1
47 10, 23-24, 27, 31 and 33-34 Family33 1
36 23-24 and 33-34 Family33 2
82 29-31 and 33-34 Family33 1
186 34 Family33 1
174 34 Family33 1
155 34 Family33 1
102 34 Family33 1
184 Complete pattern Family33 2
182 Complete pattern Family33 1
91 10, 24 and 34 Family33 1
80 10 and 33-34 Family33 1
51 3, 20-21, 30-32 and 34 Family33 1
89 24, 30-32, 34 and 40 Family33 1
129 1-5, 7-8, 10-12, 14-15, 17-21, 27-32, 34-35 and 39-43 EAI2 1
53 4-7, 19, 23, 28-32, 34 and 37 EAI5 1
95 4-7, 23-26, 29-34 and 37-38 EAI5 1
63 2-3, 10, 14-15, 18-21, 27, 29-32, 34-35, 37-39 and 42 EAI3 1
94 2-3, 18-21, 29-32, 34-35 and 37-38 EAI2 1
1 2-3, 19-21, 29-32, 34-35 and 37-38 EAI2 1
44 2-13, 29-32 and 34-43 EAI3 1
179 23, 25-27, 29-34, 37 and 41-42 EAI4 1
147 4, 10, 22-34 and 37 EAI4 1
157 4, 10, 14, 17, 23-24, 27, 29-32, 34 and 37-38 EAI5 1
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84 2-3, 8-10, 22-24, 29-32 and 34 EAI5 1
26 2-3, 8-10, 29-32, 34 and 40-42 EAI5 1
96 24-27, 29-32, 34 and 40 EAI4 1
192 2-3, 29-32 and 34 EAI5 1
189 2-3, 29-32 and 34 EAI5 1
156 23, 29-32 and 34 EAI5 1
100 23-24, 29-32 and 34 EAI5 1
54 29-32, 34 and 40 EAI5 1
27 29-32, 34 and 40 EAI5 1
126 2-3, 7-10, 17, 29-32, 34 and 37-39 EAI3 1
151 2-3, 29-32, 34 and 37-40 EAI3 1
190 2-3, 29-32, 34 and 37-39 EAI3 1
183 2-3, 29-32, 34 and 37-39 EAI3 1
178 2-3, 29-32, 34 and 37-39 EAI3 1
173 2-3, 29-32, 34 and 37-39 EAI3 1
58 1-2, 4-8, 10, 12, 14-15, 17-19, 23-34, 37, 39 and 42 CAS 1
72 4-8, 10-12, 14-15, 17-19, 23-34, 37 and 42-43 CAS 1
137 4-8, 10-12, 14-15, 17-19, 23-34 and 37-43 CAS 1
5 4-13 and 23-34 CAS 1
49 4-13 and 23-34 CAS 1
48 4-13 and 23-34 CAS 1
42 4-13 and 23-34 CAS 2
41 4-13 and 23-34 CAS 2
37 4-13 and 23-34 CAS 2
31 4-13 and 23-34 CAS 1
22 4-13 and 23-34 CAS 1
11 4-13 and 23-34 CAS 1
10 4-13 and 23-34 CAS 1
9 4-10 and 23-34 CAS 1
33 4-10 and 23-34 CAS 1
116 4-10 and 23-34 CAS 1
28 2, 3-7 and 19-34 CAS 1
177 4-7 and 20-35 CAS 1
60 1, 4-7, 10, 23-24, 27-34 and 39 CAS 1
40 1-7, 10 and 23-34 CAS 1
23 1-7 and 23-34 CAS 1
62 4-7 and 22-37 CAS 1
76 4-7, 10 and 23-37 CAS 1
141 4-7, 10 and 23-37 CAS 1
90 4-7 and 23-37 CAS 1
2 4-7 and 23-36 CAS 1
1 4-7 and 23-36 CAS 1
61 4-7, 10, 23-34 and 37-38 CAS 1
52 4-7, 23-27, 29-34 and 37-38 CAS 1
19 4-7, 23-34 and 37-39 CAS 1
43 4-7, 23-34 and 37-39 CAS 1
4 4-7, 23-34 and 37-39 CAS 1
39 4-7, 23-34 and 37-39 CAS 1
21 4-7, 23-34 and 37-39 CAS 1
20 4-7, 23-34 and 37-39 CAS 1
17 4-7, 23-34 and 37-39 CAS 1
16 4-7, 23-34 and 37-39 CAS 1
108 4-7, 23-34 and 37-39 CAS 1
107 4-7, 23-34 and 37-39 CAS 1
106 4-7, 23-34 and 37-39 CAS 1
176 4-7, 13, 15 and 23-34 CAS 1
140 4-7, 10, 17 and 23-34 CAS 1
130 4-7, 10 and 23-34 CAS 1
127 4-7, 10 and 23-34 CAS 1
118 4-7, 10 and 23-34 CAS 1
111 4-7, 10 and 23-34 CAS 1
93 4-7 and 23-34 CAS 1
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35 4-7 and 23-34 CAS 1
29 4-7 and 23-34 CAS 1
112 4-7 and 23-34 CAS 1
113 4-7 and 23-34 CAS 1
114 4-7 and 23-34 CAS 1
115 4-7 and 23-34 CAS 1
158 4-7 and 23-34 CAS 1
166 4-7 and 23-34 CAS 1
180 4-7 and 23-34 CAS 1
181 4-7 and 23-34 CAS 1
32 4-7 and 21-34 CAS 1
56 4-7, 10 and 22-34 CAS 1
103 4-7 and 22-34 CAS 1
172 4-7 and 22-34 CAS 1
171 25-36 Haarlem1 3
30 31, 33-36 and 40 Haarlem3 2
34 31, 33-36 and 40 Haarlem3 2
92 2, 29-31 and 33-36 Haarlem3 2
81 2, 29-31 and 33-36 Haarlem3 2
69 2, 29-31 and 33-36 Haarlem3 2
187 2-3, 31 and 33-36 Haarlem3 2
18 31, 33-36 and 40 Haarlem3 2
110 31, 33-36 and 40 Haarlem3 2
14 1-34 Beijing 1
68 1-34 Beijing 1
86 1-34 Beijing 1
87 1-34 Beijing 1
105 1-34 Beijing 1
139 1-34 Beijing 1
149 1-34 Beijing 1
167 1-34 Beijing 1
24 21-24 and 33-36 LAM9 2
45 2-3, 21-24, 26-31 and 33-39 LAM9 2
85 3, 13, 21-24 and 33-36 LAM2 2
117 13, 21-24, 27 and 33-36 LAM2 2
154 21-24, 27 and 33-36 LAM9 2
160 13, 21-24, 27 and 33-36 LAM9 2
165 21-24, 27 and 33-36 LAM9 2
144 4-40 and 42 LAM7 1
109 7-10, 33 and 39 M. Africanum 1
131 4, 7-10, 33 and 39 M. Africanum 1
133 1-24, 26-29, 33-39 and 42 Family36 2
75 1-24 and 33-36 Family36 2
104 1-24 and 33-36 Family36 2
148 1-24 and 33-36 Family36 2
153 1-24 and 33-36 Family36 2
136 1-24, 27 and 33-36 Family36 2
13 4-12, 18 and 33-36 X3 3
191 9-10 and 33-36 S family 2
74 4-7, 10, 14-36 and 42-43 Family35 1
143 4-7, 10, 14-36 and 42-43 Family35 1
164 3, 9, 16 and 39-43 M. bovis-BCG 1
175 3, 9, 16 and 39-43 M. bovis-BCG 1
122 3, 9-10, 16 and 39-43 M. bovis-BCG 1
124 3, 9-10, 16 and 39-43 M. bovis-BCG 1
66 10, 13, 15-16, 19-21, 33-36 and 39 H37Rv 3
70 10, 13, 15-16, 19-21, 33-36 and 39 H37Rv 3
168 4-7 and 23-43 Family34 1
119 3-10, 15-16, 24-26, 28-37 and 39-43 Unclassified 1
185 8-18, 20, 22-30 and 34-43 Unclassified 1
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Appendix 12 Spoligotyping clusters
Isolate # Missing spacers Spoligo-defined family PGG
170 10-19 and 33-36 T 3 2
169 10-19 and 33-36 T 3 2
161 10-19 and 33-36 T 3 2
8 4-7, 23-24 and 34-37 T 1 1
12 4-7, 23-24 and 34-37 T 1 1
88 3 and 33-36 T 1 3
128 3 and 33-36 T 1 3
98 33-36 and 40 T 1 2
83 33-36 and 40 T 1 2
7 33-36 and 40 T 1 2
55 33-36 and 40 T 1 2
188 13 and 33-36 T 1 3
163 13 and 33-36 T 1 3
162 13 and 33-36 T 1 3
99 33-36 T 1 3
97 33-36 T 1 3
193 33-36 T 1 3
78 21 and 33-36 T 1 2
77 21 and 33-36 T 1 2
186 34 Family33 1
174 34 Family33 1
155 34 Family33 1
102 34 Family33 1
184 Complete pattern Family33 2
182 Complete pattern Family33 1
192 2-3, 29-32 and 34 EAI5 1
189 2-3, 29-32 and 34 EAI5 1
151 2-3, 29-32, 34 and 37-40 EAI3 1
190 2-3, 29-32, 34 and 37-39 EAI3 1
183 2-3, 29-32, 34 and 37-39 EAI3 1
178 2-3, 29-32, 34 and 37-39 EAI3 1
173 2-3, 29-32, 34 and 37-39 EAI3 1
5 4-13 and 23-34 CAS 1
49 4-13 and 23-34 CAS 1
48 4-13 and 23-34 CAS 1
42 4-13 and 23-34 CAS 2
41 4-13 and 23-34 CAS 2
37 4-13 and 23-34 CAS 2
31 4-13 and 23-34 CAS 1
22 4-13 and 23-34 CAS 1
11 4-13 and 23-34 CAS 1
10 4-13 and 23-34 CAS 1
9 4-10 and 23-34 CAS 1
33 4-10 and 23-34 CAS 1
116 4-10 and 23-34 CAS 1
90 4-7 and 23-37 CAS 1
2 4-7 and 23-36 CAS 1
1 4-7 and 23-36 CAS 1
19 4-7, 23-34 and 37-39 CAS 1
43 4-7, 23-34 and 37-39 CAS 1
4 4-7, 23-34 and 37-39 CAS 1
39 4-7, 23-34 and 37-39 CAS 1
21 4-7, 23-34 and 37-39 CAS 1
20 4-7, 23-34 and 37-39 CAS 1
17 4-7, 23-34 and 37-39 CAS 1
16 4-7, 23-34 and 37-39 CAS 1
108 4-7, 23-34 and 37-39 CAS 1
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107 4-7, 23-34 and 37-39 CAS 1
106 4-7, 23-34 and 37-39 CAS 1
130 4-7, 10 and 23-34 CAS 1
127 4-7, 10 and 23-34 CAS 1
118 4-7, 10 and 23-34 CAS 1
111 4-7, 10 and 23-34 CAS 1
93 4-7 and 23-34 CAS 1
35 4-7 and 23-34 CAS 1
29 4-7 and 23-34 CAS 1
112 4-7 and 23-34 CAS 1
113 4-7 and 23-34 CAS 1
114 4-7 and 23-34 CAS 1
115 4-7 and 23-34 CAS 1
158 4-7 and 23-34 CAS 1
166 4-7 and 23-34 CAS 1
180 4-7 and 23-34 CAS 1
181 4-7 and 23-34 CAS 1
30 31, 33-36 and 40 Haarlem3 2
34 31, 33-36 and 40 Haarlem3 2
18 31, 33-36 and 40 Haarlem3 2
110 31, 33-36 and 40 Haarlem3 2
92 2, 29-31 and 33-36 Haarlem3 2
81 2, 29-31 and 33-36 Haarlem3 2
69 2, 29-31 and 33-36 Haarlem3 2
14 1-34 Beijing 1
68 1-34 Beijing 1
86 1-34 Beijing 1
87 1-34 Beijing 1
105 1-34 Beijing 1
139 1-34 Beijing 1
149 1-34 Beijing 1
167 1-34 Beijing 1
117 13, 21-24, 27 and 33-36 LAM2 2
160 13, 21-24, 27 and 33-36 LAM9 2
75 1-24 and 33-36 Family36 2
104 1-24 and 33-36 Family36 2
148 1-24 and 33-36 Family36 2
153 1-24 and 33-36 Family36 2
74 4-7, 10, 14-36 and 42-43 Family35 1
143 4-7, 10, 14-36 and 42-43 Family35 1
164 3, 9, 16 and 39-43 M. bovis-BCG 1
175 3, 9, 16 and 39-43 M. bovis-BCG 1
122 3, 9-10, 16 and 39-43 M. bovis-BCG 1
124 3, 9-10, 16 and 39-43 M. bovis-BCG 1
66 10, 13, 15-16, 19-21, 33-36 and 39 H37Rv 3
70 10, 13, 15-16, 19-21, 33-36 and 39 H37Rv 3
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Appendix 13 Matching of spoligo-clusters with the corresponding MIRU profiles
_____________________________________________________________________
Cluster number Isolate # Spoligo-defined family MIRU profile
1 170 T3 224126113332
169 T3 224126113332
161 T3 224125113332
150 T3 223527244615
2 8 T1 225525153432
12 T1 225532153533
3 88 T1 223125143314
128 T1 223425154124
4 7 T1 323325143423
50 T1 223425153322
55 T1 223325153423
83 T1 225425213432
98 T1 225125213312
5 162 T1 2?????1?333?
163 T1 223325153335
188 T1 224?262?334?
6 97 T1 222225143314
99 T1 222325123314
193 T1 255224113442
7 77 T1 123325123324
78 T1 223425123325
8 102 Family33 225525143523
155 Family33 223426144314
174 Family33 16?12?11?121
186 Family33 26?12?11??31
9 182 Family33 224??61?154?
184 Family33 25??2?1?264?
10 189 EAI5 264328223532
192 EAI5 354326223532
11 27 EAI5 243226223424
54 EAI5 233326243424
12 151 EAI3 244427223434
173 EAI3 263327223434
178 EAI3 264326223334
183 EAI3 265326223434
190 EAI3 263326223534
13 5 CAS 226425153533
313
10 CAS 226425153533
11 CAS 226425153533
22 CAS 224325143423
31 CAS 226415172413
37 CAS 226425173533
41 CAS 226425173533
42 CAS 226425173533
48 CAS 226425173423
49 CAS 226325173433
14 9 CAS 226325143533
33 CAS 223226153423
116 CAS 223427194622
15 76 CAS 223426143227
141 CAS 223525174523
16 1 CAS 254425153535
2 CAS 223326173525
17 4 CAS 226325143523
16 CAS 226525143533
17 CAS 226525143533
19 CAS 234426223414
20 CAS 226425153333
21 CAS 226425153533
39 CAS 226435153533
43 CAS 224525153331
106 CAS 225535154533
107 CAS 224535154433
108 CAS 225535154343
18 111 CAS 224525174423
118 CAS 223525154332
127 CAS 224325154313
130 CAS 224315244413
19 29 CAS 236215113523
35 CAS 224326174423
112 CAS 224525174423
113 CAS 224526174533
114 CAS 224525274513
115 CAS 224525174533
158 CAS 244526154516
166 CAS 225426161543
180 CAS 256425163543
181 CAS 22??2?1?354?
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20 103 CAS 226425153523
172 CAS 224425163543
21 18 Haarlem3 2?4426223533
30 Haarlem3 225425173423
34 Haarlem3 226325113213
110 Haarlem3 226325114333
22 69 Haarlem3 226325113323
81 Haarlem3 227225163323
92 Haarlem3 221325143321
23 14 Beijing 223325153533
68 Beijing 222325163533
86 Beijing 223325163533
87 Beijing 222315163533
105 Beijing 223215153323
139 Beijing 223425155632
149 Beijing 223325163532
167 Beijing 222325173533
24 117 LAM9 224425174236
160 LAM9 22236153332
25 154 LAM9 242326134314
165 LAM9 223417154337
26 75 Family36 124525153534
104 Family36 224326143317
148 Family36 123416144413
153 Family36 223416174313
27 74 Family35 223425133225
143 Family35 244425144314
28 164 M.bovis-BCG 222324153432
175 M.bovis-BCG 252325153322
29 122 M.bovis-BCG 222325153322
124 M.bovis-BCG 222325153321
30 66 H37Rv 233226143221
70 H37Rv 233225143223
?, indicates no amplifictaion products.
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Appendix 14 Prevalence of the most pathogenic M. tuberculosis genotypes in Al Ain
Appendix 15 Hospital-wise distribution of confirmed TB cases among nationals and non-
nationals
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Appendix 16 Reasons for the patient went to clinic/hospital
Appendix 17 Age and sex-wise distribution of TB cases among of national and non-national
patients
Nationals (N = 13) Non-Nationals (N = 10) Combined
Age
Male Male % Femal
e
Female % Male Male % Female Female % Total (N =
23)
<3 0 0.0% 0 0.0% 0 0.0% 0 0.0% 0 0.0%
3 to <
5 2 15.4% 0 0.0% 2 20.0% 0 0.0% 4
17.4
%
5 to <7 3 23.1% 1 7.7% 2 20.0% 0 0.0% 6
26.1
%
7 to <9 1 7.7% 2 15.4% 1 10.0% 1 10.0% 5
21.7
%
9 to
<11 1 7.7% 1 7.7% 1 10.0% 1 10.0% 4
17.4
%
11 to
<13 1 7.7% 1 7.7% 1 10.0% 1 0.7% 4
17.4
%
Total 8 5 7 3 23
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Appendix 18 Age-wise monthly income for nationals
Number and percentages of Nationals with Monthly Salary (UAE Dirhams)
Age
grou
p > 1500 1500-3000 3000-5000
5000-
10000 >10000 N/A* Total % (N=51)
<13 0 0 0 0 0 13 13 25.50%
13 to
<20 0 0 0 0 0 4 4 7.80%
20 to
<30 0 0 0 1 4 2 7 13.70%
30 to
<40 0 0 0 2 5 4 11 21.60%
40 to
<50 0 0 0 0 6 3 9 17.60%
50 to
<60 0 0 0 0 3 2 5 9.80%
60 &
up 0 0 0 0 2 0 2 3.90%
Total 0 0 0 3 20 28 51
* N/A - cases where patient had no direct earning (eg. children) or those who didn’t give
income details
Appendix 19 Previous history of TB in household among national and non-national patients
Family TB history
National
s
%
(N=51)
Non-
National
%
(N=143)
Tota
l
%
(N=194)
History of TB in family or
Household member 19 37.3% 65 45.5% 84 43.3%
If yes, family or
household
member has TB
symptoms 16 31.4% 60 42.0% 76 39.2%
Any screening for TB
done
at home 14 27.5% 37 25.9% 51 26.3%
Any screening procedure
for TB- not known 0 0.0% 8 5.6% 8 4.1%
If screening done, any
member TB +Ve 11 21.6% 22 15.4% 33 17.0%
Appendix 20 Pulmonary and extra-pulmonary disease in national and non-national patients
Type of TB National % (N=51) Non-National
%
(N=143) Total
%
(N=194)
Pulmonary (P) 31 60.8% 101 70.6% 132 68.0%
Extra-pulmonary (EP) 13 25.5% 21 14.7% 34 17.5%
Both (P+EP) 7 13.7% 21 14.7% 28 14.4%
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Total 51 143 194
Appendix 21 Type of cough and duration of cough among national, non-national patients, and
combined
Duratio
n of
cough
(weeks)
National (N=40) Non-National (N=105) Combined (N=145)
Type of cough Type of cough Type of cough
Productiv
e
Non-
productiv
e
Not
Known
Productiv
e
Non-
productiv
e
Not
Known
Productiv
e
Non-
productiv
e
Not
Known
<2 1 2 1 4 7 1 5 9 2
2.5% 5.0% 2.5% 3.8% 6.7% 1.0% 3.4% 6.2% 1.4%
2 to <4
4 6 1 12 11 1 16 17 2
10.0% 15.0% 2.5% 11.4% 10.5% 1.0% 11.0% 11.7% 1.4%
4 to <6 14 7 1 36 20 3 50 27 4
35.0% 17.5% 2.5% 34.3% 19.0% 2.9% 34.5% 18.6% 2.8%
6 and
up
2 1 0 6 4 0 8 5 0
5.0% 2.5% 0.0% 5.7% 3.8% 0.0% 5.5% 3.4% 0.0%
Appendix 22 Colour of sputum among national and non-national patients and combined
presented with productive cough
Type of Sputum Nationals % (N=21) Non-National % (N=58) Total % (N=79)
Clear 1 4.8% 6 10.3% 7 8.9%
White 4 19.0% 8 13.8% 12 15.2%
Yellow 10 47.6% 28 48.3% 38 48.1%
Green 5 23.8% 10 17.2% 15 19.0%
Mixed with blood 1 4.8% 6 10.3% 7 8.9%
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Appendix 23 Chest X-ray and tuberculin skin test investigation results among pulmonary
tuberculosis cases
Appendix 24 Biopsied results in patients with extra-pulmonary disease
Investigation Nationals % (N=20)
Non-
National % (N=42) Total % (N=62)
Biopsy Patients tested 10 50.0% 14 33.3% 24 38.7%
+Ve cases 2 10.0% 7 16.7% 9 14.5%
FNA Patients tested 17 85.0% 37 88.1% 54 87.1%
+Ve cases 17 85.0% 35 83.3% 52 83.9%
TST Patients tested 18 90.0% 37 88.1% 55 88.7%
+Ve cases 11 55.0% 26 61.9% 37 59.7%
AFB Patients tested 20 100.0% 42 100.0% 62 100.0%
+Ve cases 13 65.0% 29 69.0% 42 67.7%
Culture Patients tested 20 100.0% 42 100.0% 62 100.0%
+Ve cases 20 100.0% 42 100.0% 62 100.0%
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Appendix 25 Spoligotyped family strains recovered from patients presenting with cough in Al
Ain
Distribution of families among patients presented with cough. CAS family was found most
prevalent followed by T family.
Appendix 26 Source of medication for those who had previous history of symptoms and chose
to take medication
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